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ABSTRACT OF DISSERATION 
 
 
 
 
UNDERSTANDING THE CHEMICAL GYMNASTICS OF 
ENZYME-CATALYZED 1’-1 AND 1’-3 TRITERPENE LINKAGES 
 
 Squalene synthase (SS) is an essential enzyme in eukaryotic systems 
responsible for an important branch point in isoprenoid metabolism that leads to 
sterol formation. The mechanistic complexity of SS has made it a difficult enzyme 
to study. The green alga Botryococcus braunii race B possesses several 
squalene synthase-like (SSL) enzymes that afford a unique opportunity to study 
the complex mechanism of triterpene biosynthesis. SSL-1 catalyzes presqualene 
diphosphate (PSPP) formation, which can either be converted to squalene by 
SSL-2 or botryococcene by SSL-3. A rationally designed mutant study of B. 
braunii squalene synthase (BbSS) and SSL-3 was conducted to understand 
structure-function relations among these enzymes. These studies revealed two 
amino acid positions in SSL-3 (N171, G207) that appeared to control 1’-3 versus 
1’-1 linkages. The reciprocal mutations in the corresponding positions of BbSS 
did not convert this enzyme into a botryococcene synthase. 
Next, a genetic selection was developed to evolve SSL enzymes towards 
a fully functional SS. Previous studies have shown that Saccharomyces 
cerevisiae squalene synthase (ScSS) can be knocked out and although lethal, 
growth can be restored by providing an exogenous source of ergosterol. 
Additional studies have shown that successful complementation of the ScSS 
knockout with a non-fungal SS is possible but requires a fungal SS carboxy-
terminus region. Given these observations, proof-of-principle experiments were 
conducted to demonstrate that SSL-SSL fusion enzymes could complement the 
ScSS knockout followed by construction of a mutant SSL-SSL fusion enzyme 
library that was screened in the ScSS knockout yeast line. From this library, 
mutant SSL-SSL fusion enzymes were identified that were able to complement, 
which demonstrated the feasibility of this approach as a genetic selection for 
mutant SSL enzymes. 
Squalene and botryococcene have valuable industrial applications in 
vaccine adjuvant formations, cosmetic products, and renewable energy 
feedstock material. Limitations in natural sources of these molecules have made 
heterologous production of them an important research target. Algae represent a 
 desirable group of organisms that could be engineered to produce these 
metabolites because they are photosynthetic and capable of using non-arable 
farmland. The feasibility, approach, and progress for engineering green algae to 
produce squalene and botryococcene are discussed. 
 
KEYWORDS: triterpene synthase, structure-function map, directed evolution, 
metabolic engineering, green algae 
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Chapter One: Background and Introduction 
 
Part One: Triterpene Synthases 
 
Terpenoids represent a diverse class of naturally occurring molecules that 
have potential for applications as nutraceuticals,1 pharmaceuticals,2 and 
renewable fuels.3 These hydrocarbon molecules are found naturally intertwined 
with all aspects of life from essential primary metabolic functions in all eukaryotic 
organisms,4,5 to more specialized roles specific to only certain species (Figure 
1.1).6 Triterpenes are a distinct subclass composed of six isoprene units (30 
carbons) that arise from the joining of two molecules of farnesyl diphosphate 
(FPP); some very fundamental triterpenes are squalene, dehydrosqualene and 
botryococcene. The enzymes that catalyze the formation of these triterpene 
molecules are intriguing purely for the biochemical feats they catalyze and the 
evolutionary paths that gave rise to their development. Because these enzymes 
hold potential pharmacological applications (squalene and dehydrosqualene 
synthases) and their reaction products have a multitude of industrial uses 
(biofuels, cosmetics), squalene synthases and squalene synthase-like enzymes 
are attractive research targets. 
Squalene and dehydrosqualene are similarly linked 1’-1 molecules 
differing only in the presence of a double bond at the 1’-1 linkage in 
dehydrosqualene (Figure 1.2). They are investigated extensively because of 
their medical relevance to cholesterol formation in humans7 and virulence factor 
formation in Staphylococcus aureus,8 respectively. Botryococcene possesses a 
more unusual 1’-3 linkage between the two farnesyl chains9 making it more 
branched than squalene and dehydrosqualene. Botryococcene and its 
methylated derivatives are made efficiently by the extant green alga 
Botryococcus braunii race B and hold great potential as a renewable energy 
feedstock.9 These molecules are known to have contributed to current oil and 
coal shale deposits around the globe.10–12 Oil produced and extracted from B. 
braunii can be used to produce liquid fuels that are compatible with modern 
combustion engines and the currently available infrastructure for refining, 
storage, and transport.13,14 Squalene-containing oil produces high-value fuels 
from hydrocracking and distillation as well.15 Given the structural similarities of 
dehydrosqualene with squalene and botryococcene, it too would appear to be 
suitable for these purposes.   
Formation of these molecules has been studied synthetically16,17 and 
biosynthetically, with greater attention to the latter because of the chemical 
complexity associated with the biosynthetic reaction. Squalene biosynthesis has 
been shown to proceed through a two-step reaction mechanism in which the first 
step consists of a head-to-head condensation of two farnesyl diphosphate (FPP) 
molecules to form the stable cyclopropyl intermediate, presqualene diphosphate 
(PSPP) (Figure 1.2).18 In the second step, PSPP undergoes a reductive 
rearrangement in the presence of NADPH to yield squalene that possesses a 1’-
1 linkage between the two farnesyl moieties.19 A divalent cation such as Mg2+ is 
required for this mechanism, which appears to bridge the allylic diphosphate 
	   2 
 
Figure 1.1 Terpenoid diversity that arises from the five-carbon isoprenoid 
building blocks, isopentenyl diphosphate (IPP) and dimethylallyl diphosphate 
(DMAPP), generated by various modifications such as successive condensation 
of the allylic diphosphates themselves, dephosphorylation, cyclization, 
desaturation, reduction, oxidation, and hydroxylation.20,21 
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Figure 1.2 Biosynthesis of triterpenes from farnesyl diphosphate (FPP). Two 
molecules of FPP are joined to form the cyclopropyl intermediate presqualene 
diphosphate (PSPP) in the first step of the reaction.22 This is followed by a 
reductive rearrangement of PSPP to yield squalene, reductive cleavage of PSPP 
to yield botryococcene, or PSPP rearrangement to yield dehydrosqualene in the 
second-step reaction.23,24 
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with an aspartate-rich region near the opening of the active site in crystal 
structures.25,26 Other metal cofactors such as Mn2+ have been reported to 
substitute for Mg2+ but are less efficient (kcat = 3.3 s-1 with Mg2+ vs. 0.4 s-1 with 
Mn2+).27 Formation of dehydrosqualene occurs through a similar mechanism 
where the first reaction step proceeds via PSPP that is subsequently rearranged 
in the second step to yield an unsaturated 1’-1 linkage.23,24 Huang and Poulter 
(1989) suggested that because of its structural similarity to squalene, 
botryococcene biosynthesis could also occur via an analogous reaction 
mechanism with the initial reaction proceeding through PSPP, followed by a 
reductive cleavage between the 1’-2 bond of the cyclopropyl ring to yield the 
ethyl branch in the 1’-3 linked botryococcene product.28 
Squalene synthase genes have been isolated from a wide range of 
eukaryotic organisms including mammals, plants, and fungi. Interestingly, several 
amino acid sequences within functionally characterized squalene synthases are 
highly conserved across genera and even kingdoms, and ultimately have been 
correlated with particular steps in the squalene synthase reaction mechanism. 
For instance, Robinson et al. (1993) identified six domains based on sequence 
comparisons between fungal and animal squalene synthases and phytoene 
synthases from plants.29 Phytoene synthases catalyze the condensation of two 
C20 prenyl diphosphate intermediates, geranylgeranyl diphosphate (GGPP) to 
the C40 product phytoene, which like squalene, dehydrosqualene and 
botryococcene occurs via a cyclopropyl intermediate. The importance of these 
conserved domains was revealed when they were shown to line the interior 
surface of the putative active site pocket in the human squalene synthase (HsSS) 
crystal structure solved by Pandit et al. (2000).30 Gu et al. (1998) functionally 
defined the analogous domains to be associated with either the first and/or 
second step reactions based on site-directed mutations that altered or eliminated 
catalytic activities in the rat enzyme.31  
Enzymes responsible for dehydrosqualene and botryococcene formation 
have also been identified and characterized. The Götz laboratory has reported 
the successful identification and characterization of the enzymes contributing to 
staphyloxanthin formation in S. aureus.32,33 The S. aureus dehydrosqualene 
synthase (CrtM) was originally identified by screening a chromosomal DNA 
library in S. camosus, an unpigmented strain, for clones that caused 
yellow/orange coloration. Restriction mapping and sequencing of positive clones 
led to the deduced coding sequence for CrtM that was verified for activity and 
dehydrosqualene production with an in vitro enzyme assay.33  
Efforts in the Chappell laboratory were directed towards the isolation of 
genes coding for botryococcene synthase enzyme activity by focusing on the 
isolation of squalene synthase and squalene synthase-like genes from B. braunii, 
followed by biochemical characterization using in vitro and in vivo assessments. 
Various techniques were used to obtain candidate genes for B. braunii squalene 
synthase (BbSS) and the squalene synthase-like (SSL) enzymes including 
degenerate oligonucleotides, radiolabeled cDNA probes, and transcriptome 
sequencing.34–36 Collectively, this work led to the isolation and characterization of 
BbSS and three SSL enzymes (SSL-1, SSL-2, and SSL-3). Unexpectedly, 
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Niehaus et al. (2011) found that the SSL enzymes accomplish squalene and 
botryococcene biosynthesis through the activity of two pairs of these three SSL 
enzymes – SSL-1 and SSL-2 catalyze squalene biosynthesis while SSL-1 and 
SSL-3 form botryococcene.36 This was surprising because up to that time, no 
enzymes were known that catalyzed only one step of triterpene biosynthesis. 
Protein sequence alignments of squalene synthases from different kingdoms, the 
B. braunii triterpene synthases, and S. aureus CrtM are shown in Figure 1.3 with 
important regions denoted. 
Recent crystallographic studies of CrtM and HsSS solved with various 
substrates and inhibitors revealed the structure-function relationship in these 
enzymes. CrtM structures solved by Lin et al. (2010) with an unreactive thio-FPP 
analog and the stable intermediate PSPP have demonstrated that the 48DDxxD52 
motif (S1 site) acts as the prenyl donor site where diphosphate ionization occurs 
while the 172DxxED176 motif (S2 site) acts as the prenyl acceptor (Figure 1.4).26 
CrtM structures solved with PSPP in the active site showed the diphosphate 
moiety bound to the S1 site. This result suggested that after PSPP formation, the 
diphosphate relocated from the S2 to the S1 site where the second ionization 
could occur to initiate the second-step reaction of dehydrosqualene formation. 
More recent crystallographic studies with HsSS by Liu et al. (2014) corroborated 
the contention that the S1 and S2 sites were the prenyl donor and acceptor sites, 
respectively.25 Furthermore, Liu et al. (2014) also proposed a substrate-binding 
order based on their crystallographic studies and observations made from 
previous kinetic studies – the S2 site binds the first FPP molecule followed by 
binding of the second FPP in the S1 site.25,37 An important difference in the CrtM 
and HsSS structures obtained was noted wherein after PSPP formation, the 
diphosphate of PSPP does not appear to relocate to the S1 site in HsSS. Only 
when HsSS Y73A was solved with Mn2+ and PSPP was it observed that the 
diphosphate of PSPP shifted from the S2 to S1 site. Liu et al. (2014) suggested 
this was a result of the additional flexibility of the active site pocket near the S1 
substrate-binding site provided by the Y73A mutation. They hypothesized that in 
the wild-type HsSS enzyme, the S2 to S1 shift occurs but only when NADPH is 
bound to cause a conformational change. HsSS structures with NADP+ or its 
analogues were unable to be obtained as part of these studies. Interesting to 
note is an observation made where in vitro incubations of squalene synthase with 
Mn2+ in the absence of NADPH resulted in dehydrosqualene as the dominant 
reaction product.24 
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Figure 1.3 ClustalW multiple sequence alignment (gap penalty: 22 and gap 
length penalty: 0.75) of triterpene synthases. Areas boxed in red represent 
conserved regions of the triterpene synthases thought to line the active site 
pocket and/or contribute to enzymatic activity. Homo sapiens squalene synthase 
(HsSS), Nicotiana tabacum squalene synthase (NtSS), Saccharomyces 
cerevisiae squalene synthase (ScSS), Botryococcus braunii squalene synthase 
(BbSS), Botryococcus braunii squalene synthase-like (SSL-1, SSL-2, SSL-3), 
Staphylococcus aureus dehydrosqualene synthase (CrtM). 
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Figure 1.4 Similarities between CrtM and HsSS crystal structures solved with the 
unreactive substrate analogue farnesyl thiodiphosphate (FSPP) and the stable 
intermediate PSPP.25,26 FSPP substrate colored in pink resides in the S1 site; 
green FSPP is located in the S2 site. Prenyl substrates are positioned generally 
similar in both active sites; note the differences between locations of Mg2+ ions 
(CrtM – yellow spheres, HsSS – blue spheres) suggested to be a result of 
differences in the second-step reaction for these enzymes. 
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Understanding triterpene synthases at the molecular level has important 
implications for the development of small molecules that inhibit enzyme activities. 
The Oldfield laboratory has investigated and been successful in using inhibitors 
that target both dehydrosqualene synthase and squalene synthase (dual-target 
treatment) for controlling S. aureus infection by 1) inhibiting dehydrosqualene 
synthase, an important enzyme in the staphyloxanthin biosynthetic pathway, and 
2) increasing host innate immunity by inhibition of squalene synthase which 
promotes formation of neutrophil extra-cellular traps (NETs).38 Knowledge of the 
crystal structures for these enzymes coupled with in silico screening of small 
molecule libraries allowed identification of candidate inhibitors that were rationally 
modified with the goal of improving their therapeutic index, a measure that takes 
into account how effective a given inhibitor is as a dual-target treatment. 
Empirical tests of the modified inhibitors demonstrated the success of this 
approach with a ~100-fold increase in the so-called therapeutic index (TI). With 
increasing incidence of S. aureus related deaths and antibiotic resistance on the 
rise, such knowledge will continue to pay dividends. 
Alternatively, a molecular understanding of these enzymes might enable 
mutant enzymes to be created with improvements in catalytic efficiency or with 
novel activities. While mutant enzymes often have lower catalytic efficiencies 
than their wild-type counterparts, creating mutant enzymes that produce 
alternative products is not uncommon.39 For example, studies with the 
sesquiterpene cyclase, epi-isozizaene synthase (EIZS) defined a single amino 
acid mutation that resulted in a 100-fold decrease in catalytic efficiency 
compared to wild type, but yielded a new product, β-curcumene which can be 
hydrogenated to produce bisabolane, a potential biofuel. While a bisabolene 
synthase is known, the mutant EIZS catalyzes the bisabolane precursor 68-fold 
more efficiently.39 Subjecting the mutant EIZS to subsequent mutations could 
improve β-curcumene production by either promoting higher product specificity 
for β-curcumene or increasing catalytic efficiency. Enzymatic improvements such 
as these could be important for metabolic engineering efforts aimed at increasing 
product accumulation levels of these desirable compounds in heterologous 
hosts.  
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Part Two: Triterpene Metabolic Engineering 
 
World population is projected to reach 9.6 billion people by 2050.40 Natural 
resource consumption increases are sure to follow. Among these resources, 
liquid fuels rank at the top of the list in relation to coal and natural gas usage 
(Figure 1.5) (EIA, 2011). Speculatively, demand for these liquid fuels is unlikely 
to ever wane. Large construction projects will always be dependent upon diesel-
powered, heavy machinery as just one example. Moreover, the massive 
transportation fuel infrastructure currently available is designed around 
hydrocarbon-based liquid fuels. Rather than develop and implement new fuel 
sources such as hydrogen gas and the necessary infrastructure to support it, a 
sustainable means to produce renewable hydrocarbon fuels would be highly 
desirable.  
The triterpenoids biosynthesized by the extant green alga Botryococcus 
braunii race B are suggested to have contributed to current day coal10 and oil11 
shales. Additionally, it has been shown that they are an excellent feedstock for 
the hydrocracking process already used to produce liquid transportation fuels.14 
However, the slow growth rate of B. braunii has hampered the mass culture of 
this alga for production of large amounts of the triterpenoids. To circumvent this 
problem, the genetic blueprint has been investigated with the intention to 
mobilize and deploy it in alternative hosts for robust production of these valuable 
products. As already discussed, genes that catalyze botryococcene have been 
characterized and even shown to be functional in bacteria, fungi, and higher plant 
hosts for producing botryococcene. While these demonstrations are all critically 
important in the overall goal of renewable energy production platforms, other 
systems such as algae need to be evaluated. 
Algae are a polyphyletic group of water dwelling, eukaryotic single and 
multicellular organisms with diverse morphological, physiological, and 
biochemical features. Similar to plants, algae fix carbon dioxide through 
photosynthesis that can ultimately be directed to the biosynthesis of numerous 
down-stream products such as triacylglycerides, starch, and terpenoids. Mass 
algae cultures have been proposed as a means for production of large amounts 
of terpenoids and other high value chemical targets that are useful in 
nutraceutical,1 pharmaceutical,2 and renewable fuel3 applications without 
competing for arable farmland used in food production. Algae can achieve higher 
cellular densities than plants enabling them to produce more compound per 
given unit of land area.41 Several species are already cultivated on a large scale 
for the production of tetraterpene carotenoids with useful antioxidant and 
pigmentation properties, and others such as Botryococcus braunii race B are 
under consideration for renewable fuel production.42,43 Higher titers for these 
terpenoids and other products are always desirable, and metabolic engineering 
offers one route to accomplish this goal.41,44 Currently, no single alga can be 
labeled as superior for metabolic engineering in general or for terpenoid 
engineering in particular. However, from a biotechnological point of view 
Chlamydomonas reinhardtii presents the best opportunities because; 1) a large  
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Figure 1.5 World total energy consumption by fuel type according to EIA as of 
2011. 
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number of engineering tools have been developed for this alga; 2) it is the best 
studied alga ‘omically,’ physiologically, and biochemically; and 3) anecdotally, it 
is the alga where the most effort to engineer terpenoid biosynthesis has 
occurred. 
Two pathways produce the C5 isoprenoid building block isopentenyl 
diphosphate (IPP): the mevalonate (MVA) pathway and methyl erythritol 
phosphate (MEP) pathway (Figure 1.6). In the green algal lineage (Chlorophyta), 
C. reinhardtii and other members are known to possess only the MEP pathway 
based on biochemical studies where labeling patterns of terpenoid products were 
examined and shown to be specific for only MEP-derived isoprenoids.45 Other 
studies that computationally analyzed green algal genomes for the presence of 
MVA pathway related genes demonstrated their absence.46,47 Higher plants 
however, are well documented to possess both pathways.48,49 The MVA pathway 
operates in the cytoplasm and is dedicated to terpenoids derived from the C15 
intermediate FPP. These include sterols, dolichols (for glycosylation reactions) 
and substrates for protein prenylation. The MEP pathway operates exclusively in 
the chloroplast and is solely responsible for monoterpenoid, diterpenoid and 
carotenoid biosynthetic precursors. Work in the Chappell laboratory has 
assessed the efficiency of novel terpene biosynthesis and accumulation in 
transgenic plants via these two pathways by directing the relevant enzymes to 
the cytoplasm versus the chloroplast compartments.50,51 This was accomplished 
by introducing the respective genes into the nuclear genome with and without 
chloroplast targeting signal sequences appended to the 5’ ends of the 
corresponding genes and then chemically profiling the resulting transgenic lines. 
Building a new metabolic channel for diverting IPP from the MEP pathway in the 
chloroplast into sesquiterpenoids and triterpenoids has generally been the most 
successful approach in higher plants. 
A similar comparison in algae should be possible despite known 
differences in terpene metabolism between green algae and higher plants. 
Information regarding the flux of carbon from this pathway into the cytosolic 
compartment is scant. Whether the algal MEP pathway has the capacity to 
support additional isoprenoid biosynthesis, either in the cytoplasm or in the 
chloroplast, remains to be determined. Thus, a study in green algae whereby 
triterpene synthases are targeted to either the cytosol or chloroplast 
compartments would be informative not only for the ability of these algae to 
produce hydrocarbon molecules that would be useful as renewable energy 
sources, but also for information as to how these algae may be regulating carbon 
flux through the MEP pathway. 
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Figure 1.6 Generic depiction of plant and green algae cells showing locales of 
the MVA and MEP pathways and products that typically arise from them.  
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Aims of Dissertation 
 
Two over-arching objectives of the current work were to 1) unravel the 
biochemical features dictating the catalytic outcomes of squalene synthase 
versus botryococcene synthase and 2) engineer novel biosynthetic capacity for 
triterpene production into Chlamydomonas reinhardtii. Accomplishing these aims 
utilized various molecular manipulation techniques and the incredible body of 
knowledge generated over the past five decades. 
Chapter 2 focuses on enzymological studies of B. braunii squalene 
synthase and squalene synthase-like enzymes in order to dissect the molecular 
features that promote their various catalytic specificities. Techniques used to 
accomplish this work include rational design of mutants guided by protein 
sequence alignments and three-dimensional homology models. Individual 
mutants were made and tested for changes in substrate and product specificities 
with an in vitro assay (bacterial expressed protein), followed by in vivo chemical 
profiling (expression in E. coli line that makes additional FPP) for mutants of 
interest. A mutant SSL-3 enzyme is described that has been altered in its product 
specificity. 
Building on efforts described in Chapter 2 for rationally designed 
mutagenesis, Chapter 3 describes a more unbiased approach to understanding 
the structure-function maps of SS and SSL enzymes. In this work, 
Saccharomyces cerevisiae that contains a squalene synthase deletion was used 
to demonstrate how the SSL enzymes are capable of complementing. A mutant 
library was subsequently constructed and selected for mutants that were able to 
complement. Proof-of-principle was described for future studies aimed at 
evolving single SSL enzymes toward becoming a fully functional squalene 
synthase.   
 Production of squalene and botryococcene has been implicated as one 
avenue to supply renewable liquid transportation fuels. Chapter 4 will focus on 
metabolic engineering efforts in Chlamydomonas reinhardtii to determine the 
most efficient means for engineering triterpene metabolism in algae. Nuclear 
transgene expression in algae is neither well established nor have any 
appreciable reports been published for algae metabolically engineered for high-
level accumulation of triterpenoids. This chapter will discuss these issues and lay 
out an approach for how triterpene metabolism might be manipulated in C. 
reinhardtii. 
 
 
 
 
 
 
 
 
 
Copyright © Stephen A. Bell 2014 
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Chapter Two: Understanding the Mechanistic Specificity Between 1’-1 and 1’-3 
Triterpene Linkages Catalyzed by Squalene Synthase versus Botryococcene 
Synthase 
 
Background and Introduction 
Squalene is a thirty carbon, acyclic, branched chain composed of six 
isoprene units. It is an important precursor of sterols in eukaryotes and 
hopanoids in prokaryotes that play critical roles in a variety of cellular functions 
as well as membrane physical properties.52,53 Enzyme mediated catalysis of 
squalene occurs via a two-step reaction by an enzyme known as squalene 
synthase. Multiple groups have described the same mechanism for squalene 
synthase isolated from yeast, rat, and human.23,30,31,54 Briefly, the proposed 
mechanism proceeds as two steps within the same active site where two 
molecules of farnesyl diphosphate (FPP) are joined in a head-to-head coupling 
(Figure 2.1). Presqualene diphosphate (PSPP) is generated during the first 
reaction step as a stable, cyclopropyl intermediate in an NADPH independent 
fashion.18,55 It remains in the active site where, in the presence of NADPH, it is 
reductively rearranged to give the final 1’-1 linked, symmetrical squalene 
molecule.19,23,24 Normally, squalene is the sole product observed when squalene 
synthase is incubated with NADPH and FPP. In the absence of NADPH with 
prolonged incubation times, however, squalene synthase is known to generate 
various 1’-1 and 1’-3 linked solvolytic products.24,56 
Kinetic analyses performed with Saccharomyces cerevisiae squalene 
synthase (ScSS)19,23,24,54 and detailed crystallographic studies of Homo sapiens 
squalene synthase (HsSS)30,57 and Staphylococcus aureus dehydrosqualene 
synthase (CrtM)26 provide insights into how FPP is bound to this enzyme and 
subsequently catalyzed to squalene. However, much less is known about 
residues that are catalytically important beyond the aspartate-rich (DxxED) 
motifs.31 Robinson et al. (1993) predicted that the five conserved domains among 
squalene synthases are likely helices that line the active-site pocket;29 this claim 
has since been confirmed by structural evidence.30,57 Defined roles of these 
domains with respect to their involvement in diphosphate ionization, NADPH 
binding, substrate orientation and product specificity has not been described 
empirically. A detailed map of the residue(s) important for the first, second, or 
both reaction steps that correlates with kinetic and structural data is still needed. 
Therefore, we set out to map those residues important for one discrete catalytic 
function with these synthases using an activity interconversion strategy exploiting 
uniquely characterized triterpene synthases from an alga. 
Botryococcene, a structural analog of squalene, is produced in copious 
amounts by the green alga Botryococcus braunii race B.9 Due to structural 
similarities between botryococcene and squalene, botryococcene was predicted 
to arise via a squalene synthase-like reaction that proceeds through PSPP.58 
However, instead of the final 1’-1 linkage for squalene, a more branched, 1’-3 
asymmetrical linkage between the two prenyl chains is observed for 
botryococcene (Figure 2.1).28,59,60 
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Figure 2.1 Proposed reaction cascade for enzyme-catalyzed squalene and 
botryococcene formation. First-step reaction occurs where two molecules of FPP 
(black) are joined to form the stable intermediate PSPP (purple). Subsequently, in 
the presence of NADPH, a reductive rearrangement occurs during the second-
step reaction to yield either squalene (red) or botryococcene (blue). Proton 
positions are reported as described by Huang and Poulter (1989).28    
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Recently, the biochemical pathway responsible for the formation of 
botryococcene was elucidated by Niehaus et al. (2011). Two distinct squalene 
synthase-like enzymes (SSL-1 and SSL-3) were found to be responsible for the 
two reaction steps of botryococcene biosynthesis, as opposed to the single 
polypeptide that was originally hypothesized.36,59,35 This report capitalized on 
previous efforts to identify and characterize enzymes35,61 that contribute to the 
ability of B. braunii to accumulate ~30% of its biomass in hydrocarbon oils.62  
The biochemistry in B. braunii as described by Niehaus et al. (2011) has 
not been definitively demonstrated, as key experiments like SSL gene knockouts 
needed for proof have been hampered by a lack in methodology for genetic 
transformation. Nonetheless, the SSL enzymes present an interesting opportunity 
to aid in the identification of residues responsible for the first- and second-step 
reaction activities of squalene and botryococcene biosynthesis. By exploiting 
these enzymes, we proposed to either introduce reaction activities (i.e., introduce 
second-step reaction capability into SSL-1) or interconvert product specificities 
between enzymes (i.e., convert BbSS product specificity to botryococcene) in 
order to map functional residues and/or domains. To identify catalytically 
important residues, protein sequence alignments were examined in concert with 
three-dimensional models generated by threading the B. braunii enzymes onto 
previously determined crystal structures for squalene synthase30,57 and 
dehydrosqualene synthase26 (Figure 2.2). Residues differing in the highly 
conserved domains were substituted to match the enzyme in which we wanted to 
introduce a new activity. In vitro assays were subsequently used to screen for 
mutant enzyme activities, followed by in vivo characterization achieved by 
heterologous expression and chemical profiling of the triterpene products 
accumulating in bacterial cultures. Of the mutants that were rationally designed, 
constructed and tested, residues N171 and G207 of SSL-3 were identified from 
this approach and appeared to play a role in controlling product specificity of this 
enzyme whereas the corresponding residues in BbSS, A177 and Q213, were 
probably necessary but not sufficient for squalene product specificity. 
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Figure 2.2 Strategy for identification of residues controlling first- and second-step 
reaction activity and product specificity in triterpene synthases. Simplified 
biosynthetic pathway for squalene and botryococcene is depicted for the first- 
and second-step reactions and the enzymes responsible (A). Map of domain 
organization for a triterpene synthase and protein sequence alignment of the 
corresponding regions I-IV. Underlined positions denote regions of SSL-3 and 
SSL-1 that were significantly different than the squalene synthase enzymes and 
hypothesized to contribute to their lack of first- or second-step reaction 
specificities, respectively (B). Crystal structure of HsSS (PDB 3VJ8) and 3D 
models of BbSS and SSL-3 with PSPP docked in the active site. Residues 
highlighted in pink represented positions that were interchanged between BbSS 
and SSL-3 that control product specificity in SSL-3 (C). Abbreviations: farnesyl 
diphosphate (FPP); presqualene diphosphate (PSPP); transmembrane domain 
(TMD); Homo sapiens squalene synthase (HsSS); Rattus norvegicus squalene 
synthase (RnSS); Nicotiana tabacum squalene synthase (NtSS); Saccharomyces 
cerevisiae squalene synthase (ScSS); Chlamydomonas reinhardtii squalene 
synthase (CrSS); Botryococcus braunii squalene synthase (BbSS); squalene 
synthase-like (SSL). 
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Results 
 
Identification of candidate residues for mutation. Amino acid positions 
chosen for mutagenesis were based on several fundamental characteristics. 
First, the residues needed to be present within domains I-IV of the protein 
sequence (Figure 2.2B) with their R-group positioned into the active site where 
interaction with the substrate could occur (Figure 2.2C). ClustalW sequence 
alignments of squalene synthases from various kingdoms along with the B. 
braunii triterpene synthases were analyzed in the first step to identify candidate 
residues. Positions differing in these regions were analyzed in a second step 
using 3D models generated with MODELLER 9v8.63 Originally, our B. braunii 
triterpene synthases were threaded onto the HsSS structure (PDB 1EZF), which 
was solved at a resolution of 2.15Å.30 Other higher resolution structures have 
since been published for HsSS (PDB 3VJ8) as well as structures for CrtM (PDB 
3ADZ, 2ZCO).26,57 We used these structures to generate additional threaded 
models of the B. braunii triterpene synthases to obtain the highest quality models 
possible with no significant differences observed between any of the models.  
Rationale for in vitro activity screening of wild-type and mutant triterpene 
synthases. Because BbSS is a bifunctional enzyme that can catalyze 
predominantly PSPP or squalene given the appropriate assay conditions, we 
desired to assay both reaction step capabilities for all mutants because of the 
possibility one reaction step or the other may have been introduced or altered. 
However, our assay only detects hexane extractable products from the second-
step reaction of these enzymes so a mutant BbSS enzyme compromised in 
catalyzing PSPP but still capable of second-step reaction activity would be 
overlooked because we provide only FPP as a substrate. Another possibility 
exists where a mutant BbSS has lost second-step reaction capability but still 
produces PSPP not detectable by our assay causing more valuable information 
to go unseen. To overcome these technicalities, we chose to perform co-
incubations with either SSL-1 (to provide PSPP) or SSL-3 (to convert PSPP to 
botryococcene) rather than attempting arduous synthetic means to produce 
enough PSPP for use as substrate in second-step reaction assays or labor 
intensive, time consuming extractions of PSPP followed by dephosphorylation to 
assay for first-step reaction capability. Although all of these techniques have 
been documented,36,64 we felt the most direct means to screen mutants for both 
reaction step activities would be a co-incubation or coupled assay approach 
(Figure 2.3). An important caveat of these assays is the use of bacterially 
expressed proteins. Despite standardization of expression technique, variation in 
assay results was always possible between experiments. Therefore, control 
constructs were always expressed and assayed in parallel with mutants to allow 
for normalization across experiments. 
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Figure 2.3. Coupled assay approach to screen mutant triterpene synthases for 
the first, second, and both steps of the squalene/botryococcene synthase 
reactions. Wild-type and mutant enzymes are over-expressed in bacteria 
followed by cell lysis via sonication and centrifugation to clear lysate (A). The 
crude extract is subsequently used in a series of assays as illustrated in (B) to 
assay for the given enzyme’s ability to catalyze either the first, second or both 
steps of the reaction. Schematic depiction of radiolabeled substrate based 
activity assay for triterpene synthases. 3H-FPP is incubated with enzyme(s) 
followed by hexane extraction. TLC is used to separate extractable products and 
the zones corresponding to botryococcene and squalene (boxed areas) are 
scraped from TLC plate and analyzed by scintillation spectroscopy (C). 
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Overexpression of key MEP pathway biosynthetic genes in E. coli. For 
verification of in vitro assay results obtained for mutant triterpene synthases in 
this study, an in vivo system in E. coli was developed because it would be 
compatible with pET28a expression vectors that already contained mutant 
enzyme sequences. The approach was to overexpress key MEP biosynthetic 
genes responsible for supplying the five-carbon building blocks of isoprenoid 
biosynthesis: IPP and DMAPP. pSB1:operon3 was constructed to encode a 
synthetic operon containing 1-deoxy-D-xylulose-5-phosphate synthase (DXS), 
isopentenyl diphosphate isomerase (idi), and farnesyl diphosphate synthase 
(FPS) under control of a lactose inducible promoter (plac). To prove that the 
system was functional as well as examine if DXS, idi, or FPS contributed more 
carbon flux into squalene, each enzyme of the operon was expressed individually 
with BbSS (Figure 2.4). No background levels of squalene were observed with 
empty vectors (pSB1 + pET28a) or pSB1 expressing operon 3; BbSS expressed 
alone, however, did accumulate squalene. BbSS expressed individually with 
DXS, idi, or FPS did not accumulate additional squalene in comparison to BbSS 
only. Squalene titers were highest only when the entire operon 3 was expressed 
with BbSS. 
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Figure 2.4 In vivo determinations for which of four enzymes affects carbon flux 
into squalene in E. coli BL21 (DE3).  Constructs used for study: plac, lac 
promoter in pSB1 vector; DXS, 1-deoxy-D-xylulose 5-phosphate synthase; idi, 
isopentenyl diphosphate isomerase; FPS, farnesyl diphosphate synthase; operon 
3, operon containing DXS, idi, and FPS; T7P, T7 promoter in pET28a vector; 
BbSS, Botryococcus braunii squalene synthase (A). Constructs described in (A) 
were expressed in BL21 for 24 hours followed by lysis with acetone, hexane 
extraction, and GC-MS product profiling. Results are representative of three 
biological replicates from three independent experiments (n=3) (B). 
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Triterpene synthase permutations. Efforts were undertaken throughout the 
course of this work to swap all combinations of domains between BbSS and 
SSL-1 (very early effort; M1-M16 mutants), BbSS and SSL-3 (M2 series), and 
SSL-1 and SSL-3 (M6 series) based on the conserved domains as defined in 
Figure 2.2B. These three series of permutations containing 16 mutants each (4 
domains, 2 enzymes = 42 = 16 mutants) yielded enzymes that were not 
catalytically active and expressed poorly in E. coli (data not shown). The poor 
results led us to focus on the site-directed mutations described in the sections to 
follow. 
M1 series mutants. Initial mutants were constructed based on differences 
in domain II of BbSS and SSL-3. This region exhibits high sequence homology 
between all squalene synthases, including SSL-1 and SSL-2, but harbors 
considerable differences in the corresponding area of SSL-3 (Figure 2.2B, 
underlined sequence). Therefore, this region was proposed to be responsible for 
mediating product specificity for squalene or botryococcene in BbSS and SSL-3, 
respectively. The M1 series mutants were constructed in domain II of the BbSS 
backbone because these mutations would interconvert product specificity from 
squalene to botryococcene. Eight mutants were made containing various 
mutation(s) based on corresponding differences in the same position for SSL-3 
(Figure 2.5). In vitro assay results suggested that BbSS A177 was critical in the 
first-step reaction activity based on results for M1-6 – no squalene synthase 
activity was detected in the mutant-only assays, but was recovered when co-
incubated with SSL-1, which provides PSPP. Botryococcene was not detected in 
any mutant assessments suggesting none of the mutations made in the BbSS 
background caused second-step reaction loss (+ SSL-3 assays) or product 
specificity interconversion (mutant only, + SSL-1 assays). Important to note here 
is the possibility that BbSS second-step reaction capability may have been lost in 
some mutants while maintaining first-step reaction activity, but because squalene 
synthases are known to retain the intermediate PSPP during catalysis,19 any 
PSPP made by a mutant might not have been released for SSL-3 to convert to 
botryococcene. 
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Figure 2.5 M1 series mutants. Conserved positions in domain II of BbSS were 
assessed for their role in catalytic activity by introducing reciprocal mutations to 
match the corresponding positions in SSL-3 (A). Each mutant was tested in vitro 
for the ability to perform the first-step reaction (+ SSL-3), the second-step 
reaction (+ SSL-1), or both steps of the reaction (mutant only). Results represent 
one independent experiment (B).  
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M3 series mutants. Based on results from M1 series mutants, residues 
occupying space in close proximity (≤ 5Å) to the cyclopropyl ring might affect 
catalytic activity as evidenced by the BbSS A177N mutant (M1-6). Thus, 
additional positions in BbSS and SSL-3 that occupy such spaces with residues 
that were drastically different between the two enzymes were sought out. Further 
analysis of sequence alignments and 3D models led to the identification of 
position Q213 in BbSS, which is highly conserved in domain III of all squalene 
synthases. In SSL-3, the corresponding position (207) is occupied by glycine. We 
hypothesized that positions A177 and Q213 of BbSS might together be 
responsible for product specificity between these two enzymes. Furthermore, 
positions further from where bond formations take place might favor slight 
changes in substrate orientation and thus alter product specificity. With this in 
mind, BbSS F188 and I295 were identified; the corresponding positions in SSL-3 
were W182 and V288, respectively. The M3 mutant series was constructed to 
assess these residues’ contribution to catalytic activity by mutating positions 
BbSS Q213, F188, and I295 to match the corresponding position in SSL-3. 
Single, double, and multiple mutations were made to determine if one, two or 
multiple changes were necessary for activity interconversion (Figure 2.6). 
Activity screening of the M3 series revealed position Q213 of BbSS to be 
critically important for both steps of the reaction for squalene biosynthesis. 
Mutation of this residue to glycine to match the position in SSL-3 resulted in 
considerable loss of activity (M3-7, mutant only). Even when PSPP was provided 
to this mutant by inclusion of SSL-1 in the assay (M3-7, + SSL-1), the apparent 
activity was still greatly diminished. Co-incubation of M3-7 with SSL-3 indicated 
that this mutant does not make PSPP or it is made but not released which would 
be necessary for SSL-3 to convert it to botryococcene. Mutation of BbSS Q213 to 
alanine (M3-6) and asparagine (M3-8) resulted in similar effects. The BbSS 
double mutant A177N, Q213G (M3-11) retained some second-step reaction 
activity but appeared completely devoid of the first. Contrary to the hypothesis 
that residues A177 and Q213 of BbSS control product specificity for squalene in 
BbSS, instead it seems that these residues play an important role in the ability to 
perform the first-step reaction. F188W and I295V mutations did not seem to alter 
product specificities either by themselves (M3-5 and M3-9) or in combination with 
other mutations (M3-15 and M3-16). M1-5, M1-6, and M1-7 mutants were 
simultaneously assayed in this experiment to allow for cross comparison 
between experiments. Although the activities measured in Figure 2.6 were 
approximately double the activities determined in Figure 2.5, the product profiles 
were identical, which attested to the reproducibility of this approach.   
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Figure 2.6 M3 series mutants. Conserved positions in domains II, III, and IV of 
BbSS were assessed for their role in catalytic activity by introducing reciprocal 
mutations to match the corresponding positions in SSL-3 (A). Each mutant was 
tested in vitro for the ability to perform the first-step reaction (+ SSL-3), the 
second-step reaction (+ SSL-1), or both steps of the reaction (mutant only). 
Results represent one independent experiment (B). 
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M4 series mutants. Results from the M1 and M3 mutant series suggested 
BbSS positions A177 and Q213 play key roles in the catalytic activity for both 
steps of the reaction leading to squalene, especially the first-step reaction. Given 
this, we next asked what the effect would be if the corresponding positions in 
SSL-3 were interconverted to match BbSS. We hypothesized that interconverting 
the corresponding SSL-3 positions (N171, G207) to match those of BbSS (A177, 
Q213) would confer first-step reaction capability to SSL-3, in effect creating a 
bifunctional, botryococcene synthase. Additional residues investigated in SSL-3 
include A167 and N170, which were mutated to match the corresponding 
positions in BbSS, C173 and V176, respectively. As before, a series of mutants 
were made to assess the effects of individual and multiple mutations on SSL-3 
enzyme activity (Figure 2.7). Surprisingly, the double mutations N171A and 
G207Q in SSL-3 (M4-10) made to match the corresponding residues in BbSS 
(A177 and Q213) did not confer first-step reaction capability to SSL-3 but instead 
converted its product specificity from botryococcene to squalene (M4-10, + SSL-
1). Neither single mutation (N171A or G207Q) in SSL-3 was by itself enough to 
introduce first-step reaction capability or convert product specificity from 
botryococcene to squalene. The A167C did not have an effect on SSL-3 by itself 
or when in combination with other mutations. N170V had differing effects on 
botryococcene activity – by itself, the mutation did not alter activity but in 
combination with N171A and G207Q, activity was abolished. 
	   27 
 
Figure 2.7 M4 series mutants. Conserved positions in domains II and III of SSL-3 
were assessed for their role in catalytic activity by introducing reciprocal 
mutations to match the corresponding positions in BbSS (A). Each mutant was 
tested in vitro for the ability to perform the first-step reaction (+ SSL-3), the 
second-step reaction (+ SSL-1), or both steps of the reaction (mutant only). 
Results represent one independent experiment (B). 
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 M5 series mutants. Because SSL-2 produces squalene when supplied 
with PSPP, the contribution of the two positions in SSL-2 (A173 and Q209) that 
correspond to BbSS A177, Q213 and SSL-3 N171, G207 were assessed. To 
understand the role of positions A173 and Q209 in SSL-2 enzyme activity, 
mutations were introduced to match the corresponding positions in SSL-3 
followed by enzyme activity measurements for squalene/botryococcene. 
Mutations with similar amino acids were also introduced in SSL-2 including 
A173G and Q209N. Additionally, SSL-2 can solely catalyze formation of bis-
farnesyl ether (bFE) from two molecules of FPP, so this enzyme activity was also 
tested for the mutants. To follow up on the observation that the BbSS A177N 
mutant loses first-step reaction capability, an A177G mutation was made to verify 
the role of this position in proper shaping of the active site topography. Also, a 
F53Y mutant was made in BbSS because this position is present in the highly 
conserved ‘Flap Region,’ and the corresponding position in SSL-3 is occupied by 
tyrosine. Finally, a few SSL-3 mutants were made to examine key difference 
between it and the S1 DxxED site of squalene synthases; these mutations 
include L77V and Q78E. As for previous mutant series, individual mutations were 
examined by themselves and in combination with others. (Figure 2.8)  
BbSS mutants A177G (M5-1) and F53Y (M5-2) did not appear to greatly 
effect activity for squalene biosynthesis; the decrease in activity observed for + 
SSL-1 and + SSL-3 assays might be due to the additional SSL-1, SSL-3, or 
milieu of proteins in the crude lysate ‘soaking up’ substrate thereby making it 
unavailable for the mutant enzyme. Alternatively, the mutant enzymes present in 
the crude bacterial lysate could have lost activity over the course of the 
experiment. SSL-2 A173G (M5-3) did not greatly affect squalene formation, as 
was the case for BbSS A177G (M5-1). SSL-2 mutations A173N, Q209G, and 
Q209N did appear to have a detrimental effect on this enzyme’s catalysis for 
squalene, similar to mutations of the corresponding sites within the BbSS 
enzyme. bis-farnesyl ether activity of SSL-2 was also affected by these 
mutations. The SSL-2 A173N, Q209G (M5-7) double mutant also compromised 
activities for both squalene and bFE formation. SSL-3 mutations L77V and Q78E 
did not appear to significantly alter activity when assessed individually (M5-8 and 
M5-9), as a double mutant (M5-10), or in combination with N171A and G207Q 
mutations (M5-11 and M5-12). 
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Figure 2.8 M5 series mutants. Conserved positions in BbSS, SSL-2, and SSL-3 
were assessed for their role in catalytic activity by introducing reciprocal 
mutations to match corresponding positions in the other B. braunii triterpene 
synthases (A). Each mutant was tested in vitro for the ability to perform the first-
step reaction (+ SSL-3), the second-step reaction (+ SSL-1), or both steps of the 
reaction (mutant only). Results represent one independent experiment (B). 
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M7 series mutants. SSL-1 can perform only the first-step reaction in 
botryococcene and squalene formation – the biosynthesis of PSPP. Several 
reasons for this outcome derive from the mechanism for both steps of the 
reaction. These include 1) release of PSPP before diphosphate ionization can 
occur, 2) inability to ionize PSPP due to lack of the appropriate residues needed 
for Mg2+ binding/orientation, 3) inability to ionize PSPP due to lack of the 
appropriate residues in the active site, 4) inability to rearrange the cyclopropyl 
intermediate after PSPP ionization, 5) inability to bind NADPH, or 6) some 
combination of these possibilities. From sequence alignments of the B. braunii 
triterpene synthases, it was observed that four positions in domain IV are 
conserved among BbSS, SSL-2, and SSL-3. Because this domain seems to be 
specific to squalene synthases, it has been postulated as being important for 
completion of the second-step reaction.29,30 SSL-1 cannot perform the second-
step reaction and displays considerable sequence divergence in these 
corresponding positions of domain IV. To address the possibility that these 
changes in SSL-1 domain IV might be contributing to its inability to carry out the 
second-step reaction, they were mutated to match the consensus sequence of 
BbSS, SSL-2, and SSL-3 in this region. A fifth residue was also mutated which is 
a glutamine in squalene synthases and glutamate in SSL-2 and SSL-3. Six SSL-
1 single mutants were made at each of the five positions, and three other 
mutants that contained either four or five of the mutations were also made – 
these mutants comprise the M7 series (Figure 2.9). Mutant enzymes that were 
assayed containing only one amino acid substitutions (M7-2, M7-3, M7-4, M7-5, 
M7-8, M7-9) did not display drastic alterations in catalytic ability in the coupled 
assays with SSL-3 where botryococcene was measured. Coupled assays for 
mutants containing four (M7-1, + SSL-3) or five (M7-6 and M7-7, + SSL-3) of the 
substitutions did not produce significant levels of botryococcene, which 
suggested that these multiple SSL-1 mutations negatively affected SSL-1, either 
in its ability to properly fold, catalyze PSPP formation, or some combination of 
both. 
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Figure 2.9 M7 series mutants. Divergent positions in domain IV of SSL-1 were 
assessed for their role in catalytic activity by introducing reciprocal mutations to 
match the corresponding positions in BbSS, SSL-2, and SSL-3 (A). Each mutant 
was tested in vitro for the ability to perform the first-step reaction (+ SSL-3) or 
both steps of the reaction (mutant only). Results represent one independent 
experiment (B). 
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 M8 series mutants. According to a structure-function study of rat squalene 
synthase performed by Schechter et al. (1998), Y171S, Y171F, and Y171W 
mutations resulted in the loss of both first- and second-step reaction activities, 
which suggested that this residue, specifically the tyrosine hydroxyl, was critically 
involved in catalytic activity.31 To assess the contribution of this highly conserved 
position to squalene and botryococcene catalysis in the B. braunii triterpene 
synthases, it was mutated to alanine and phenylalanine in BbSS, SSL-1, SSL-2, 
and SSL-3 (Figure 2.10). Mutants were assessed as previously described where 
the first, second and both steps of the reaction were tested. Contrary to results 
published by Schechter et al. (1998), it does not appear that the highly conserved 
Tyr residue plays such a critical role in BbSS and SSL-3 whereas SSL-1 and 
SSL-2 are affected considerably. All mutants do however seem to be more 
effected by the tyrosine to alanine mutation.   
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Figure 2.10 M8 series mutants. Assessment of a highly conserved tyrosine 
residue in domain II of BbSS, SSL-1, SSL-2, and SSL-3 for its role in catalytic 
activity by mutating it to phenylalanine and alanine (A). Each mutant was tested 
in vitro for the ability to perform the first-step reaction (+ SSL-3), the second-step 
reaction (+ SSL-1), or both steps of the reaction (mutant only). Results represent 
one independent experiment (B).  
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 M11 series mutants. A hallmark feature of class I terpene synthase 
enzymes are the aspartate/glutamate-rich domain(s) thought to be responsible 
for coordination and ionization of the diphosphate moiety of the prenyl 
substrate(s). In squalene synthases, these are designated as the S1 and S2 sites 
depending on whether they are proximal to the N- or C-terminus, 
respectively;25,65 the consensus sequence for the S1 and S2 sites are RxxDxxED 
and RDxxED, respectively. The conserved arginine residues included in the 
consensus sequences have been implicated in diphosphate anion removal from 
active site to prevent bond reformation with the primary carbocation while the 
conserved aspartate/glutamate residues appeared to be important for organizing 
the overall architecture of the Mg2+-diphosphate complexes near the active site 
entry.25,26,29 Lin et al. (2011) suggested that the S1 site in CrtM is the location 
where ionization occurs for FPP and PSPP in the first- and second-step 
reactions.26 To assess the possibility that the S1 or S2 site function independent 
or together as the site of ionization in the B. braunii triterpene synthases, each 
position of the consensus in BbSS (Figure 2.11), SSL-1 (Figure 2.12), and SSL-
3 (Figure 2.14) was individually mutated to alanine then tested for both reaction-
step capabilities. BbSS single mutations D79A (M11-2) and D220A (M11-6) in the 
S1 and S2 sites, respectively, resulted in an apparent complete loss of activity for 
both reaction steps. Squalene was not detected for M11-2 or M11-6 in mutant 
only assessments or when co-incubated with SSL-1 nor was botryococcene 
detected in co-incubations with SSL-3. The other alanine single mutations had 
less drastic effects, possibly even increasing activity for BbSS E223A (M11-7). 
Effects of the single alanine mutations in SSL-1 were similar to BbSS; D84A 
(M11-10) and D222A (M11-14) resulted in an apparent inability to catalyze PSPP 
formation based on co-incubation with SSL-3. Additionally, the R81A mutation in 
SSL-1 also had near complete loss of activity, an outcome that was not observed 
for BbSS. Other single alanine mutations appeared to reduce activity in the SSL-
1 mutants. SSL-3 was affected similarly to BbSS. The D75A (M11-18) and D213A 
(M11-22) mutants were nearly inactive; the other single alanine mutants were 
less affected.  
	   35 
 
Figure 2.11 BbSS M11 series mutants. Conserved positions in BbSS aspartate-
rich motifs were assessed for their role in catalytic activity by introducing single 
alanine mutations (A). Each mutant was tested in vitro for the ability to perform 
the first-step reaction (+ SSL-3), the second-step reaction (+ SSL-1), or both 
steps of the reaction (mutant only). Results represent one independent 
experiment (B). 
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Figure 2.12 SSL-1 M11 series mutants. Conserved positions in SSL-1 aspartate-
rich motifs were assessed for their role in catalytic activity by introducing single 
alanine mutations (A). Each mutant was tested in vitro for the ability to perform 
the first-step reaction (+ SSL-3). Results represent one independent experiment 
(B). 
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Figure 2.13 SSL-3 M11 series mutants. Conserved positions in SSL-3 aspartate-
rich motifs were assessed for their role in catalytic activity by introducing single 
alanine mutations (A). Each mutant was tested in vitro for the ability to perform 
the second-step reaction (+ SSL-1). Results represent one independent 
experiment (B). 
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Additional verification for mutants of interest from previous mutant series. 
Because the previously described work was only an initial screen to check 
enzymatic activities for respective mutants, further testing was needed with the 
appropriate replications for in vitro assays to support these initial observations. 
Figure 2.14A lists the M1, M3, and M4 series mutants that were chosen for 
subsequent in vitro analyses with their corresponding mutations and the enzyme 
backbone from which they were constructed. In vitro assays using crude lysate 
were performed in replicate for these mutants as previously described; protein 
levels in crude lysate total protein were assessed via Western blotting (Figure 
2.15). Activity levels for the mutant enzymes, although somewhat variable, were 
repeatable and consistent with previously made measurements. Protein 
expression levels were relatively similar for mutants compared to wild type. In 
addition to the in vitro assays, the bacterial line expressing operon 3 to produce 
additional FPP was used to chemically profile the M1-6, M3-7, M3-11, M4-3, M4-
4, and M4-10 mutants to obtain an in vivo enzyme assessment. In vivo analyses 
of mutant enzymes were conducted by expressing mutants only or co-expressing 
mutants with either SSL-1 or SSL-3 such that both steps of the reaction could be 
assessed, much the same way they were for in vitro assays (Figure 2.16). These 
analyses recapitulated observations made for in vitro activity screening where 
residues A177 and Q213 of BbSS appear to play roles in both first- and second-
step reactions without affecting product specificity whereas N171 and G207 
appear responsible for squalene and botryococcene product specificity in SSL-3. 
Further assessment of the M8 and M11 series mutants was also carried out in 
replicate in the bacterial line that produces additional FPP to verify the mutant 
enzyme activities (Figure 2.17).    
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Figure 2.14 M1, M3, and M4 series mutants follow-up in vitro assays. M1, M3, 
and M4 series mutants used for this analysis are listed along with the backbone 
from which they are derived and their respective mutation(s) (A). Generic 
depiction of BbSS and SSL-3 enzymes showing where the positions mutated 
reside in relation to the conserved domains (B). Crude extracts of bacterially 
expressed enzymes were used as described in Figure 2.3 to assay for the given 
enzyme’s ability to perform the first, second, or both steps of squalene and 
botryococcene biosynthesis (C). Results are representative of three independent 
replicates (two technical replicates each; (n=3). 
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Figure 2.15 M1, M3, and M4 series mutants Western blots. Anti-His Western blot 
assessment of N-terminal hexahistidine-tagged proteins in bacterial crude lysate 
used for in vitro activity measurement in Figure 2.14C. Fifteen µL of each crude 
extract was loaded per lane and resolved on a 9.5% acrylamide gel followed by 
transfer to nitrocellulose and blotting with monoclonal Anti-His-alkaline 
phosphatase conjugate antibody. 
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Figure 2.16 M1, M3, and M4 series mutants follow-up in vivo assays. In vivo 
chemical profiling of BbSS and SSL-3 mutants expressed in E. coli BL21 (DE3) 
harboring pSB1:operon3. Depiction of general scheme used for in vivo analysis 
of a mutant triterpene synthase for the ability to catalyze the first (+ SSL-3), 
second (+ SSL-1), or both (mutant only) reaction steps of squalene or 
botryococcene biosynthesis. Mutant enzymes were expressed from the pET28a 
vector while co-expressed SSL-1 or SSL-3 was expressed from pACYCDuet-1 
(A). M1, M3, and M4 series mutants used for this analysis are listed along with 
the backbone from which they are derived and their respective mutation(s) (B). 
Hexane extractable products were quantified after GC-MS product profiling of the 
wild-type and mutant enzymes. Results are representative of three independent 
experiments with two biological replicates for each (n=3) (C). 
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Figure 2.17 M8 and M11 series mutants in vivo chemical profiling to assess 
contribution of highly conserved residues to first, second, and both steps of 
squalene and botryococcene biosynthesis. Chemical profiling of the M8 mutant 
series where the highly conserved Tyr residue in domain II was mutated to Phe 
or Ala in BbSS, SSL-1, SSL-2, and SSL-3 (A). Chemical profiling for the BbSS 
M11 series mutants where each conserved position of the S1 and S2 DxxED 
motifs were individually mutated to Ala (B). Chemical profiling for the SSL-1 and 
SSL-3 M11 series mutants where each conserved position of the S1 and S2 
DxxED motifs were individually mutated to Ala (C). Data shown is representative 
of three independent replicates (n=3). 
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GC-MS verification of in vitro and in vivo enzyme products. GC-MS 
product profiling verified products from in vitro and in vivo analyses as squalene 
or botryococcene. Authentic standards of squalene and botryococcene were 
compared to the products from in vitro and in vivo assays in terms of retention 
time (Figure 2.18) and mass spectral fragmentation pattern (data not shown). 
Additionally, NADPH dependence of the mutant triterpene synthases was 
examined to verify this had not been altered due to the introduced mutation(s). 
These experiments demonstrated not only that products observed from in vitro 
and in vivo analyses were in fact squalene and botryococcene, but also the 
dependence of these enzymes on NADPH for the second-step reaction (Figure 
2.18). Minor activities were observed in minus NADPH samples for in vitro 
reactions, perhaps due to NADPH present in the crude lysate used as the source 
of enzyme (Figure 2.18B). 
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Figure 2.18 GC-MS analysis of wild-type and mutant triterpene synthase product 
profiles. In vitro assays conducted using bacterial crude lysates with 50 µM FPP 
in the presence (A) and absence (B) of 5 mM NADPH. In vivo analysis of 
triterpene synthase(s) co-expressed in bacteria as described in Figure 2.16 (C). 
Chemical profiles represent hexane extractable products for the in vitro and in 
vivo analyses. 
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Crude catalytic efficiency assessment of mutants relative to wild type. 
Ideally, assessing enzyme catalytic efficiency involves purifying enzymes to 
homogeneity followed by a substrate-dependent analysis using Michaelis-Menten 
models. As stated earlier, PSPP is not a readily available substrate. Further 
complicating this effort is the loss of activity observed when enzymes are 
assayed after purification (Figure 2.19). This loss of activity was observed after 
multiple independent enzyme purifications. Due to these complications, a 
strategy from Greenhagen et al. (2003) was exploited whereby varying enzyme 
amounts in a coupled assay were used to glean information about the catalytic 
efficiency of one of the coupled enzymes in the mixture.66 These authors faced 
similar obstacles in terms of substrate availability and rationalized this method to 
assess various P450 enzymatic activities with a given sesquiterpene scaffold. 
Using this approach, we estimated how efficiently M4-10 could catalyze squalene 
formation relative to botryococcene by SSL-3 via two different reaction schemes, 
A and B. Scheme A used increasing amounts of SSL-1 crude lysate (0, 1, 2.5, 5, 
and 7.5µg) with the intention of providing increasing amounts of PSPP to achieve 
a ‘pseudo-kinetic’ assessment of SSL-3 and M4-10; the second enzyme amount 
was held constant at 5 µg. Scheme A assessment of SSL-3 and M4-10 led to a 
relative efficiency of 70.1% product formation by the mutant M4-10 enzyme 
(Figure 2.20A). Relative efficiency was calculated as a ratio of product formed by 
mutant enzyme to product formed by wild-type enzyme for each corresponding 
data point then expressed as a percentage. Overall relative efficiency was 
obtained by averaging the relative efficiencies for each data point. Scheme B 
was conducted similarly to Scheme A with the difference that the SSL-1 amount 
was held constant in the first reaction while the amount of SSL-3, M4-10, BbSS, 
or M3-11 was varied (0, 1, 2.5, 5, and 7.5µg) in the second reaction. This 
revealed a relative efficiency of 64.6% for SSL-3 and M4-10 (Figure 2.20B). 
BbSS and M3-11 relative efficiency assessed using Scheme B was calculated as 
46.1% (Figure 2.20C). Relative efficiencies for Scheme B assays were 
calculated identically to those for Scheme A. 
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Figure 2.19 Purified wild-type and mutant triterpene synthase quality control 
assays. Simple assay to check activities of purified enzymes for botryococcene 
and squalene. Enzymes were incubated with 30 µM FPP (S.A. ≈ 1000DPM/pmol) 
and 5 mM NADPH for 10 minutes followed by extraction with hexane from which 
an aliquot was used directly for scintillation spectroscopy. Results represent one 
replicate 
 
 
 
 
 
 
 
 
 
 
to
ta
l p
m
ol
 p
ro
du
ct
 / 
m
in
 
0 
5 
10 
15 
20 
25 
30 
35 
Bb
SS
 
SS
L-
1 
SS
L-
3 
Bb
SS
+S
SL
-1
 
Bb
SS
+S
SL
-3
 
SS
L-
1+
SS
L-
3 
M
1-
6 
M
3-
7 
M
3-
11
 
M
4-
3 
M
4-
4 
M
4-
10
 
M
1-
6 
M
3-
7 
M
3-
11
 
M
4-
3 
M
4-
4 
M
4-
10
 
M
1-
6 
M
3-
7 
M
3-
11
 
M
4-
3 
M
4-
4 
M
4-
10
 
Mutant  
Only 
+ SSL-1 + SSL-3 Controls 
	   48 
 
Figure 2.20 Relative efficiency assays for squalene (red line) and botryococcene 
(blue line) formation by M3-11 and M4-10 mutants. Scheme A – measurement of 
botryococcene and squalene activity with increasing amounts (0 – 7.5 µg) of 
SSL-1 crude lysate in first reaction and a constant amount (5 µg) of SSL-3 
(upper) or M4-10 (lower) crude lysate in second reaction (A). Scheme B – 
botryococcene and squalene activity measurements with a constant amount (2.5 
µg) of SSL-1 crude lysate in first reaction and increasing amounts (0 – 7.5 µg) of 
SSL-3 (upper) or M4-10 (lower) crude lysate in second reaction (B). Scheme B 
reactions for BbSS (upper) or M3-11 (lower) to measure relative efficiency of 
squalene and botryococcene catalysis (C). All assays contained 5 mM NADPH. 
Results are representative of six independent replicates (n=6) except for assays 
with 7.5 µg crude lysate in the second reaction (n=4). 
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Discussion 
 
Unraveling the intricate structure-function relationships among the head-
to-head coupling class of triterpene synthases is a grand challenge. Structure-
function maps for squalene synthase were first suggested by Robinson et al. 
(1993) using protein sequence alignments with other known squalene and 
phytoene synthases29 that have been largely corroborated by crystallographic 
studies of HsSS and CrtM.26,30,57 The structures are quite similar overall, with an 
all-alpha helical fold in which domains I-IV comprise the active site pocket. 
Notable features include the aspartate-rich (DxxED) motifs responsible for 
coordination of the prenyl diphosphate-Mg2+(Mn2+) functionality of the two 
identical substrates. Additionally, hydrophobic residues predominate in the rear of 
the pocket presumably for coordinating the prenyl chains through van der Waals 
interactions with a gradual shift to more polar/charged amino acids near the entry 
of the active site.  
Structure-function studies conducted using site-directed mutants of Rattus 
norvegicus squalene synthase (RnSS) suggested a few residues that are 
important for the second (F288) or both (Y171) reaction steps based on negative 
phenotypes whereby the first, second or both reaction steps were decreased or 
eliminated.31 We performed an analysis of the corresponding position in the B. 
braunii triterpene synthases where the native tyrosine residue was mutated to 
phenylalanine and alanine (Figure 2.10 and Figure 2.17A). These studies 
suggested varying contributions of this residue to squalene or botryococcene 
catalysis in BbSS, SSL-1, SSL-2, and SSL-3. Importantly, the BbSS Y172F 
mutant retained significant activity with a slight decrease in catalytic activity for 
the Y172A mutant. These results suggest that the tyrosine hydroxyl does not play 
a direct role in catalysis. Instead, it may be contributing carbocation stabilizing 
effects from pi orbitals in its ring structure. Another puzzling observation 
regarding structure-function relationships in squalene synthase was made in 
Arabidopsis thaliana which contains two copies of squalene synthase, one that is 
active (AtSS1) and one that is not (AtSS2) despite 79% sequence identity 
between the two.67 Interestingly, AtSS2 possesses a Ser in the position that 
corresponds to F288 in RnSS. This does not seem to explain the lack of 
squalene activity however, because an AtSS2 S287F mutant that was 
constructed and assayed showed no squalene activity. Moreover, when F287 
was mutated to Ser in AtSS1, activity appears to be diminished but not 
completely lost indicating that other residues in AtSS2 are contributing to the loss 
of squalene activity.67 
Our interconversion approach to study product specificity in BbSS and 
SSL-3 has yielded new insight into the amino acids controlling product specificity 
in the 1’-1 and 1’-3 linkage class of triterpene synthases in B. braunii. Residues 
N171 and G207 of SSL-3 contribute dramatically to botryococcene/squalene 
second-step reaction product specificity in this enzyme. When interconverted to 
match the corresponding positions in BbSS, the SSL-3 mutant makes squalene 
70.1% as efficiently as wild-type SSL-3 makes botryococcene. The 
corresponding positions in BbSS, A177 and Q213, do not appear to be entirely 
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responsible for this enzyme’s product specificity. Instead, A177 appears to 
contribute to first-step reaction capability (M1-6) while Q213 seems important for 
both steps of the reaction (M3-7). Interestingly, the M3-11 (A177N, Q213G) 
mutant retains more second-step reaction activity than the single-position mutant 
M3-7 (Q213G) pointing to a significant contribution from the carboxamide 
functional group of this residue in the active site of BbSS. 
Although these results were neither the perfect reciprocal nor a complete 
structure-function map of these enzymes, the positions identified in this analysis 
are interesting and important to consider along with prior work in the field. Poulter 
(1990) surmised, largely through a chemical rationale, that 
squalene/botryococcene product specificity is likely maintained by strict 
regiospecificity of the hydride transfer from NADPH. This conclusion is in 
opposition to the idea that PSPP conformation in the enzyme-substrate complex 
plays a major role in the final 1’-1 or 1’-3 linkage.59 Poulter (1990) also suggested 
that for the 1’-1 linkage to occur with the observed stereochemistry, a stereo-
electronic barrier is required to preclude premature hydride transfer at the C1’ 
carbocation position prior to the c1’-1-2 rearrangement (see Figure 2.1 for 
reaction cascade) such that an inversion at C1’ is caused by hydride transfer. 
This barrier was presumed to be unnecessary for the observed 1’-3 linkage.59 
Results from the current studies suggest all of these possible mechanisms 
may contribute to the product specificity observed in BbSS and SSL-3 (Figure 
2.21). For instance, the notion of a stereo-electronic barrier was supported in the 
context of the Q213 and G207 positions in BbSS and SSL-3, respectively. These 
positions reside on the solvent face of the cyclopropyl ring in the active site. The 
BbSS Q213 carboxamide could act as the stereo-electronic barrier needed to 
prevent premature hydride transfer from NADPH to C1’ during squalene 
biosynthesis. In SSL-3, the corresponding G207 position lacks the carboxamide 
functionality, which fits well with the idea that this barrier is unnecessary for the 
1’-3 linkage. Alternatively, these positions could aid in the positioning of the 
NADPH cofactor such that when Gln is present in this position of the active site, 
hydride transfer proceeds to the C1’ position as observed in squalene. These 
circumstances alone, however, cannot fully be responsible for either the 1’-1 or 
1’-3 linkage because in SSL-3, both mutations (N171A, G207Q) are necessary to 
convert product specificity from botryococcene to squalene. It seems likely that 
during the cascade of squalene biosynthesis, proper spatial requirements are 
necessary for the chemical gymnastics that occur during the c1’-2-3 à c1’-1-2 à 
1’-1 reaction cascade. The proper amount of space seems important for this to 
occur and could be supplied by in part by the A177 position in BbSS, which is 
asparagine in the corresponding position of SSL-3. This would likely prevent the 
necessary spatial requirements during the rearrangement of PSPP to squalene in 
SSL-3.  
In light of the spatial requirements discussed above, an interesting model 
was presented by Lin et al. (2010) regarding the dynamic movements of the FPP 
and PSPP diphosphate groups from one aspartate-rich motif to the other during 
the dehydrosqualene catalytic cascade based on structures solved with less 
reactive thio-FPP analogs and PSPP.26 Their model suggests that the FPP- 
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Figure 2.21 3D models of BbSS and SSL-3 with PSPP docked into active site 
showing residues known to affect product specificity as spheres. Model depicts 
orientation of PSPP in relation to the residues identified in this study that control 
product specificity in SSL-3. Residues shown with carbon backbone sphere 
colored magenta could be acting to orient PSPP in the active site such that c1’-3 
bond breakage and reformation to c1’-1-2 is favored in BbSS while c1’-2 
breakage to yield botryococcene is favored in SSL-3.  
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diphosphate in the S1 site (aspartate-rich motif proximal to CrtM N-terminus; 
present in domain I) is the prenyl-diphosphate that ionizes, followed by 
electrophilic attack of the C1’ carbocation on the C2-C3 double bond of the FPP 
in the S2 site to yield PSPP. The PSPP-diphosphate is then proposed to migrate 
from the S2 site (aspartate-rich motif proximal to CrtM C-terminus; present in 
domain III) to the S1 site where again, the diphosphate is ionized to initiate 
cyclopropyl rearrangement to dehydrosqualene. Although second-step reactions 
of CrtM and SS yield slightly different products, the dynamics of the substrates 
described here are likely similar for both enzymes based on protein 3D 
similarities. Given these results, previous chemical rationale about the 
mechanism, and our mutagenesis results, its seems plausible that more flexibility 
within the active site is necessary for the c1’-2-3 à c1’-1-2 à 1’-1 rearrangement 
of squalene biosynthesis. This flexibility could be provided by A177 in BbSS to 
allow for the necessary movements during catalysis of the 1’-1 linkage with Q213 
playing an important role as a stereo-electronic barrier and/or in NADPH 
positioning. SSL-3 likely favors the 1’-3 linkage over the 1’-1 linkage by fixing the 
substrate in the active site via N171 and removal the stereo-electronic barrier 
and/or repositioning of NADPH by G207 possibly by constricting the size of the 
active site pocket. 
Until the NADPH binding site of 1’-1 and 1’-3 triterpene synthases is 
empirically defined, using either crystallographic or mutagenic studies, the 
conundrum of 1’-1 and 1’-3 linkages observed in squalene and botryococcene 
will remain unresolved. Moreover, based on the large number of mutants 
rationally designed and tested for this study and the incompleteness of the 
structure-function map, a more high-throughput technique will be of considerable 
importance for understanding the complex structure-function relationships of 
these enzymes. 
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Materials and Methods 
 
3D modeling. Generation of three-dimensional models for the B. braunii 
triterpene synthases was accomplished using MODELLER 9v8.63 Online tutorials 
for basic modeling were followed using empirically determined structures of 
HsSS30,57 (PDB: 1EZF and 3VJ8) and CrtM26 (PDB: 2ZCO) as templates. B. 
braunii GenBank accession numbers are as follows: BbSS – AF205791.1, SSL-1 
- HQ585058.1, and SSL-3 - HQ585060.1. Models were generated by first 
performing an alignment of the template and B. braunii enzyme of interest using 
MODELLER 9v8. The B. braunii enzyme sequence was then trimmed at its N- 
and C-terminal ends to match the length of the template. A second alignment 
was performed with the shortened B. braunii sequence and original template; this 
alignment was then used for the modeling program. All parameters were left as 
default with five models generated for each run. Models with the lowest DOPE 
score were chosen for subsequent analyses. 
PSPP docking. PSPP was docked into HsSS (PDB: 3VJ8) and the B. 
braunii 3D models of BbSS and SSL-3 (threaded onto 3VJ8) using Genetic 
Optimisation for Ligand Docking (GOLD; Cambridge Crystallographic Data 
Centre, CCDC; Cambridge UK).68 Proteins were set up as follows: all hydrogens 
added, all waters and ligands removed, distance constraints (3.5 – 4.5Å) set to 
anchor the C11 prenyl chain to L184, C9 prenyl chain to Y280, and cyclopropyl 
methyl group to L212 (distance constraints based on measurements of CrtM-
PSPP (PDB: 3ADZ); conserved residues listed are numbered according to 
BbSS). Binding site was defined as a sphere with a 10Å radius centered on V180 
in domain II. Twenty-five runs were performed for each GOLD run with 1,000,000 
operations per run. Hydrophobic constraints were put on all hydrophobic residues 
within the active site sphere and all hydrophobic ligand atoms during docking 
runs. The PSPP file used for docking was created using atom coordinates from 
PSPP co-crystallized with CrtM (PDB: 3ADZ). These coordinates were submitted 
to the PRODRG server69 (University of Dundee, UK) with the ‘chirality’, ‘EM’, and 
‘charges’ options selected as yes, reduced, and yes, respectively. The MDL 
Molfile output with all hydrogens was saved in mol2 file format and used for 
docking. All other parameters were left as default during docking runs. 
Wild-type B. braunii triterpene synthase cloning. Primers used for most 
constructs can be found in Table 2.1; plasmid DNA (courtesy of Dr. T.D. 
Niehaus)36 was used as template. All wild-type and mutant genes used in this 
study were directionally cloned into the pET28a vector (Novagen) NdeI and 
HindIII sites such that expressed enzymes contain N-terminal hexahistidine tags 
that could be used for purification and immunodetection purposes. SSL-3 had an 
internal HindIII site intentionally altered at the time it was cloned into pET28a; 
mutants subsequently constructed from it contain the HindIII site deletion. 
Because BbSS and SSL-2 were predicted to be membrane-bound enzymes,36,61 
they were truncated at their C-terminal ends 65 and 87 amino acids, respectively, 
to produce catalytically competent, soluble enzymes that could be expressed in 
E. coli. 
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Table 2.1 Primers used for cloning and screening enzymology constructs. 
Restriction sites are underlined. Nucleotides in lower case represent mutations. 
Primer 5’ à 3’ Sequence 
5’ NdeI BbSS GGAATTCCATATGGGGATGCTTCGCTGGGG 
3’ HindIII BbSStr64 CCCAAGCTTTTAGCTCCTCAATTCGTCAAAGG 
5’ NdeI SSL-1 GGAATTCCATATGACTATGCACCAAGACCACGG 
5’ NcoI SSL-1 CATGCCATGGGCACTATGCACCAAGAC 
3’ HindIII SSL-1 CCCAAGCTTTCACTTGGTGGGAGTTGGGGCTGC 
5’ NcoI His6 SSL-2 CATGCCATGGGCACTCACCATCACCATCACCATT
CAGGAAGTATGGTGAAACTCGTCGAG 
3’ XhoI SSL-2tr87 CCGCTCGAGTTAGCTGAGAGCGGCTTTGCATG 
5’ SSL-2 (-NcoI) GGGGAGGCGAGTGGAGACCCaATGGTGGCCACA
ACGCTGAAGC 
3’ SSL-2 (-NcoI) GCTTCAGCGTTGTGGCCACCATtGGGTCTCCACTC
GCCTCCCC 
5’ NdeI SSL-3 GGAATTCCATATGAAACTTCGGGAAGTCTTGCAG
C 
5’ NcoI SSL-3 CATGCCATGGGCAAACTTCGGGAAGTCTTGCAGC
ACC 
3’ HindIII SSL-3 CCCAAGCTTTCAAGCACCCTTAGCTGAAACC 
5’ SSL-3 (-HindIII) GTTTGCAGACCCAAAaCTTCTGGACCGGGAG 
3’ SSL-3 (-HindIII) CTCCCGGTCCAGAAGtTTTGGGTCTGCAAAC 
5’ M1-4 IF gcttttacaaataatGGGGTGGTGGGTCTCGGGCTTTCC
C 
3’ M1-4 IR caccccattatttgtaaaagcGTAAAGGTCGTAGTCCCCCA
C 
5’ M1-5 IF TACTGCCACTATaatGCTGGGGTGGTGGGTCTCGG
GCTTTCCC 
3’ M1-5 IR GGGAAAGCCCGAGACCCACCACCCCAGCattATAG
TGGCAGTA 
5’ M1-6 IF TACTGCCACTATGTTaatGGGGTGGTGGGTCTCGG
GCTTTCCC 
3’ M1-6 IR GGGAAAGCCCGAGACCCACCACCCCattAACATAG
TGGCAGTA 
5’ M1-7 IF TACTGCCACTATaataatGGGGTGGTGGGTCTCGGG
CTTTCCC 
3’ M1-7 IR GGGAAAGCCCGAGACCCACCACCCCattattATAGT
GGCAGTA 
5’ M3-7 IF GGGCCTCTTCCTTgggAAGACCAACATCATCC 
3’ M3-7 IR GGATGATGTTGGTCTTcccAAGGAAGAGGCCC 
5’ M3-8 IF GGGCCTCTTCCTTaatAAGACCAACATCATCC 
3’ M3-8 IR GGATGATGTTGGTCTTattAAGGAAGAGGCCC 
5’ M3-11 IF USE M1-6 AND M3-7 PRIMERS  
3’ M3-11 IR USE M1-6 AND M3-7 PRIMERS 
5’ M4-3 IF GCCTTCACTAATgccGGGCCAGTTGCTATC  
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Table 2.1 (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3’ M4-3 IR GATAGCAACTGGCCCggcATTAGTGAAGGC  
5’ M4-4 IF CATGGCCATGTTCTTGcagAAGATTAACGTCATCC  
3’ M4-4 IR GGATGACGTTAATCTTctgCAAGAACATGGCCATG  
5’ M4-10 IF USE M4-3 AND M4-4 PRIMERS 
3’ M4-10 IR USE M4-3 AND M4-4 PRIMERS 
5’ XbaI op3DXS GCTCTAGAATGAGCTTCGACATCGCCAAGTATCC 
3’ KpnI op3DXS CGGGGTACCTCACGCCAGCCACGCCTTGATCTTC
G 
5’ XbaI op3idi GCTCTAGAATGCAGACCGAGCACGTCATCCTCC 
3’ KpnI op3idi CGGGGTACCTCACTTGAGCTGGGTGAACGCCG 
5’ XbaI op3FPS GCTCTAGAATGCAGCCGCACCACCACCATAAGG 
3’ KpnI op3FPS CGGGGTACCTCACTTCTGGCGCTTGTAGATCTTC 
5’ SacI plac AATTGCAGAGCTCATTTATCAGGGTTATTG 
3’ XbaI plac TTCTCTAGATTAATTTCTCCTCTTTAATTC 
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For in vivo analyses of mutants co-expressed with SSL-1 or SSL-3 in E. coli, 
SSL-1 and SSL-3 were cloned into MCS1 NcoI/HindIII sites of pACYCDuet-1 
(Novagen). All constructs were verified by BigDye Terminator automated 
sequencing (ABI). 
PCR construction of mutant genes. Sequence overlap extension 
polymerase chain reaction (SOE PCR)70 afforded the ability to construct mutants 
described in this work as follows. Internal primers containing the altered 
nucleotide(s) of interest (IF, IR primers in Table 2.1) were used along with either 
the 5’ or 3’ end primer to first PCR amplify the gene of interest in two fragments 
in two separate reactions. The two gene fragments were gel purified and used as 
template in a second SOE PCR with the 5’ and 3’ end primers to reassemble the 
mutated gene. The reassembled gene was gel purified, digested with 
NcoI/HindIII and ligated into the same sites of pET28a. Reassembly was 
routinely performed with up to four fragments of a gene in an SOE PCR. 
Conditions for the first PCR and second SOE PCR were 98°C, 1 minute initial 
denaturation followed by 25 cycles of 98°C, 10 seconds à 55°C, 15 seconds à 
72°C, 1min/kb with a final elongation step of 72°C, 10 minutes. All constructs 
were verified by BigDye Terminator automated sequencing (ABI). 
Construction of a methyl erythritol phosphate (MEP) pathway 
overexpression cassette. pSB1:operon3 plasmid construction involved relocating 
the Tetracycline resistance (TetR) marker from pBBR1MCS-3 to the pBBR1MCS-
2 backbone.71 To accomplish this, the kanamycin resistance (KanR) marker was 
removed by first digesting pBBR1MCS-2 with BglII then treating with Klenow to 
obtain blunt ends. This product was then digested with KpnI to completely excise 
the KanR gene from the vector followed by gel purification of the vector 
backbone. TetR was then digested from pBBR1MCS-3 with KpnI/ZraI and ligated 
into the pBBR1MCS-2 backbone; clones containing the TetR marker were 
isolated via tetracycline resistance selection on LB-Tet plates (12.5 mg/L). This 
vector was named pSB. The A1/03/04 Lac promoter was PCR amplified from 
pIND472 (courtesy of Dr. Judith Armitage) using primers 5’ SacI plac / 3’ XbaI 
plac and cloned into the SacI and XbaI sites of pSB resulting in the expression 
vector pSB1. To enhance in vivo titers of the substrate FPP, a synthetic operon 
consisting of a deoxyxylulose 5-phosphate synthase gene (DXS) and the 
isopentenyl diphosphate isomerase gene (idi) from E. coli and a farnesyl 
pyrophosphate synthase gene (FPS) from Gallus gallus was constructed.  The 
genes were synthesized (GenScript Corporation) as a single polycistron with an 
optimized Shine Dalgarno sequence in front of each gene for expression in E. 
coli (AGGAGGA).73 The operon consisting of DXS, idi, and FPS was digested 
from pUC57-operon3 as an XbaI/BamHI fragment and subcloned into the same 
sites of pUC19 to give construct pUC19:operon3.  The entire operon3 was 
cloned into pSB1 as an XbaI/KpnI fragment to afford pSB1:operon3. This 
construct was functionally verified in E. coli BL21 (DE3) by co-expressing it with 
pET28a:BbSS and analyzing squalene levels. Additionally, each gene of operon3 
was individually cloned into pSB1 using the XbaI/KpnI sites in pSB1 to yield the 
vectors pSB1:DXS, pSB1:idi, and pSB1:FPS. These constructs were verified by 
BigDye Terminator automated sequencing (ABI). 
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Protein expression. The following general scheme for protein expression 
was utilized throughout the course of this work for all wild-type and mutant 
enzymes. Fresh transformations of E. coli BL21 (DE3) (Life Technologies) cells 
with a given construct were always performed. Single colonies were selected to 
start 2 mL LB-Kan (50 mg/L) cultures that were incubated overnight at 37°C on a 
platform shaker. 500 µL of the overnight culture was used to inoculate 50 mL of 
Terrific Broth (TB) supplemented with 1% glycerol and 50 mg/L Kan in a 250 mL 
flask. Cultures were incubated at 37°C for 2 hours on a platform shaker then 
cooled on ice for 2-3 minutes and induced with IPTG (0.5 mM). Protein 
expression was allowed for 5 hours at 23°C on a platform shaker. Cultures were 
divided into 10 mL aliquots and centrifuged (2000 x g, 10 min) to pellet cells; 
growth media was decanted and pellets were stored at -80°C for use up to two 
weeks later. 
Hot 3H-FPP in vitro enzyme assays. Activity screening assays were 
conducted as described by Niehaus et al. (2011) and Okada et al. (2004).35,36 
General assays were performed as follows. Ten mL cell culture pellets were 
thawed on ice and reconstituted in 1 mL of cold reaction buffer (50 mM MOPS, 
pH 7.3, 2.5 mM β-mercaptoethanol, 20 mM MgCl2). Cells were lysed using a 
probe dismembranator (50% power, 3 bursts, 10 seconds each, 5 minutes ice 
between bursts) at 4°C followed by centrifugation clarification (4°C, 10,000 x g, 
10 minutes). Five µL of crude lysate(s) were used in 50 µL assays with 30 µM 
FPP (S.A. ≈ 1250 DPM/pmol) and 5 mM NADPH. The reaction mixture was 
incubated at 37°C for 30 minutes followed by termination with 50 µL of stop 
reagent (0.4 M NaOH, 0.2 M EDTA). Hydrocarbon products were extracted with 
200 µL of hexane. 150 µL of organic phase was removed to a fresh tube, dried to 
completion, and resuspended in 15 µL of hexane. All 15µL of resuspension was 
used for TLC (silica gel 60 plates, hexane solvent) to separate botryococcene 
and squalene. Authentic standards of squalene and botryococcene were ran 
alongside experimental samples to define zones from which the silica gel was 
scraped into a scintillation vial, dissolved in scintillation cocktail, and quantified 
using scintillation spectroscopy. 
Cold FPP in vitro enzyme assays. Assays containing only one enzyme 
were incubated with 50 µM FPP in a volume of 400 µL for 30 minutes at which 
point 100 µL of 25 mM NADPH was added or 100 µL of reaction buffer for 
assays without NADPH. The reaction was then incubated at 37°C for 30 more 
minutes until 500 µL of stop reagent was added. Coupled assays performed with 
two enzymes were done identically as described except that 50 µL of BbSS, M3-
11, SSL-3 or M4-10 crude lysate was added in addition to NADPH (50 µL of 50 
mM) or buffer (50 µL) after the first 30 minute incubation at 37°C. Hydrocarbon 
product analysis consisted of two 1 mL extractions with hexane where 900 µL of 
the organic phase was removed after each extraction to a fresh vial and dried to 
completion. Samples were reconstituted in 50 µL of hexane and analyzed by GC-
MS using 1 µL of the sample. GC-MS analyses were performed on an Agilent 
7890A GC equipped with a HP-5MS column (30m x 0.25mm x 0.25µm) coupled 
to an Agilent 5975C MS insert XL MSD with Triple-Axis Detector (Agilent 
Technologies, Inc.). Initial oven temperature was held at 150°C for 1 minute 
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followed by two ramps: 10°C/min to 280°C à 5°C/min to 310°C and held for 1 
minute. Mass spectral scan range was from 50-500 amu. 
In vivo chemical profiling. Wild-type and mutant triterpene synthases were 
chemically profiled in vivo by co-expressing operon3, a triterpene synthase, and 
the pACYCDuet-1 expression vector containing SSL-1 or SSL-3 (for triterpene 
synthase only analyses, empty pACYCDuet-1 vector was present to account for 
metabolic burden of maintaining the additional plasmid in co-expression 
analyses). Initially, pSB1:operon3 was transformed into E. coli BL21 (DE3) and 
plated on LB-Tet (12.5 mg/L); from this transformation a single colony was 
selected to generate competent cells. Competent cells were then transformed 
with a pET28a:construct and pACYCDuet-1:construct or empty pACYCDuet-1. 
Transformations were plated on LB-Tet-Kan-Chlr (12.5 mg/L Tet, 25 mg/L Kan, 
12.5 mg/L Chlr). Single colonies were chosen and cultured in 2 mL of LB-Tet-
Kan-Chlr overnight at 37°C on a platform shaker. Fifty µL of overnight culture 
was used to inoculate 5 mL of TB-Tet-Kan-Chlr which was grown at 37°C for 2 
hours on a platform shaker. Cultures were then cooled on ice for 1-2 minutes 
until IPTG was added (0.5 mM) followed by incubation at 23°C for 24 hours on a 
platform shaker. Samples were frozen at -80°C until needed. Extractions were 
done in 4 mL screw cap vials using 1 mL culture: 1 mL acetone: 1 mL hexane. 
Extraction mixtures were vortexed vigorously 5 times for 30 seconds before 
centrifugation at 2000 x g for 2 minutes. Three hundred fifty µL of organic phase 
was removed to a 2 mL GC vial insert where it was allowed to evaporate at room 
temperature. Samples were reconstituted in 50 µL of hexane and analyzed via 
GC-MS as described above. 
Radiolabeled crude relative efficiency assays. Reaction schemes were 
based on those described by Greenhagen et al. (2003) where product 
accumulation was measured using incremental amounts of one enzyme and a 
constant amount of another enzyme in a coupled assay as an assessment of 
enzyme efficiency.66 Crude lysates for these assays were prepared identically as 
described earlier. Total protein amounts in crude lysates were measured using a 
Bradford dye assay and quantified by comparison with a BSA standard curve. 
Scheme A assays were setup with increasing amounts (0, 1, 2.5, 5, and 7.5 µg) 
of SSL-1 crude lysate in a 40 µL reaction with 50 µM FPP (S.A. ≈ 250 DPM/pmol) 
in the same reaction buffer conditions described earlier. Reactions were 
incubated at 37°C for 30 minutes at which point 5 µL of 50 mM NADPH was 
added followed by 5 µg of SSL-3 or M4-10 crude lysate. Reaction final volumes 
were adjusted to 50 µL with reaction buffer and incubated at 37°C for 30 more 
minutes followed by termination, extraction, and analysis as described earlier. 
Scheme B assays were setup with a constant amount (2.5 µg) of SSL-1 crude 
lysate in a 40 µL reaction with 50 µM FPP (S.A. ≈ 250 DPM/pmol). The reaction 
was incubated at 37°C for 30 minutes until 5 µL of 50 mM NADPH was added 
followed by the addition of increasing amounts (0, 1, 2.5, 5, and 7.5 µg) of either 
SSL-3, M4-10, BbSS, or M3-11 crude lysate. Final volumes were adjusted to 50 
µL with reaction buffer and incubated at 37°C for 30 more minutes. Calculation of 
relative efficiency was made as follows: pmol squalene / assay for M4-10 with 1 
µg SSL-1 crude lysate divided by pmol botryococcene / assay for SSL-3 with 1 
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µg SSL-1 crude lysate; this value was then multiplied by 100. Example: 
(43.09/53.98)*100 = 79.82%. Percentage values for the other amounts of SSL-1 
crude lysate tested were then calculated; all percentage values were then 
averaged to yield the final relative efficiency for the given Scheme (A or B) 
assessment. ([mutant activity / wild-type activity * 100] for each varying amount 
then averaged to yield the final relative efficiency) 
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Chapter Three: Development of a Selection Platform for the Directed Evolution of 
Triterpene Synthases  
 
Background and Introduction 
 
Squalene synthase (EC 2.5.1.21) catalyzes the first dedicated step in 
eukaryotic sterol biosynthesis by coupling two molecules of farnesyl diphosphate 
(FPP) together to yield squalene.74 The importance of squalene for sterol 
biosynthesis is well documented in plants, animals, and fungi. A squalene 
synthase gene knockout in organisms from these kingdoms is lethal.75,76,77 
Squalene synthase and other enzymes involved in sterol biosynthesis have 
drawn considerable attention in the past, particularly kingdom specific differences 
that can be exploited as targets for anti-fungal drugs.78 Although differences are 
typically found in post-oxidosqualene steps of the pathway, interest remains in 
squalene synthase at the molecular level.25 Understanding how to regulate 
squalene synthase activity could have important medical implications for 
controlling cholesterol levels in humans.7 Alternatively, deregulating this 
enzyme’s activity has industrial application for the production of squalene and 
other triterpenes used in vaccine adjuvant formulations and cosmetic 
products.79,80 Squalene and squalene analogs could even be used as a 
feedstock for the production of liquid transportation fuels.81  
More knowledge of the structure-function map for squalene synthase 
could translate to better rational design of mutant enzymes with more desirable 
characteristics (i.e., improved catalytic efficiency, thermostability, or even tailored 
substrate/product specificity). The design of small molecule inhibitors targeting 
squalene synthase could also benefit from an improved understanding of this 
enzyme. Squalene biosynthesis has been of interest for decades prompting 
detailed kinetic and structural assessments under various conditions.19,23–
25,30,37,56,65 Collectively, these studies support a two-step mechanism for squalene 
synthase where both steps take place in the same active site cavity without 
release of the intermediate. First, two molecules of FPP are joined head-to-head 
to form the cyclopropyl intermediate presqualene diphosphate (PSPP).22,55 PSPP 
is then reductively rearranged to yield a 1’-1 linked squalene with a requirement 
for hydride transfer from NAD(P)H in the second step.82 (Figure 3.1) Although 
many groups have reported mutations that affect squalene synthase activity,6,31-
57 many of these have been loss-of-function mutations that only allow for 
relatively constrained inferences. In contrast, gain-of-function mutants could 
provide positive evidence for ascribing a contribution of a residue or domain to a 
catalytic role, which is the intent of the work reported in this chapter.  
Squalene synthase-like (SSL) enzymes from the green alga Botryococcus 
braunii race B synthesize squalene and a 1’-3 linked molecular relative, 
botryococcene.36 Interestingly, these enzymes adopt a similar mechanism to 
squalene synthase but instead accomplish it with two separate enzymes. SSL-1 
catalyzes the first step by joining two molecules of FPP to produce PSPP. This 
PSPP can then be acted on by either SSL-2 to produce squalene or SSL-3 to 
form botryococcene with both reactions requiring NADPH (Figure 3.1). 
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Figure 3.1 Two-step reaction mechanism for the biosynthesis of squalene and 
botryococcene and possible directed evolutions for SSL enzymes. SSL-1 forms 
PSPP from two molecules of FPP in the first step followed by reductive 
rearrangement of PSPP to squalene by SSL-2 or botryococcene by SSL-3 in the 
second step. BbSS performs both steps of squalene biosynthesis within one 
enzyme active site (A). Possible effects of mutations introduced in BbSS, SSL-1, 
SSL-2, and SSL-3 on substrate and product specificity (B). List is not 
comprehensive. 
 
 
Enzyme 
 
Possible directed evolutions  
for mutant enzymes  
 
Substrate  
(wt / mutant) 
 
Product  
(wt / mutant) 
BbSS 1st step reaction activity lost FPP / PSPP Squalene /Squalene 
BbSS 2nd step reaction activity lost FPP / FPP Squalene / PSPP 
BbSS 1st step reaction activity lost, 2nd step reaction 
product specificity changed to botryococcene 
FPP / PSPP Squalene /
Botryococcene 
BbSS 2nd step reaction product specificity changed to 
botryococcene 
FPP / FPP Squalene /
Botryococcene 
SSL-1 Squalene 2nd step reaction introduced   FPP / FPP PSPP / Squalene 
SSL-1 Botryococcene 2nd step reaction introduced FPP / FPP PSPP / 
Botryococcene 
SSL-1 1st step reaction lost, squalene 2nd step reaction 
introduced   
FPP / PSPP PSPP / Squalene 
SSL-1 1st step reaction lost, botryococcene 2nd step 
reaction introduced   
FPP / PSPP 
 
PSPP / 
Botryococcene 
SSL-2 1st step reaction activity introduced 
 
PSPP / FPP 
 
Squalene / 
Squalene 
SSL-2 1st step reaction activity introduced, 
2nd step reaction activity lost 
PSPP / FPP 
 
Squalene / PSPP 
SSL-2 1st step reaction activity introduced, 2nd step reaction 
activity product specificity changed to botryococcene 
PSPP / FPP 
 
Squalene / 
Botryococcene 
SSL-2 2nd step reaction activity product specificity changed 
to botryococcene 
PSPP / PSPP 
 
Squalene / 
Botryococcene 
SSL-3 1st step reaction activity introduced PSPP / FPP Botryococcene / 
Botryococcene 
SSL-3 1st step reaction activity introduced, 
2nd step reaction activity lost 
PSPP / FPP Botryococcene / 
PSPP 
SSL-3 1st step reaction activity introduced, 2nd step reaction 
activity product specificity changed to squalene 
PSPP / FPP Botryococcene / 
Squalene 
SSL-3 2nd step reaction activity product specificity changed 
to squalene 
PSPP / PSPP Botryococcene / 
Squalene 
A 
B 
BbSS 
-2PPi, H+ 
NADPH 
SSL-1 
-PPi, H+ 
SSL-2 
-PPi 
NADPH 
Squalene 
SSL-3 
-PPi 
NADPH 
Botryococcene 
PSPP 
FPP 
OPP
PPO
OPP
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SSL-2 also catalyzes the formation of an ether linkage between two molecules of 
FPP to produce bis-farnesyl ether (bFE) by a novel SN2 Williamson ether 
synthesis-type reaction.36 B. braunii also harbors a bona fide squalene synthase 
(BbSS) that likely supports necessary requirements for sterol biosynthesis.61 For 
reasons not entirely clear, B. braunii evolved to become very proficient at the 
production of these triterpene hydrocarbons,62 likely through the action of the 
SSL enzymes though this has not been unequivocally demonstrated in the alga 
itself. The oils associate with an extracellular matrix housing the algal cells, 
comprise 30% (w:w) of B. braunii’s biomass, and give it the ability to float in 
undisturbed water.9,62 
Regardless of the evolutionary advantage these enzymes might offer to B. 
braunii, SSL-1, SSL-2 and SSL-3 present a unique opportunity to study the two 
reaction steps for squalene and botryococcene biosynthesis separately. Rational 
mutant design had been employed with BbSS, SSL-1, SSL-2 and SSL-3 with 
intentions of interconverting substrate and/or product specificities among the 
BbSS and SSL enzymes by introducing reciprocal mutations in putatively critical 
positions within the active site cavity that differed between the respective 
enzymes. While not a saturating assessment, differences between two active site 
residues of BbSS and SSL-3 were shown to influence catalytic outcomes. 
Notably, a double mutant (N171A, G207Q) in SSL-3 was identified that converted 
product specificity from botryococcene to squalene; reciprocal mutations in the 
corresponding positions of BbSS (A177N, Q213G) did not, however, convert its 
product specificity from squalene to botryococcene. These and aforementioned 
studies provide valuable insight into the structure-function map for triterpene 
synthases. While the SSL enzymes present a great avenue through which 
structure-function studies can be conducted, the lack of sequence identity among 
the protein sequences (~60%) coupled with the number of possible outcomes for 
given SS and SSL mutant enzymes (Figure 3.1B) has made rational design 
approaches difficult at this stage.  
A robust screening platform allowing for the identification and selection of 
1’-1 and 1’-3 triterpene biocatalysis from large pools of mutants would be 
desirable. Such a selection platform would need to meet a variety of criteria 
(Figure 3.2). Studies with Saccharomyces cerevisiae have demonstrated that 
while a squalene synthase knockout (erg9Δ) is typically lethal, exogenous 
ergosterol can complement the erg9 knockout as long as the yeast also harbors 
a second mutation allowing for the uptake of exogenous sterol.83 Interestingly, 
previous work with erg9Δ yeast lines has shown that expression of a gene 
encoding a non-fungal squalene synthase in an erg9Δ yeast line does not 
genetically complement the loss of the native ERG9 gene. However, catalytic 
domains of heterologous squalene synthases fused with the carboxy terminus 
from a fungal squalene synthase does complement (Figure 3.3).84–86 Given this 
information, we asked if wild-type SSL enzymes that already make squalene 
could complement an erg9 knockout in S. cerevisiae and if so, could a mutant 
library of SSL-3 be created and screened with the erg9Δ yeast line to isolate the 
previously described SSL-3 N171A, G207Q double mutant as well as others. The 
present work was undertaken to establish a proof-of-principle for a yeast 
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selection platform that would allow mutant SSL enzyme libraries to be screened 
by erg9Δ complementation. 
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Figure 3.2 Using S. cerevisiae as a selection platform for directed evolution of 
SSL enzymes. Mutant enzyme libraries are constructed in the pESC-URA vector 
with SSL-1, SSL-2, or SSL-3 appended to the ScSS carboxy-terminal domain 
(YCt) followed by selection for mutants that complement erg9Δ (A). Description 
of ZX178-08 and ZXD yeast lines used for complementation testing and chemical 
profiling of constructs used in this study. ERG1 – squalene epoxidase, ERG9 – 
squalene synthase. ZXD yeast line is used for chemical profiling to prevent 
triterpene products from further modification (B). 
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Figure 3.3 Architecture of squalene synthase in the eukaryotic cell. Squalene 
synthase is a membrane-bound enzyme localized to the endoplasmic reticulum 
(ER) by its carboxy terminus.29,67,87,88 This domain consists of a membrane 
spanning (blue) and linker region (red) that attaches to the amino terminus, or 
catalytic domain (green), which lies on the cytoplasmic face of the ER (A).84 
Complementation of erg9Δ in S. cerevisiae requires the carboxy terminus from 
ScSS or another fungal squalene synthase (B).29,67,84,86 
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Results 
 
Establishing the yeast selection platform. The yeast line ZX178-08 was 
developed by Dr. Xun Zhuang in the Chappell laboratory by first selecting for 
enhanced sterol uptake from the culture media when cells were grown under 
aerobic conditions.89 Next, a deletion of the resident ERG9 gene was introduced 
to disable squalene biosynthesis in the yeast. This line is derived from the 
laboratory yeast strain BY4741. Yeast line ZXD is derived from ZX178-08 by the 
deletion of the resident squalene epoxidase gene (ERG1), thus eliminating 
further metabolism of any squalene produced via the ergosterol biosynthetic 
pathway. 
The first choice of promoter for gene expression was a strong, constitutive 
promoter to circumvent the additional steps needed to initiate gene expression 
with an inducible promoter. Initially, a divergent GPD/TEF promoter setup made 
by interchanging the Gal1/Gal10 divergent promoter in the pESC-URA vector 
series was utilized.89,90 The initial constructs were made to assess the 
complementation ability of SSL-1 and SSL-2 in the erg9Δ yeast genetic 
background (ZX178-08).89 However, upon transformation into ZX178-08 it was 
observed that any vector containing a SSL-1 construct never yielded 
transformants while colonies were always obtained with vectors lacking this gene 
(data not shown). From this observation, we surmised that the product of the 
SSL-1 enzyme, PSPP, might be toxic when made in excess and therefore chose 
to use the galactose-inducible gene expression system provided by the pESC-
URA vector. With this setup, transformants were readily obtained under non-
inducing conditions, allowing us to obtain the necessary independent 
transformants for subsequent analyses.  
Validation of inducible gene expression system and complementation 
testing in ZX178-08. To validate the inducible gene expression system and 
provide confidence the complementation test was working, positive and negative 
control transformants were assessed. As previously mentioned, the non-catalytic 
C-terminal region of squalene synthase anchors the enzyme to the ER 
membrane and possibly aids in metabolon formation with other sterol 
biosynthetic machinery.84,86 This region may be kingdom specific as plant and 
animal squalene synthases can only complement a fungal squalene synthase 
knockout when a fungal squalene synthase C-terminal (YCt) is substituted for the 
corresponding region. In an attempt to mirror work on squalene synthase by 
Niehaus (2011),84 six constructs were made under control of the Gal1 promoter: 
two full-length enzymes (BbSS and ScSS), two C-terminally truncated enzymes 
(BbSStr109 and ScSStr92 – numbers correspond to amino acids truncated from 
the carboxy-termini), and two chimeric enzymes where the C-terminal regions 
were interchanged (BbSStr109YCt92 and ScSStr92BCt109). The ability of 
ZX178-08 harboring these plasmids to grow on four different media types were 
assessed: SCglu; SCEglu; SCgal; and SCEgal. SC represents minimal media, E 
represents the presence of exogenous ergosterol in the media, and glu/gal 
denote which carbon source is present for non-inducing (glu) and inducing (gal) 
gene expression conditions. Three independent biological transformants selected 
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for each construct were subsequently grown in SCEglu liquid media for three 
days, then 1 mL of cells were pelleted, washed and resuspended in water, then 
diluted 50, 250, and 1250 times (to an ~OD600  of 0.1, 0.02, 0.004, respectively). 
Five µL of each dilution for each replicate was spot plated on all four media types 
and grown at 28°C for five days, then transferred to room temperature for 
another ten days; pictures were taken at five days. The results validating the 
expression and complementation system as designed are shown in Figure 3.4. 
As expected, ZX178-08 that contained empty vector (pESC-URA) or the 
truncated squalene synthases (BbSStr109 and ScSStr92) grew only in the 
presence of exogenous ergosterol independent of carbon source. Expression of 
ScSS (full length yeast squalene synthase) showed vigorous growth on SCglu 
and SCEglu but marginal growth on SCgal and SCEgal media types. These 
results were both surprising and unexpected. First, complementation when the 
yeast cells were grown on glucose containing media without exogenous 
ergosterol was unexpected because the GAL1 promoter driving expression of the 
ScSS gene is not expected to be very significant. Leaky gene expression with the 
GAL1 promoter has been previously reported in non-induced (glucose) 
conditions.91,92 This result suggested that only a modest level of squalene 
synthase gene expression was necessary to complement the knockout of the 
native ERG9 (squalene synthase) gene. When these same lines were grown in 
SCgal and SCEgal, media that should support strong expression of the 
heterologous yeast squalene synthase gene, growth was significantly 
compromised. Assuming that the heterologous yeast squalene synthase gene 
was vigorously expressed and producing catalytically competent enzyme, this 
result suggests that too much squalene production by the membrane-targeted 
squalene synthase imposed some level of toxicity that limited growth. The notion 
of site-specific production of squalene having an impact on growth is consistent 
with the complementation effects of carboxy-truncated heterologous yeast 
squalene synthase, ScSStr92. This construct yields a functionally soluble form of 
squalene synthase but is not able to complement erg9Δ either with weak 
expression (SCglu), or when it is strongly overexpressed (SCgal). Importantly, 
when these transformants were grown in media containing exogenous ergosterol 
vigorous growth was exhibited. 
Heterologous expression of the algal full-length and truncated squalene 
synthase (BbSS and BbSStr109) corroborates these inferences. The growth 
pattern of ZX178-08 yeast lines expressing the truncated form of the algal 
squalene synthase resembles the pattern seen for the heterologously expressed 
yeast squalene synthase that is truncated. Leaky expression of the algal full-
length squalene synthase in yeast grown on SCglu media was significantly less 
than when a wild-type yeast squalene synthase gene was used, but growth was 
evident. When these yeast lines were grown under strong inducing conditions, 
SCgal or SCEgal, no viable yeast were observed. These results again support an 
interpretation that complementation of the ERG9 deletion is sensitive to both the 
expression level of the heterologous squalene synthase and its targeting to the 
ER membrane. 
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Figure 3.4 Complementation and growth testing of ScSS and BbSS full-length, 
truncated, and chimeric constructs in ZX178-08 on four different media types. 
ZX178-08 harbors a deletion of the ERG9 gene as denoted by the erg9Δ 
designation at the top of the figure frame. Three biological replicates (top to 
bottom within each panel) for each construct were grown for three days in liquid 
SCEglu media; 1 mL of cell cultures were pelleted, washed with water, then 
diluted 50X, 250X, and 1250X. Five µL of each dilution (lowest to highest 
dilutions from right to left within each panel) for each biological replicate was spot 
plated on the four different media types as indicated at the top of each column. 
Pictures were taken after five days of growth at 28°C. 
 
 
 
 
 
 
 
 
 
 
 
	   69 
Complementation with chimeric enzymes showed identical growth 
patterns as their full-length counterpart. BbSStr109YCt92, which has its carboxy-
terminal tail domain substituted with the yeast domain grew on all four media 
types as the full length ScSS did.  In contrast, when the yeast squalene synthase 
had its carboxy-terminal domain replaced with that from the alga, the 
transformants harboring the ScSStr92Bct109 construct grew only on SCglu and 
SCEglu as did the full-length BbSS construct. To confirm constructs were 
enzymatically active, chemical profiling was done by overexpressing the various 
constructs in the erg1Δ, erg9Δ yeast line (ZXD)89 under SCEgal conditions then 
analyzing hexane-extractable products by GC-FID.  All showed squalene product 
accumulation, albeit varying amounts were observed (data not shown). 
Additionally, when growth of all these ZXD lines in SCEgal media were 
monitored, they all grew comparable to the empty vector control lines, further 
suggesting that a product downstream from squalene could be toxic (data not 
shown). 
Complementation testing of SSL-1 and SSL-2 single-gene and co-
expressed constructs in ZX178-08. Co-expression of the algal SSL-1 and SSL-2 
genes in an industrial yeast line capable of high level FPP accumulation was 
previously shown to produce squalene.36 Given the unexpected observation 
above that the site of squalene biosynthesis plays an important role in whether 
the squalene produced can be utilized by the resident ergosterol biosynthetic 
pathway, we wanted to determine if co-expression of SSL-1 for PSPP 
biosynthesis and SSL-2 for the conversion of PSPP to squalene could 
complement the ERG9 deletion. The SSL-1 wild-type gene was expressed under 
control of the Gal1 promoter, while all the SSL-2 constructs were under control of 
the Gal10 promoter in the dual promoter pESC-URA vector. Because SSL-2 has 
a predicted membrane-anchoring region, we tested the full-length enzyme and 
two different C-terminal truncations with and without three permutations of the 
yeast carboxy terminal (YCt) region: the membrane-spanning region (YCt65); the 
linker domain (YCt27); and the complete carboxy terminus (YCt92). For reasons 
previously demonstrated with full-length BbSS, the resulting transgenic yeast 
lines were tested for complementation on SCglu/SCgal and growth on 
SCEglu/SCEgal. As controls, transformants harboring empty pESC-URA vector, 
SSL-1, and SSL-2 were assessed individually in ZX178-08. None complemented 
the squalene synthase knockout mutation when grown on SCglu or SCgal. All 
SSL-2 constructs and empty pESC-URA vector lines grew on SCEglu and 
SCEgal, while vectors with SSL-1 only grew on SCEglu (Figure 3.5A). 
These results were not entirely unexpected based on earlier observations 
wherein vectors harboring the SSL-1 gene under transcriptional control of the 
strong, constitutive GPD promoter, comparable to the inducible Gal promoters, 
never yielded yeast transformants. These two results were consistent with a 
toxicity effect of the SSL-1 gene, perhaps caused by the accumulation of PSPP. 
Co-expression of SSL-1 and the SSL-2 constructs in ZX178-08 revealed the 
inability of these enzymes to complement the erg9 knockout when expressed at 
low (SCglu) or high levels (SCgal). Growth was observed on SCEglu for all 
construct combinations but not on SCEgal, again suggesting a possible toxic 
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effect of these enzymes when overexpressed in the presence of high FPP levels 
(Figure 3.5B). Interpretation of these results is somewhat confounded by the 
earlier observation that high level expression of BbSS (a complete squalene 
synthase) inhibited growth of ZX178-08, as did the high level expression of SSL-
1. Because the reaction products of the two respective enzymes, squalene for 
BbSS and PSPP for SSL-1, are different, the cause of toxicity might actually be 
different for the two genes. 
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Figure 3.5A Complementation, growth, and chemical profile analysis of SSL-1 
and SSL-2 single-gene constructs in ZX178-08 and ZXD yeast lines. ZX178-08 
harbors a deletion of the ERG9 gene while ZXD contains deletions of both ERG9 
and ERG1 genes as denoted by the erg9Δ and erg1Δ, erg9Δ designation across 
the top of the figure frame, respectively. Three biological replicates (top to bottom 
within each panel) for each construct in ZX178-08 or ZXD were grown for three 
days in liquid SCEglu media. One mL of cell culture was pelleted, washed, and 
then diluted 50X, 250X, and 1250X. Five µL of each dilution (lowest to highest 
dilutions from right to left within each panel) for each biological replicate was spot 
plated on the four different media types as indicated at the top of each column. 
Pictures were taken after five days of growth at 28°C. Chemical profiles were 
generated from the same three ZXD biological replicates used for the SCEgal 
growth test. Cultures were grown in liquid SCEgal media for seven days at room 
temperature; hexane-extractable products were quantified via GC-FID in 
comparison to authentic standards. 
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Figure 3.5B Complementation, growth, and chemical profile analysis of SSL-1 
and SSL-2 co-expressed constructs in ZX178-08 and ZXD yeast lines. ZX178-08 
harbors a deletion of the ERG9 gene while ZXD contains deletions of both ERG9 
and ERG1 genes as denoted by the erg9Δ and erg1Δ, erg9Δ designation across 
the top of the figure frame, respectively. Three biological replicates (top to bottom 
within each panel) for each construct in ZX178-08 or ZXD were grown for three 
days in liquid SCEglu media. One mL of cell culture was pelleted, washed, and 
then diluted 50X, 250X, and 1250X. Five µL of each dilution (lowest to highest 
dilutions from right to left within each panel) for each biological replicate was spot 
plated on the four different media types as indicated at the top of each column. 
Pictures were taken after five days of growth at 28°C. Chemical profiles were 
generated from the same three ZXD biological replicates used for the SCEgal 
growth test. Cultures were grown in liquid SCEgal media for seven days at room 
temperature; hexane-extractable products were quantified via GC-FID in 
comparison to authentic standards. 
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Chemical profiling and growth assessment of SSL-1 and SSL-2 single-
gene and co-expressed constructs in ZXD. To verify functional enzymes were 
expressed in the yeast, SSL-1 and SSL-2 constructs were expressed alone and 
together in ZXD, followed by analysis of hexane-extractable products via GC-
FID. Detecting the presence of presqualene alcohol (PSOH), the 
dephosphorylated form of PSPP, would indicate the expression of functional 
SSL-1. SSL-2, in addition to catalyzing the conversion of PSPP to squalene, also 
possesses the ability to catalyze the conversion of FPP to bis-farnesyl ether 
(bFE). Detection of bFE would indicate the expression of functional SSL-2 
enzyme. Formation of squalene in yeast co-expressing SSL-1 and SSL-2 would 
demonstrate the functionality of both enzymes working together to catalyze the 
conversion of FPP to squalene. Finally, yeast line ZXD expressing the SSL-1 and 
SSL-2 genes singularly and together were assessed for growth on SCEgal. This 
experiment was intended to determine if the toxic effects observed in ZX178-08 
were the result of SSL-1 producing excessive PSPP or SSL-1 and SSL-2 
providing too much squalene to the ergosterol biosynthetic pathway.  
Growth assessments for single-gene constructs showed that ZXD 
overexpressing SSL-1 in the presence of ergosterol (SCEgal) was unable to 
grow while all SSL-2 single-gene constructs were able to grow (Figure 3.5A). 
Only ZXD lines overexpressing SSL1:SSL2full and SSL1:SSL2tr87 were able to 
grow on SCEgal; the SSL1:SSL2tr120 construct series and SSL1:SSL2tr87YCt 
construct series showed no growth on SCEgal plates (Figure 3.5B). Because 
ZXD overexpressing SSL-1 would not grow on plates or in liquid culture, 
obtaining a chemical profile was not possible. Squalene and bFE product 
accumulation levels are listed in Figure 3.5A and Figure 3.5B for the single-
gene and co-expressed gene constructs, respectively. 
Complementation testing of SSL1-SSL2 fusion constructs in ZX178-08. 
Because of the inability of SSL-1 and SSL-2 to complement the erg9 knockout in 
ZX178-08 when co-expressed as separate enzymes and the observation that 
SSL-1 overexpression caused yeast cell death, we supposed these enzymes 
either did not couple together well or the substrate affinity of SSL-2 for PSPP was 
so low that PSPP could not be converted to squalene efficiently enough before it 
caused cell death. To circumvent the former, we constructed fusion enzymes of 
SSL-1 and SSL-2 under control of the Gal1 promoter. SSL-1 wild-type sequence 
was used with a GGSGGGSGGGSG linker in frame with SSL2full (full-length 
enzyme), SSL2tr120 (SSL-2 with the carboxy-terminal 120 amino acids deleted), 
and SSL2tr87 (SSL-2 with the carboxy-terminal 87 amino acids deleted) with and 
without the YCt regions previously described. Using this approach, 
complementation was still not observed in ZX178-08 even when the low-level 
and high-level expression capability of the Gal1 promoter was exploited (Figure 
3.5C). All fusion constructs grew on SCEglu, although the SSL1-SSL2tr87 fusion 
series appeared to be somewhat growth compromised. Much like the co-
expressed SSL-1 and SSL-2 enzymes in ZX178-08, no growth was observed on 
SCEgal for any of the fusion constructs with the exception of SSL1-SSL2tr120. 
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Figure 3.5C Complementation, growth, and chemical profile analysis of SSL-1 
and SSL-2 gene-fusion constructs in ZX178-08 and ZXD yeast lines. ZX178-08 
harbors a deletion of the ERG9 gene while ZXD contains deletions of both ERG9 
and ERG1 genes as denoted by the erg9Δ and erg1Δ, erg9Δ designation across 
the top of the figure frame, respectively. Three biological replicates (top to bottom 
within each panel) for each construct in ZX178-08 or ZXD were grown for three 
days in liquid SCEglu media. One mL of cell culture was pelleted, washed, and 
then diluted 50X, 250X, and 1250X. Five µL of each dilution (lowest to highest 
dilutions from right to left within each panel) for each biological replicate was spot 
plated on the four different media types as indicated at the top of each column. 
Pictures were taken after five days of growth at 28°C. Chemical profiles were 
generated from the same three ZXD biological replicates used for the SCEgal 
growth test. Cultures were grown in liquid SCEgal media for seven days at room 
temperature; hexane-extractable products were quantified via GC-FID in 
comparison to authentic standards. 
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Chemical profiling and growth assessment of SSL1-SSL2 fusion 
constructs in ZXD. Similar to the results for co-expressed enzymes in ZXD on 
SCEgal media, SSL1-SSL2full exhibited growth. However, unlike their co-
expressed counterparts in ZXD, SSL1-SSL2tr120, SSL1-SSL2tr120YCt27, and 
SSL1-SSL2tr87YCt65 fusion constructs were able to grow on SCEgal while 
SSL1-SSL2tr87 was not (Figure 3.5C). All other fusion constructs in ZXD were 
unable to grow on SCEgal like their co-expressed counterparts. Chemical profiles 
for the fusion constructs in ZXD showed a similar pattern as those for the co-
expressed constructs, which can be seen in Figure 3.5C. No bFE was detected 
in any of the cultures expressing the SSL1-SSL2 fusion constructs. 
Complementation testing of SSL-1, SSL-3, and mtSSL-3 co-expressed 
constructs in ZX178-08. SSL-3 predominantly produced botryococcene (~95%) 
and a small amount of squalene (~5%). mtSSL3 (N171A, G207Q) described in 
Chapter 2 was about ~70% efficient as SSL-3, but with ~90% of the reaction 
product as squalene. Given this and the lack of success demonstrating the ability 
of SSL-1 and SSL-2 to complement the erg9 knockout, SSL-1 with either SSL-3 
or mtSSL-3 was tested for their ability to supply squalene to the ergosterol 
pathway and thus complement the erg9 deletion. SSL-3 and mtSSL-3 behave as 
functionally soluble enzymes because they do not possess a carboxy-terminal 
membrane-spanning region. Hence, no C-terminal truncations were tested for the 
SSL-3 or mtSSL-3 enzymes. Only YCt92 and BCt109 were appended to the C-
terminus to test for their contribution to complementation of the erg9 deletion. 
The promoters used to drive gene expression were the Gal1 promoter for SSL-1 
(as in earlier studies), and the Gal10 promoter for SSL-3 and mtSSL-3 
constructs. 
As shown in Figure 3.6A, the pESC-URA vector without a transgene 
(empty vector control) expressed in ZX178-08 was unable to grow on SCglu and 
SCgal, but showed normal growth on media that contained ergosterol. ZX178-08 
harboring the SSL-1 gene only grew on SCEglu as previously observed. SSL-1 
and mtSSL3 constructs co-expressed in ZX178-08 only grew on SCEglu, again 
suggesting a toxic effect of either PSPP or a downstream product of squalene in 
the ergosterol biosynthetic pathway. SSL-1 and SSL-3 constructs co-expressed 
in ZX178-08 showed no growth on SCglu or SCgal but demonstrated normal 
growth on SCEglu and SCEgal at the five-day mark (Figure 3.6A). Interestingly, 
ZX178-08 that co-expressed SSL1:SSL3 or SSL1:SSL3YCt92 constructs 
showed growth after ten days on SCgal, which was more apparent at fifteen days 
(Figure 3.6B). While only a partial restoration of growth in comparison to yeast 
expressing ScSSfull on SCgal media (growth observable within three days), 
these results demonstrated the ability of SSL-1 and SSL-3 to complement the 
erg9 knockout in S. cerevisiae with or without a carboxy-terminal, membrane-
spanning domain (Figure 3.6B). 
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Figure 3.6A Complementation, growth, and chemical profile analysis of SSL-1, 
SSL-3, and mtSSL-3 co-expressed constructs in ZX178-08 and ZXD yeast lines. 
ZX178-08 harbors a deletion of the ERG9 gene while ZXD contains deletions of 
both ERG9 and ERG1 genes as denoted by the erg9Δ and erg1Δ, erg9Δ 
designation across the top of the figure frame, respectively. Three biological 
replicates (top to bottom within each panel) for each construct in ZX178-08 or 
ZXD were grown for three days in liquid SCEglu media. One mL of cell culture 
was pelleted, washed, then diluted 50X, 250X, and 1250X. Five µL of each 
dilution (lowest to highest dilutions from right to left within each panel) for each 
biological replicate was spot plated on the four different media types as indicated 
at the top of each column. Pictures were taken after five days of growth at 28°C. 
Chemical profiles were generated from the same three ZXD biological replicates 
used for the SCEgal growth test. Cultures were grown in liquid SCEgal media for 
seven days at room temperature; hexane-extractable products were quantified 
via GC-FID in comparison to authentic standards. 
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Figure 3.6B SSL-1, SSL-3 and mtSSL-3 co-expressed constructs after fifteen 
days of growth. Constructs were transformed into ZX178-08 (erg9Δ) and grown 
on SCglu and SCgal media for five days at 28°, then transferred to room 
temperature for ten more days. 
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Chemical profiling and growth assessment of SSL-1, SSL-3, and mtSSL-3 
co-expressed constructs in ZXD. SSL-1 overexpressed in ZXD, as already 
described, was unable to grow on SCEgal. However, when SSL-1 and SSL-3 
were co-expressed, the yeast lines were able to grow on SCEgal. Similarly, all 
co-expressed SSL-1 and mtSSL-3 ZXD yeast lines demonstrated growth. 
Product profiling for ZXD lines that overexpressed empty vector and single-gene 
constructs, except for SSL-1, which does not grow in SCEgal, revealed no 
squalene or botryococcene accumulation (Figure 3.6A). ZXD that co-expressed 
SSL-1 and SSL-3 constructs showed all constructs to be functional based on 
botryococcene and squalene accumulation as shown in Figure 3.6A. SSL-1 and 
mtSSL3 overexpressed in ZXD also displayed enzymatic activity based on 
botryococcene and squalene accumulations as shown in Figure 3.6A. 
Complementation testing of SSL1-SSL3 and SSL1-mtSSL3 fusion 
constructs in ZX178-08. Previous experiments with SSL-1 and SSL-2 
demonstrated the inability of co-expressed and fusion enzymes with varying C-
terminal tail arrangements expressed at low and high levels to complement the 
erg9 knockout in ZX178-08. Moreover, SSL-1 and mtSSL-3 constructs that 
predominantly produce squalene were also unable to complement when co-
expressed as separate enzymes with or without two different C-terminal tails. 
SSL-1 and SSL-3 however, when co-expressed with or without the carboxy- 
terminal tail from ScSS (YCt92), did display the ability to complement erg9Δ after 
ten days on SCgal media (high-level expression). In an attempt to improve 
complementation ability of SSL-1 and (mt)SSL3 constructs, fusion enzymes were 
again employed with varying C-terminal regions. As before, all fusion constructs 
were under control of the Gal1 promoter in pESC-URA, assessed on all four 
media types, and observed for growth after five days at 28°C, followed by ten 
days of growth at room temperature. 
Unlike their co-expressed counterparts, SSL1-mtSSL3 fusion constructs 
were able to complement on SCglu regardless of C-terminal tail. SSL1-
mtSSL3BCt109 complemented with the most vigorous growth, followed by SSL1-
mtSSL3YCt92, and SSL1-mtSSL3 (Figure 3.6C). Complementation for these 
constructs was not observed when expressed at a high level (SCgal media). 
Growth on SCEglu was comparable to empty vector while no growth was 
observed on SCEgal for the SSL1-mtSSL3 constructs. After five days of growth, 
only the SSL1-SSL3 construct displayed signs of growth on SCglu media, which 
became more apparent at ten and fifteen days (Figure 3.6D). For ZX178-08 
expressing SSL1-SSL3YCt92 at a low level (SCglu), growth was observed after 
ten days. No growth was seen when this construct was expressed at a high level 
(SCgal). Only the SSL1-SSL3BCt109 construct expressed at a high level in 
ZX178-08 complemented the erg9 deletion with growth observed after ten days 
(Figure 3.6D). All ZX178-08 lines that expressed SSL1-SSL3 constructs grew 
normally on SCEglu and SCEgal. 	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Figure 3.6C Complementation, growth, and chemical profile analysis of SSL1-
SSL3 and SSL1-mtSSL3 fusion constructs in ZX178-08 and ZXD yeast lines. 
ZX178-08 harbors a deletion of the ERG9 gene while ZXD contains deletions of 
both ERG9 and ERG1 genes as denoted by the erg9Δ and erg1Δ, erg9Δ 
designation across the top of the figure frame, respectively. Three biological 
replicates (top to bottom within each panel) for each construct in ZX178-08 or 
ZXD were grown for three days in liquid SCEglu media. One mL of cell culture 
was pelleted, washed, then diluted 50X, 250X, and 1250X. Five µL of each 
dilution (lowest to highest dilutions from right to left within each panel) for each 
biological replicate was spot plated on the four different media types as indicated 
at the top of each column. Pictures were taken after five days of growth at 28°C. 
Chemical profiles were generated from the same three ZXD biological replicates 
used for the SCEgal growth test. Cultures were grown in liquid SCEgal media for 
seven days at room temperature; hexane-extractable products were quantified 
via GC-FID in comparison to authentic standards. 
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Figure 3.6D SSL1-SSL3 and SSL1-mtSSL3 fusion constructs in ZX178-08 after 
fifteen days of growth. Constructs were transformed into ZX178-08 (erg9Δ) and 
grown on SCglu and SCgal media for five days at 28°, then transferred to room 
temperature for ten more days. 
 
 
 
 
 
 
 
 
 
 
 
 
	   81 
Chemical profiling and growth assessment of SSL1-SSL3 and SSL1-
mtSSL3 fusion constructs in ZXD.  All ZXD lines overexpressing SSL1-SSL3 and 
SSL1-mtSSL3 constructs were viable, and the introduced enzyme fusions 
appeared functional based on the chemical profiling of the respective cultures. 
These results are found in Figure 3.6C. 
Complementation and growth analysis of SSL-1, SSL-3, and mtSSL-3 
single-gene and fusion constructs with normalized cell concentrations. Because 
previous figures with yeast lines tested for complementation and growth were not 
normalized before spot plating, select lines with specific constructs were chosen 
for subsequent analyses with normalized cell concentrations to obtain a 
comparison for a given construct’s effect on complementation and/or growth. 
Empty pESC-URA and ScSS full-length were chosen as negative and positive 
controls, respectively. SSL-1, SSL-3, and mtSSL-3 single-gene constructs with 
and without YCt92 were assessed along with SSL1-SSL3 and SSL1-mtSSL3 
fusion constructs with and without YCt92. All the ZX178-08 lines were tested for 
complementation and growth on all four media types; ZXD lines were grown only 
on SCEgal. Chemical profiles were generated as previously described for ZXD 
lines. As illustrated in Figure 3.7, these results clearly demonstrated the ability of 
the fusion enzymes to complement the erg9 knockout in ZX178, albeit with only a 
partial restoration of growth when compared to complementation of the same 
genetic background transformed with the heterologous full-length ScSS construct 
grown on SCglu media. Growth tests for ZXD lines on SCEgal media and 
chemical profiles were generated from the corresponding ZXD yeast lines for 
botryococcene and squalene accumulation, which can be seen in Figure 3.7. 
SSL-1, SSL-3, and mtSSL-3 single-gene constructs did not produce any 
detectable botryococcene or squalene while ScSS and the fusion constructs did 
demonstrating the expression of functional enzymes. 
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Figure 3.7 Quantitative comparison of yeast lines ZX178-08 and ZXD 
transformed with the indicated constructs for their ability to complement the erg9 
deletion. ZX178-08 harbors a deletion of the ERG9 gene while ZXD contains 
deletions of both ERG9 and ERG1 genes as denoted by the erg9Δ and erg1Δ, 
erg9Δ designation across the top of the figure frame, respectively. Biological 
replicates (top to bottom within each panel) were grown for three days in SCEglu 
liquid media, one mL of cells were pelleted, washed, and resuspended in sterile 
water, then used for OD600 normalization to 0.1, 0.02, 0.004. Five µL of each 
dilution for each biological replicate was plated on all four media types for the 
ZX178-08 lines and SCEgal for the ZXD lines. Chemical profiles were generated 
from the same three ZXD biological replicates that were used for the SCEgal 
growth tests. Cultures used for chemical profiling were grown in liquid SCEgal 
media for seven days at room temperature; hexane-extractable products were 
quantified via GC-FID in comparison to authentic standards. 
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Sterol profiling of the squalene synthase knockout lines complemented 
with mutant squalene synthase-like genes. As noted earlier, the ability of SSL-3 
to complement the erg9 knockout despite only catalyzing 5% squalene formation 
and 95% botryococcene left open the possibility that botryococcene might serve 
as a surrogate for the biosynthesis of novel sterols (Figure 3.8A). To determine if 
squalene or botryococcene was leading to the production of bona fide ergosterol 
or alternative sterols, chemical profiles were examined for ZX178-08 expressing 
(SCglu media) ScSS, SSL1-SSL3, SSL1-SSL3YCt92, SSL1-mtSSL3, and SSL1-
mtSSL3YCt92. Cells from starter cultures grown in SCEglu media were collected, 
washed with sterile water, and used to inoculate SCglu media which was grown 
for seven days at 28°C. Cells were then collected, washed, and lyophilized. 
Equal weights of freeze dried cells were saponified (methanolic KOH, 85°C), 
extracted with petroleum ether, concentrated, and analyzed by GC-MS in 
comparison to squalene, botryococcene and ergosterol authentic standards. No 
samples were derivatized although considerations were made to do so but 
ultimately abandoned given the excellent ability to detect ergosterol without 
derivatization (data not shown). As shown in Figure 3.8B, yeast line ZX178-08 
harboring either SSL1-SSL3 or SSL1-mtSSL3 fusion enzymes with and without 
the YCt domain were able to channel squalene to ergosterol biosynthesis and 
accumulation. A comparison of the growth rates of ZX178-08 expressing these 
five constructs grown in SCglu media was also determined (Figure 3.9C), which 
showed an approximate 5-fold difference in growth at the seven day time point 
for the lines that complemented with the SSL1-(mt)SSL3 (except SSL1-mtSSL3, 
52-fold difference) constructs and the native squalene synthase gene (ScSS). 
When compared to the quantified product profiles however (Figure 3.9D), these 
results were not consistent with the accumulation of ergosterol levels for the 
complementing ScSS (4950 ng ergosterol / mg dry cell weight) and fusion 
constructs: SSL1-SSL3(YCt92) (~93 ng ergosterol / mg dry cell weight; 53-fold 
difference) and SSL1-mtSSL3(YCt92) (~300 ng ergosterol / mg dry cell weight; 
16.5-fold difference). 
Close examination of the GC-MS chromatograms also revealed another 
very interesting correlation. That is, the site of squalene production, either 
targeted to the ER membrane via the YCt domain or defaulted to the cytoplasm 
for constructs without the YCt, influenced the conversion of squalene to its 
epoxide form, a necessary transformation for squalene to feed into the ergosterol 
biosynthetic pathway. This observation can be seen in the two additional peaks 
present in the chromatograph analysis. Inspection of the mass spectral 
fragmentation pattern revealed squalene (m/z 410) and botryococcene (m/z 410) 
like properties, but with a parent ion of m/z 426, suggesting the addition of an 
oxygen atom to the molecule. Comparison of these peaks to an oxidosqualene 
standard revealed the identity of one of the peaks, and by inference we 
tentatively identified the second unknown peak as oxidobotryococcene. The 
disappearance of these two peaks when the respective constructs were 
expressed in the ZXD yeast line that contained a knockout of the squalene 
epoxidase gene as well as squalene synthase corroborated the chemical 
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identification of these peaks as oxidosqualene and oxidobotryococcene (Figure 
3.8B). 
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Figure 3.8A Proposed cyclization of botryococcene after epoxidation by Erg1p. 
Only two rings are likely to be formed from oxidobotryococcene; the additional 
OH in the cyclized botryococcene might originate from water quenching of the 
tertiary carbocation in that position to terminate the reaction.  
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Figure 3.8B GC-MS sterol profiling for ZX178-08 and ZXD with complementing 
constructs. ZX178-08 (a-e) and ZXD (f-j) yeast lines expressing ScSS (a,f), 
SSL1-mtSSL3 (b,g), SSL1-mtSSL3YCt92 (c,h), SSL1-SSL3 (d,i), and SSL1-
SSL3YCt92 (e,j). ZX178-08 cultures were grown in SCglu media (low-level 
expression) while ZXD cultures were grown in SCEgal (high-level expression). 
Peak numbers correspond to botryococcene (1), putative oxidobotryococcene 
(2), squalene (3), oxidosqualene (4), and ergosterol (5). 
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Figure 3.8C Comparison of growth rates for the ZX178-08 yeast line expressing 
ScSS, SSL1-SSL3, SSL1-SSL3YCt92, SSL1-mtSSL3, and SSL1-mtSSL3YCt92 
in SCglu media. Data points are representative of three biological replicates from 
one independent experiment. 
 
 
Figure 3.8D Quantified GC-MS results for sterol profiling of the ZX178-08 
(erg9Δ) yeast line complemented with ScSS, SSL1-SSL3, SSL1-SSL3YCt92, 
SSL1-mtSSL3, and SSL1-mtSSL3YCt92. Note the y-axis break to emphasize 
lower levels of certain products. 
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The importance of oxidosqualene formation for the complementation 
phenotype was apparent when the levels of this intermediate were compared 
between lines where squalene synthase activity was targeted and not targeted to 
the ER membrane (Figure 3.8B, panels a-e). First, when a full-length ScSS 
targeted to the ER membrane was used for complementation, very little if any 
squalene or squalene epoxide was evident, yet ergosterol levels were very high 
(panel a). The growth rate of this line was also very robust (Figure 3.8C). In 
contrast, significant levels of squalene and its epoxide form were apparent in 
yeast complemented with the SSL1-mtSSL3 gene not targeted to the membrane 
(panel b). When this same enzyme was targeted to the ER membrane via the 
YCt targeting domain (SSL1-mtSSL3YCt92), no squalene accumulated, yet 
greater levels of the epoxide were evident (compare panels b and c). The growth 
rate of the yeast line harboring the non-targeted SSL1-mtSSL3 enzyme also 
exhibited the slowest growth rate compared to the other lines, approximately 
one-tenth of SSL1-mtSSL3YCt, which was targeted to the ER membrane. 
Equally striking was when the levels of these intermediates were considered in 
relation to the growth rates of the respective yeast lines with botryococcene 
synthase (SSL1-SSL3). When the SSL1-SSL3 gene was used to complement 
the erg9 knockout, no squalene accumulated regardless of whether or not the 
encoded enzyme was targeted to the ER membrane (compare panels d and e). 
However, when the SSL1-SSL3 enzyme was directed to the ER membrane, 
slightly higher levels of the epoxide were observed which was even more evident 
when the SSL1-mtSSL3YCt complementing line was compared to the SSL1-
mtSSL3 in ZX178-08. Both of the SSL1-SSL3 lines grew similarly to yeast 
complemented with the SSL1-mtSSL3YCt and certainly exhibited more vigorous 
growth than the yeast line harboring the SSL1-mtSSL3 construct not targeted to 
the ER membrane, which accumulated significantly more squalene than any of 
the other lines. These results suggested that while a soluble form of squalene 
synthase enzyme activity can complement the erg9 knockout, cellular growth 
rates are negatively impacted by either the burden of excess squalene 
biosynthesis. Alternatively, the effects observed might be an effect of the inability 
to provide the ergosterol biosynthetic pathway with enough squalene, which 
further indicates the importance of controlling carbon flux into this pathway for 
optimal cellular performance. 
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Library construction and validation. With the demonstration that SSL1-
mtSSL3YCt92 could complement the erg9 knockout in S. cerevisiae, a mutant 
enzyme library was constructed to validate the idea that ZX178-08 could be used 
as a complementation screen to identify mutants with altered catalytic activities. 
As discussed in Chapter 2, two positions in SSL-3 were identified that contribute 
to product specificity for either botryococcene or squalene. The wild-type enzyme 
possesses an asparagine at position 171 (N171) and a glycine at position 207 
(G207) and catalyzes the biosynthesis of botryococcene with ~95% specificity. A 
SSL-3 mutant harboring an asparagine to alanine mutation at position 171 and a 
glycine to glutamine mutation at position 207 exhibited ~90% specificity for the 
biosynthesis of squalene. Thus, if the complementation screen is possible, the 
two mutations that convert product specificity in SSL-3 (N171A, G207Q) should 
be isolated from the mutant library. To assess all possible amino acid 
combinations in these two positions, both sites were mutated to saturation 
(N171X, G207X) for a total of 202 = 400 possible combinations. Mutations were 
introduced by employing sequence overlap extension (SOE) PCR with 
oligonucleotides that contained the NNS codon in positions 171 and 207 of SSL-
3. N171X was introduced first followed by G207X and the final reassembled PCR 
products were inserted into an intermediate cloning vector (Figure 3.9A). 
To assess the randomness and biases of the SOE PCR technique, 20 
independent clones were chosen randomly for sequencing. Eleven different 
codons were found in both positions 171 and 207. The mtSSL-3 sequences were 
then released in bulk from the intermediate cloning vector by restriction digestion 
and ligated into the corresponding restriction sites in-frame and in between the 
SSL-1 gene and the yeast carboxy-terminal sequence, YCt92, in the yeast 
expression vector pESC-URA. The recombinant vector reconstituted a fusion 
gene configured as SSL1-mtSSL3-YCt92 encoding for a multifunctional 
presqualene diphosphate (PSPP) synthase followed by a triterpene synthase 
capable of using PSPP for the biosynthesis of variable triterpene products 
(botryococcene, squalene, and other unknowns) and harboring a carboxy-
terminal domain that targeted the enzyme complex to the endoplasmic reticulum.  
Expression of the chimeric gene was placed under the control of the Gal1 
promoter. Twenty-seven independent clones of the assembled constructs were 
sequenced; all were found to be properly assembled, in-frame gene 
constructions. Codons for 16 different amino acids were found at position 171 
and codons for 14 different amino acids were found at position 207. Of the total 
47 independent clones sequenced from both libraries, 17 of 20 amino acids were 
encoded for at position 171 and 16 of 20 amino acids were coded for in position 
207 (Figure 3.9B). To ensure 100% library coverage (all possible combinations = 
202), it was estimated based on sequencing results that a 2X library size (800 
members) would ensure complete coverage (400 total mutants). From library 
size estimations based on CFU/cm2, the constructed library was calculated to be 
8,943X the necessary size which well exceeded the desired 2X coverage. 
Library screening in ZX178-08 for erg9Δ complementation. ZX178-08 
yeast cells were transformed with the pESC-URA:SSL1-mtSSL3-YCt92 (N171X, 
G207X) mutant enzyme library and directly selected on SCglu and SCgal media 
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for mutants able to complement erg9Δ. By selecting on low- and high-level 
expression media, mutants with low squalene synthase activity would be isolated 
on SCgal media and mutants more efficient at making squalene would be found 
on SCglu. If the selection worked as envisioned, recovery of the SSL1-SSL3 
wild-type and original SSL1-mtSSL3 mutant (N171A, G207Q) sequences were 
expected (Figure 3.10A). Many colonies arose on these plates at various times 
after plating. Some colonies were observed five days after plating, while others 
were only visible fifteen days after plating. Additionally, although not quantified, 
some colonies seemed to grow more robustly only after the plates were 
transferred to room temperature from 28°C, which suggested temperature 
sensitivity in either the mutant enzymes or the ZX178-08 yeast line itself. At ten 
and twenty days, colonies were restreaked from the original plates onto fresh 
selection plates. An independent colony was picked from these plates for growth 
in liquid selection media followed by plasmid DNA extraction and transformation 
into E. coli. Single bacterial colonies were chosen, grown in selection media, 
mini-prepped, and sequenced. Independent colonies failing to grow at any one of 
these steps were discarded from subsequent analyses. 
Ultimately, forty independent colonies that arose on the original selection 
plates were sequenced. Two colonies selected on SCgal that were isolated were 
found to contain the wild-type protein sequence for SSL-3 and two colonies 
selected on SCglu contained the N171A, G207Q mutations. Other mutations 
were also identified at both positions 171 and 207 which include: A171, E207; 
S171, Q207; S171, E207; T171, Q207; T171, E207; and C171, Q207. Figure 
3.10B provides a breakdown of the number of independent colonies for each 
mutant isolated, selection media mutants were isolated on, and product profile 
results. Confirmation that each clone sequenced was not a false positive and that 
both SSL-1 and the mtSSL-3 sequence were required for complementation, 
complementation and growth testing as well as chemical profiling were 
performed for each mtSSL-3 constructs as well as the entire fusion construct in 
ZX178-08 and ZXD as described earlier. Shown in Figure 3.10C, these results 
further verified the authenticity of the mutants isolated from the selection as well 
as provided information regarding their chemical profiles.  
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Figure 3.9 Construction of the mutant enzyme library to test the ZX178-08 
selection methodology. Mutants were constructed by SOE PCR to incorporate 
mutagenic oligonucleotides at positions 171 and 207 of SSL-3 (A). During 
construction, independent mutants were randomly selected from the pGEM and 
pESC-URA libraries for sequencing to assess the fidelity of regions outside 
targeted mutagenic positions and the introduction of mutations in the mtSSL-3 
sequences. The library size was estimated from bacterial CFU (B) before 
preparation of the plasmid DNA.    
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Figure 3.10 Mutant library selection in ZX178-08. Sequences already shown to 
complement Δerg9 (1 and 2) that were expected to be isolated if selection works. 
Additional mutants (3) were hypothesized to be isolated if the mutant library and 
selection platform were robust enough (A). Results from selection of the mutant 
library included six new mutants previously uncharacterized, number of 
independent clones isolated for each mutant, selection media mutants were 
isolated on, and their chemical productivities for botryococcene and squalene 
(B). 
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N171T,G207Q 1 All on SCglu 590 ± 28 330 ± 19 
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Figure 3.10C Complementation, growth, and chemical profile analyses for 
mutants isolated from ZX178-08 selection of mutant library. OD600 normalized 
cells were used for complementation and growth testing in ZX178-08 and ZXD. 
Three biological replicates (top to bottom within one panel) were grown for three 
days in SCEglu liquid media, one mL of cells were pelleted, washed, and 
resuspended in sterile water then used for OD600 normalization to 0.1, 0.02, 
0.004. Five µL of each dilution for each biological replicate was plated on all four 
media types for ZX178-08 lines and SCEgal for ZXD lines. Chemical profiles 
were generated from the same three ZXD biological replicates that were used for 
the SCEgal growth tests. Cultures were grown in liquid SCEgal media for seven 
days at room temperature; hexane-extractable products were quantified via GC-
FID in comparison to authentic standards. 
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Discussion 
 
 Squalene synthases are critically important in sterol metabolism for all 
eukaryotic organisms but have been difficult enzymes to study. Initially, technical 
challenges were faced because these enzymes are membrane-bound making 
enzyme kinetic studies intractable due to difficulties in protein purification. 
Recombinant DNA technologies have helped clear this hurdle by allowing 
removal of the C-terminal membrane-spanning region from the open reading 
frame. The truncated form was then overexpressed in bacteria, a technique 
commonly employed nowadays. Since then, very detailed kinetic assessments 
have been achieved for the S. cerevisiae squalene synthase while 
crystallographic studies have revealed the overall structure of the human 
squalene synthase in addition to substrate and inhibitor binding properties. 
Structure-function studies of these enzymes are still complicated because of the 
two-step reaction mechanism for squalene that occurs all within one active site of 
one enzyme. The squalene synthase-like triterpene synthases from B. braunii 
offer an advantage in studying this mechanism because they catalyze one 
reaction step or the other for squalene and botryococcene catalysis. A rationally 
designed mutant study of these enzymes (Chapter 2) revealed some structure-
function relationships; however, more complete and unbiased assessments are 
desirable. Thus, a more robust approach for studying the SSL enzymes of B. 
braunii was developed by employing mutant enzyme libraries and a selection for 
the evolution of squalene biosynthesis. The initial proof-of-principle established 
the ability of SSL fusion enzymes capable of squalene biosynthesis to 
complement the erg9 knockout in ZX178-08. Once this was accomplished, a 
second proof-of-principle was demonstrated where a mutation already known to 
convert SSL-3 product specificity from botryococcene to squalene was isolated 
from a mutant library screen.  
Several unexpected observations were made throughout the course of this 
work that concerned not only the original selection platform devised for SSL 
enzyme directed evolution, but also the ability of non-fungal squalene synthases 
to complement the erg9 knockout in S. cerevisiae. For instance, during the 
establishment of positive and negative controls for this work, a non-fungal 
squalene synthase (the algal BbSS) was shown to complement the erg9 
knockout without the carboxy-terminal region from a fungal squalene synthase. 
This was unexpected because a large body of work has been established in this 
area suggesting otherwise. Previous work showed that when yeast lines with an 
erg9 knockout were used to overexpress a non-fungal squalene synthase, the 
cells were unable to grow in the absence of ergosterol. The cells overexpressing 
these non-fungal squalene synthases were neither assessed for growth in the 
presence of ergosterol nor were their catalytic activities determined or if they had 
the ability to produce squalene in vivo. Other key differences between these 
previous studies and those conducted here include the promoters used for gene 
expression. Earlier studies all used strong, constitutive promoters (PMA1, 
ADH1), while we used a strong, inducible promoter (GAL1). With this promoter, 
we were able to exploit leaky expression in non-inducing conditions that allowed 
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for “low-level” gene expression as well as “high-level” gene expression when the 
yeast were grown in the presence of galactose.  
Using this promoter system, both algal (BbSS) and yeast (ScSS) full-
length squalene synthases were able to complement the erg9 knockout in 
ZX178-08 under low-level expression conditions. However, when assessed 
under high-level expression conditions (galactose media), only the ScSS gene 
was able to complement. Moreover, when BbSS was expressed at a high level in 
the presence of exogenous ergosterol, no growth was observed. Taken together, 
these results suggested the production of a toxic metabolite downstream from 
oxidosqualene. The dependence of BbSS and ScSS on the presence of a C-
terminal region for complementation was demonstrated by testing truncated 
enzymes, which actively produced squalene but were unable to complement. 
Chimeric BbSS and ScSS enzymes where their C-terminal regions were 
interchanged resulted in a reversal of the phenotypes observed for BbSS and 
ScSS. Chimeric BbSS behaved as ScSS did which grew on all four media types, 
while chimeric ScSS mirrored BbSS behavior only growing on glucose media. 
One possible explanation for these observations is that either the amount of 
squalene synthase protein or squalene synthase activity tightly regulates 
squalene levels in S. cerevisiae, which has important implications for the 
production of a toxic intermediate or shunt product.  Such controls are likely 
functioning through a sequence specific region present only in the fungal 
squalene synthase, perhaps the linker region as defined by Niehaus (2011).84 
Thus, if this interpretation is correct, other non-fungal squalene synthases in their 
wild-type forms should be able to complement the erg9 knockout if expressed at 
a low level in S. cerevisiae.    
Another intriguing observation made at the outset of this work was the 
inability of ZX178-08 to grow in the presence of exogenous ergosterol when SSL-
1 was overexpressed. Because ZX178-08 produces high levels of the substrate 
FPP, it was presumed that when SSL-1 was overexpressed much of this FPP is 
converted to PSPP. Only when SSL-1 was co-expressed with SSL-3 in ZX178-08 
were the cells able to survive, implicating PSPP in the yeast cell death. Niehaus 
et al. (2011) showed the presence of presqualene alcohol (PSOH, 
dephosphorylated PSPP) when SSL-1 was overexpressed in a similar yeast line. 
We were unable to obtain an analogous chemical profile in the current studies 
because of the complete lack of growth for these yeast lines, although we could 
detect PSOH in samples where SSL-1 and SSL-3, mtSSL3, or SSL2 constructs 
were co-expressed. This suggests that PSOH by itself might not be cytotoxic, at 
least when produced within a certain threshold.  
In this work, we were able to demonstrate specific combinations of the 
SSL enzymes that could complement the erg9 knockout in ZX178-08. Although 
SSL-1 (FPP to PSPP synthase) and SSL-2 (PSPP to squalene synthase) 
seemed to be incapable of complementing the erg9 knockout, we were able to 
show several arrangements of SSL-1 and SSL-3 (PSPP to >90% botryococcene, 
~10% squalene) or mtSSL-3 (PSPP to <10% botryococcene, ~90% squalene) 
could restore ergosterol prototrophy, albeit less efficient than ScSS. The lack of 
growth for the ZXD lines expressing SSL-1 and SSL-2 constructs suggested the 
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production of a toxic intermediate made either by SSL-1 or the unique 
combination of SSL-1 and SSL-2. Alternatively, this effect could be the result of 
too much squalene being made by SSL-1 and SSL-2 that is fed into the 
ergosterol pathway to produce a different toxic metabolite or finally, it could be a 
combination of both of these possibilities. SSL-1 and SSL-3 setups that showed 
successful complementation were somewhat unexpected, but not entirely 
surprising as these enzymes are known to produce small amounts of squalene. 
More surprising was ability of the SSL-1 and (mt)SSL-3 enzyme arrangements to 
complement regardless of C-terminal tail which suggested that SSL-3 may have 
some ability to associate itself with the ergosterol biosynthetic machinery, 
perhaps a vestige of its supposed evolution from BbSS. SSL-3 C-terminal 
truncations tested using the complementation system described in this work 
could help resolve this issue.  
This work provided new mechanistic insight into the controlled regulation 
of squalene and its enzyme, squalene synthase in fungal systems, which might 
extend to other eukaryotic organisms. Most importantly however, the intention of 
this work was to develop a directed evolution selection platform for the SSL 
enzymes. In general, this was accomplished, but with an important caveat. The 
range of squalene levels that can be channeled into sterols and viably tolerated 
is important – too little squalene and cells either die or grow so slow that growth 
is not apparent; too much squalene and a toxic intermediate/shunt product 
occurs that leads to cell death. Although this could limit the robustness of this 
approach to successfully evolve the SSL enzymes, using the Gal promoter 
system can help circumvent this downfall as evidenced by the new mutant 
enzymes that were isolated from the two-position mutant library using the ZX178-
08 screen. In position 171 of SSL-3, only small polar amino acids cysteine, 
serine, and threonine substitutions were isolated, while only glutamine or 
glutamate were found in position 207 of SSL-3. Important to note here is that 
significance should not be attributed to the number of independent clones 
identified for any one mutant because this may be a reflection of codon bias for 
those particular mutants in the library. Nonetheless, the diversity of amino acids 
found in position 171 possibly suggest the importance of this position in shaping 
of the active site surface to favor squalene biosynthesis. Identification of only 
glutamine or glutamate substitutions in position 207 suggests a possible role of 
the carbonyl functionality in these two amino acid R-groups, as well as the proper 
length of the R-group. In Chapter 2, the Q213N mutation was observed to have 
substantially lower activity. The recent report by Liu et al. (2014) corroborates 
this observation by a Q212N mutation in the human squalene synthase. 
Additionally, Liu et al. (2014) documented HsSS Q212E to retain 85% activity. 
However, these interpretations are not sufficient to explain all the current 
observations. Based on the above rationale, the N171C, G207Q mutant would be 
expected to favor squalene production over botryococcene, as does the SSL-3 
N171A, G207Q mutant. However, this mutation still favors product specificity for 
botryococcene. 
The next step in this work will be utilization of the selection platform 
developed here to directly evolve single SSL enzymes towards fully functional 
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squalene synthases. Any number of methods can be used for construction of the 
mutant libraries; these include but are not limited to structure guided, 
phylogenetic based, insertion-deletion (indel), or random mutagenesis (see 
Goldsmith and Tawfik (2012) for review).93 This stage will likely be the most 
critical for the successful use of the selection platform, however with careful 
thought, consideration, and enough quality control checks, successful directed 
evolution of the SSL enzymes will be achieved. If future studies of mutant SSL 
enzyme libraries are successful, other squalene synthase-like enzymes such as 
dehydrosqualene synthase and phytoene synthase could also be studied for their 
ability to be evolved towards fully functional squalene synthases.  
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Materials and Methods 
 
 Plasmids and yeast strains. All constructs used for this work were cloned 
into this pESC-URA vector (Agilent). BbSS, ScSS, SSL-1, and all fusion 
constructs were cloned into the MCS1 NotI and SpeI sites. SSL-2 constructs 
were cloned into the MCS2 BamHI and XhoI sites while SSL-3 constructs were 
cloned into the SalI and KpnI sites. Chimeric and fusion constructs were 
assembled by sequence overlap extension (SOE) PCR. As an example, 
BbSStr109YCt92 was constructed as follows: plasmid DNA templates containing 
the full-length BbSS and ScSS coding sequences provided generously by 
Niehaus et al. (2011)84 were used to amplify the BbSStr109 section with 5’ NotI 
BbSS and 3’ BbSStr109-YCt92 IR primers with BbSSfull as template in one 
reaction while the YCt92 section was amplified with 5’ BbSStr109-YCt92 IF and 
3’ SpeI ScSSfull primers with ScSSfull as template in a separate reaction. 
Appropriately sized PCR products were gel purified then used as template in a 
second reaction with 5’ NotI BbSS and 3’ SpeI ScSSfull primers to assemble the 
entire chimeric BbSStr109YCt92 construct with 5’ NotI and 3’ SpeI sites. This 
product was gel purified, digested with NotI/SpeI (NEB), and ligated into 
NotI/SpeI digested pESC-URA vector. All oligonucleotides used for the 
construction of genes in this work can be found in Table 3.1. All constructs were 
sequence verified before use. ZX178-08 and ZXD yeast lines were provided 
courtesy of Dr. Xun Zhuang; description of their derivations and genetic 
backgrounds can be found in Zhuang (2013).89  
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Table 3.1 Primers used for cloning and screening yeast constructs. 
Primer 5' à 3' Sequence 
5' NotI BbSS AAGGAAAAAAGCGGCCGCAAAACAATGGGGATGC
TTCGCTGGGGAGTGG 
3' SpeI BbSSfull GGACTAGTTTAGGCGCTGAGTGTGGGTCTAGGTG
AGG 
3' SpeI BbSStr109 GGACTAGTTCAAAGCTTCTCTGCGAAGTTGAGG 
5' BbSStr-YCt92 IF CGTCATTTCCTCAACTTCGCAGAGAAGCTTAAATC
TAAATTGGCTGTGCAAGATCC 
3' BbSStr-YCt92 IR GGATCTTGCACAGCCAATTTAGATTTAAGCTTCTC
TGCGAAGTTGAGGAAATGACG 
3' XhoI BbSSfull CCGCTCGAGTTAGGCGCTGAGTGTGGGTCTAGG 
3' KpnI BbSSfull GGGGTACCTTAGGCGCTGAGTGTGGGTCTAGGTG
AGG 
  
5' NotI ScSS AAGGAAAAAAGCGGCCGCAAAACAATGGGAAAGC
TATTACAATTGGCATTGC 
3' SpeI ScSSfull GGACTAGTTCACGCTCTGTGTAAAGTGTATATATA
ATAAAACC 
3' SpeI ScSStr92 GGACTAGTTCAGATATCACGTAAGTAATAGTCAAA
AATC 
5' ScSStr92-BCt109 
IF 
GACTATTACTTACGTGATATCGAAGTCAGATGCAA
CACCGAGAC 
3' ScSStr92-BCt109 
IR 
GTCTCGGTGTTGCATCTGACTTCGATATCACGTAA
GTAATAGTC 
3' XhoI ScSSfull CCGCTCGAGTCACGCTCTGTGTAAAGTGTATATAT
AATAAAACC 
3' KpnI ScSSfull GGGGTACCTCACGCTCTGTGTAAAGTGTATATATA
ATAAAACC 
  
5' NotI SSL-1 AAGGAAAAAAGCGGCCGCAAAACAATGACTATGC
ACCAAGACCACGGAG 
3' SpeI SSL-1 GGACTAGTTCACTTGGTGGGAGTTGGGGCTGCG 
5' SSL1-YCt92 IF CTTTCTGCGCAGCCCCAACTCCCACCAAGAAATCT
AAATTGGCTGTGCAAGATCC 
3' SSL1-YCt92 IR GGATCTTGCACAGCCAATTTAGATTTCTTGGTGGG
AGTTGGGGCTGCGCAGAAAG 
3' SSL1-Linker ACCAGAACCACCACCAGAACCACCACCAGAACCA
CCCTTGGTGGGAGTTGGGGCTGCGC 
5' SSL1-AatII-KasI-
YCt92 IF 
GGTGGTTCTGGTGACGTCGGCGCCAAATCTAAAT
TGGCTGTGCAAGATCC 
3' SSL1-AatII-KasI-
YCt92 IR 
CCAATTTAGATTTGGCGCCGACGTCACCAGAACC
ACCACCAGAACCACCACC 
5' BamHI SSL-2 CGGGATCCAAAACAATGGTGAAACTCGTCGAGGT
TTTGC 
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Table 3.1 (continued) 
3' XhoI SSL2full CCGCTCGAGCTACTGCTTGGAAGAAGCAGAGGTG
AGC 
3' XhoI SSL2tr120 CCGCTCGAGCTACAACTCGTTCGCGAGTCGGAGA
TATGTTTGG 
3' XhoI SSL2tr87 CCGCTCGAGTTAGCTGAGAGCGGCTTTGCATG 
3' SpeI SSL2tr87 GGACTAGTTTAGCTGAGAGCGGCTTTGCATGACT
TCTGG 
3' SpeI SSL2full GGACTAGTCTACTGCTTGGAAGAAGCAGAGGTGA
GC 
3' SpeI SSL2tr120 GGACTAGTCTACAACTCGTTCGCGAGTCGGAGAT
ATG 
5' SSL2tr120-YCt92 
IF 
CAAACATATCTCCGACTCGCGAACGAGTTGAAATC
TAAATTGGCTGTGCAAGATCC 
3' SSL2tr120-YCt92 
IR 
GGATCTTGCACAGCCAATTTAGATTTCAACTCGTT
CGCGAGTCGGAGATATGTTTG 
5' SSL2tr120-BCt109 
IF 
CTCCGACTCGCGAACGAGTTGGAAGTCAGATGCA
ACACCGAGACCAGCG 
3' SSL2tr120-BCt109 
IR 
CGCTGGTCTCGGTGTTGCATCTGACTTCCAACTC
GTTCGCGAGTCGGAG 
5' SSL2tr87-YCt92 IF CCAGAAGTCATGCAAAGCCGCTCTCAGCAAATCT
AAATTGGCTGTGCAAGATCC 
3' SSL2tr87-YCt92 IR GGATCTTGCACAGCCAATTTAGATTTGCTGAGAGC
GGCTTTGCATGACTTCTGG 
3' 1st SSL2tr120-
YCt27 
AATTTTAAGAAATTTGGATCTTGCACAGCCAATTTA
GATTTCAACTCGTTCGCGAGTCGG 
3' 2nd SSL2tr120-
YCt27 
TCCATAAACTGTTCGATCTTGGAGATTTGAATGTT
CAATTTTAAGAAATTTGGATCTTGC 
3' 3rd SpeI YCt27 GGACTAGTTCATTCTTCCATAAACTGTTCGATCTT
GG 
3' 3rd XhoI YCt27 CCGCTCGAGTCATTCTTCCATAAACTGTTCGATCT
TGGAGATTTGAATGTTCAATTTTAA 
5' SSL2tr120-YCt65 
IF 
CATATCTCCGACTCGCGAACGAGTTGATGTACCA
GGATAAATTACCTCCTAACGTG 
3' SSL2tr120-YCt65 
IR 
CACGTTAGGAGGTAATTTATCCTGGTACATCAACT
CGTTCGCGAGTCGGAGATATG 
5' SSL2tr87-YCt65 IF CCAGAAGTCATGCAAAGCCGCTCTCAGCATGTAC
CAGGATAAATTACCTCCTAACG 
3' SSL2tr87-YCt65 IR CGTTAGGAGGTAATTTATCCTGGTACATGCTGAGA
GCGGCTTTGCATGACTTCTGG 
3' 1st SSL2tr87-YCt27 
IR 
AAATTTGGATCTTGCACAGCCAATTTAGATTTGCT
GAGAGCGGCTTTGCATGACTTCTGG 
5' Linker-SSL2 GGTGGTTCTGGTGGTGGTTCTGGTGGTGGTTCTG
GTATGGTGAAACTCGTCGAGGTTTTG 
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Table 3.1 (continued) 
5' SalI SSL-3 ACGCGTCGACAAAACAATGAAACTTCGGGAAGTC
TTGCAGCACC 
5' SSL3-YCt92 IF GGAAAGGTTTCAGCTAAGGGTGCTAAATCTAAAT
TGGCTGTGCAAGATCC 
3' SSL3-YCt92 IR GGATCTTGCACAGCCAATTTAGATTTAGCACCCTT
AGCTGAAACCTTTCC 
5' SSL3-BCt109 IF GGAAAGGTTTCAGCTAAGGGTGCTGAAGTCAGAT
GCAACACCGAGACCAGC 
3' SSL3-BCt109 IR GCTGGTCTCGGTGTTGCATCTGACTTCAGCACCC
TTAGCTGAAACCTTTCC 
5' SSL-3 N171X GCCTTCACTAATNNSGGGCCAGTTGCTATC 
3' SSL-3 N171X GATAGCAACTGGCCCSNNATTAGTGAAGGC 
5' SSL-3 G207X CATGGCCATGTTCTTGNNSAAGATTAACGTCATC
C 
3' SSL-3 G207X GGATGACGTTAATCTTSNNCAAGAACATGGCCAT
G 
3' SpeI SSL-3  GGACTAGTTCAAGCACCCTTAGCTGAAACCTTTC
C 
3' KpnI SSL-3 GGGGTACCTCAAGCACCCTTAGCTGAAACCTTTC
C 
5' AatII SSL-3 (no 
start) 
GGTGGTTCTGGTGACGTCAAACTTCGGGAAGTCT
TGCAGCACC 
3' KasI SSL-3 (no 
stop) 
CCAATTTAGATTTGGCGCCAGCACCCTTAGCTGA
AACCTTTCC 
5' Linker-SSL3 GTTCTGGTGGTGGTTCTGGTGGTGGTTCTGGTAT
GAAACTTCGGGAAGTCTTGCAGCACC 
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 Maintenance of ZX178-08 and ZXD yeast lines, transformation, and 
media. Through the course of this work, ZX178-08 and ZXD yeast lines were 
maintained on YPDE plates at room temperature; plates were restreaked every 
two weeks. For transformation of ZX178-08 or ZXD, a fresh plate was restreaked 
and incubated at 28°C for 3 days. Three colonies were then selected with pipette 
tips to inoculate 3 mL of YPDE media in a 14 mL culture tube and grown for 52-
54 hours at 28°C with 220 rpm orbital shaking. 500 µL of the 3 mL cultures were 
then used to inoculate 50 mL of YPDE media in a 500 mL flask and grown for 12-
13 hours at 28°C with 220 rpm orbital shaking. The culture with highest visible 
cell density was then used to prepare competent cells with Solutions 1 and 2 
from the Zymo Frozen-EZ Yeast Transformation kit as described by the 
manufacturer. 50 µL of cells were mixed with 5 µL of plasmid DNA and Solution 3 
from the Zymo Frozen-EZ Yeast Transformation kit in a 14 mL culture tube that 
was incubated for 3 hours at 28°C with 220 rpm orbital shaking. 1 mL of room 
temperature YPDE media was added to the transformation mixture and then 
allowed to recover for 6 hours at 28°C with 220 rpm orbital shaking. 
Transformation mixtures were transferred to sterile 2 mL tubes, cells were 
pelleted, washed with water, then plated on SCEglu (-uracil) media. Plates were 
incubated at 28°C for 5 days; colonies were typically visible by 3 days. YPD(E) 
and SC(E)media recipe were used as described by Zhuang (2013).89  
 Complementation and growth testing. All complementation (- ergosterol 
media) and growth (+ ergosterol media) experiments were performed as follows. 
Three biological replicates from fresh transformations (five days after plating) for 
each construct were selected to inoculate 3 mL of SCEglu media in a 14 mL 
culture tube; cultures were grown for 3 days at 28°C with 220 rpm orbital 
shaking. 1 mL of cultures was transferred to 1.5 mL tube, cells were pelleted, 
media was discarded, cells were washed in sterile water once, pelleted again, 
then resuspended in 1 mL of sterile water. For complementation and growth 
testing shown in Figures 3.4 thru 3.6, cells were simply diluted 50X in sterile 
water followed by two 5-fold dilutions. Cells for complementation and growth 
testing shown in Figures 3.7 and 3.10C were first normalized to OD600 0.1 then 
diluted 5-fold two times to OD600 0.02 and 0.004. 5 µL of each dilution was then 
used for spot plating on the four different SC media types. Plates were incubated 
at 28°C for 5 days until pictures were taken then transferred to room temperature 
to observe for 15 more days.     
 Chemical profiling of hydrocarbon products. All chemical profiling was 
performed for constructs in the ZXD yeast line. In general, three biological 
replicates from fresh transformations for a given construct were selected with a 
pipette tip to inoculate 3 mL of SCEglu media then grown for 3 days at 28°C with 
220 rpm orbital shaking. 30 µL of this culture was then used to inoculate 3 mL of 
SCEgal media in a 14 mL culture tube then grown at room temperature for 1 
week with 220 rpm orbital shaking. To extract hydrocarbon products, 1 mL of 
culture was vortexed periodically for 30 minutes with 1 mL of acetone in a 4 mL 
glass screw cap vial. 1 mL of hexane was then added and vortexed periodically 
for 30 more minutes. After separation of layers, 350 µL of the hexane phase was 
added to a GC vial insert in a 2 mL GC vial and allowed to evaporate overnight. 
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50 µL of iso-octane was then used to reconstitute the sample; 1 µL was analyzed 
via GC-FID containing an HP-5 column with the following oven program: initial 
oven temperature held at 150°C for 1 minute followed by a 10°C/min ramp to 
280°C then a 5°C/min ramp to 310°C which was held for 1 minute. Hydrocarbon 
products were identified by comparison of retention times to authentic standards 
of botryococcene and bis-farnesyl ether provided by Niehaus et al. (2011) or 
squalene (Sigma). Hydrocarbon products were quantified by comparison to a 
squalene standard curve. 
 Sterol profiling for complementing constructs. ScSS, SSL1-SSL3, SSL1-
SSL3YCt92, SSL1-mtSSL3, SSL1-mtSSL3YCt92 constructs in pESC-URA were 
transformed into ZX178-08. 5 days after transformation a single colony for each 
construct was selected by pipette tip to inoculate 3 mL of SCEglu media in a 14 
mL culture tube. Starter cultures were grown for 3 days at 28°C with 220 rpm 
orbital shaking. At 3 days, 1 mL of each starter culture was transferred to a sterile 
1.5 mL tube, cells were pelleted, washed with 1 mL of water, then reconstituted 
in 1 mL of sterile water which was used to inoculate 100 mL of SCglu media in a 
500 mL flask. 100 mL SCglu cultures were grown at 28°C with 220 rpm orbital 
shaking for 7 days until cells were pelleted, washed with 50 mL of water twice, 
then lyophilized. 30 mg of freeze dried cells in a 4 mL glass screw cap vial were 
saponified as described by Guan et al. (2010).94 Briefly, cells were dissolved in 1 
mL of methanol with 30% KOH and 0.25% pyrogallol. This was incubated at 
85°C for two hours with gentle vortexing every 30 minutes. Mixture was cooled to 
room temperature then extracted with 2 mL of petroleum ether; 1 mL of the 
petroleum ether extract was dried to completion then resuspended in 50 µL of 
iso-octane. 1 µL was analyzed on an Agilent 7890A GC equipped with a HP-5MS 
column (30m x 0.25mm x 0.25µm) coupled to an Agilent 5975C MS insert XL 
MSD with Triple-Axis Detector (Agilent Technologies, Inc.). Initial oven 
temperature was held at 200°C for 0.5 minutes then ramped 10°C/min to 270°C 
followed by a second 3°C/min ramp to 320°C and held for 10 minutes. Mass 
spectral scan range was from 50-500 amu. 
 Growth analysis for complementing constructs. ScSS, SSL1-SSL3, SSL1-
SSL3YCt92, SSL1-mtSSL3, SSL1-mtSSL3YCt92 constructs in pESC-URA were 
transformed into ZX178-08. 5 days after transformation, 3 biological replicates for 
each construct were selected by pipette tip to inoculate 3 mL of SCEglu media in 
a 14 mL culture tube. Starter cultures were grown for 3 days at 28°C with 220 
rpm orbital shaking. At 3 days, 1 mL of each starter culture was transferred to a 
sterile 1.5 mL tube, cells were pelleted, washed with 1 mL of water, then 
reconstituted in 1 mL of sterile water. 500 µL of washed cells were used to 
inoculate 50 mL of SCglu media in a 250 mL flask. 50 mL SCglu cultures were 
grown at 28°C with 220 rpm orbital shaking for 7days. OD600 measurements were 
taken every 24 hours for each biological replicate to generate the data in Figure 
3.8C.  
 Mutant library construction. A general depiction of the process for 
constructing the two-position saturation library can be seen in Figure 3.9A. To 
begin, a special pESC-URA yeast vector was constructed with SSL1YCt92 
cloned into the NotI/SpeI sites of MCS1. Between the two coding sequences for 
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SSL-1 and YCt92, AatII and KasI restriction sites were introduced via SOE PCR 
using the 5’ SSL1-AatII-KasI-YCt92 IF and 3’ SSL1-AatII-KasI-YCt92 IR primers. 
This construct was sequence verified and titled as the pESC-URA:SSL1 
(AatII/KasI)YCt92 vector. Next, pET28a:SSL-3 template DNA (Chapter 2) was 
used in the first two reactions to introduce N171X mutations with the 5’ SSL-3 
N171X and 3’ SSL-3 N171X primers. After reassembly and gel purification, the 
SSL-3 N171X PCR product was used as template for two more reactions to 
introduce the G207X mutations with the 5’ SSL-3 G207X and 3’ SSL-3 G207X 
primers. The final PCR product containing both N171X and G207X mutations 
was A-tailed by amplifying with ExTaq polymerase (Takara); primers 5’ AatII 
SSL-3 (no start) and 3’ KasI SSL-3 (no stop) were used such that AatII and KasI 
sites were introduced at the 5’ and 3’ ends, respectively. A-tailed PCR product 
was quantified by spectroscopy then used for ligation into pGEM-T Easy 
(Promega) at a ratio of 3:1 (insert:vector); 10 identical reactions were setup in 
parallel and allowed to incubate at 16°C for 24 hours. Ligations were pooled and 
transformed into freshly made DH5α competent cells. Recovered cells were 
divided evenly and plated between 20 LB Amp/IPTG/X-gal plates which were 
grown at 37° for ~15 hours until colonies were distinctly blue or white such that 
they could easily be scored. At this point, forty independent white colonies were 
randomly selected for a colony PCR analysis; twenty positive clones were then 
selected for a sequencing analysis. With satisfactory results from the sequencing 
analysis, all colonies from the pGEM-T Easy plates were scraped and used to 
inoculate four 100 mL LB Amp cultures that were grown at 37°C for ~15 hours. 
These cells were used to prepare a pGEM:mtSSL-3 (N171X,G207X) plasmid 
DNA library. 50 µg of this library was used for a digestion with AatII and KasI 
restriction enzymes; released insert of the appropriate size was gel purified, 
quantified, and used to set up 10 identical ligations with the specially made 
pESC-URA:SSL1(AatII/KasI)YCt92 vector. A 3:1 (insert:vector) ratio was used 
for these ligations that were then incubated at 16°C for 24 hours. Ligations were 
pooled and transformed into freshly made DH5α competent cells. Recovered 
cells were divided evenly and plated between ten 150 cm LB Amp plates which 
were grown at 37°C for ~15 hours. 40 randomly selected colonies from these 
plates were first analyzed via colony PCR to 1) quantify the percentage of 
colonies that had mtSSL-3 inserts and 2) identify colonies for a subsequent 
sequencing analysis. With satisfactory results from the sequencing analysis, an 
estimate of the library size was calculated by first counting colonies in a randomly 
chosen 10 cm2 region for each 150 cm plate. Colonies per 10 cm2 areas were 
then averaged and used to calculate colonies/plate based on the area of a 
150cm plate; colonies/plate was then multiplied by the number of plates (10) to 
obtain the total number of colonies which was multiplied by 0.75 to account for 
only 75% of the colonies having a mtSSL-3 insert. All colonies from these plates 
were scraped and used to start four 100 mL LB Amp cultures which were grown 
for ~15 hours at 37°C. These cells were then used to prepare a pESC-
URA:SSL1-mtSSL3 (N171X,G207X) plasmid DNA library. 
 Mutant library selection in ZX178-08. Selection of the mutant library was 
conducted by transforming 2.5 µg aliquots of the pESC-URA:SSL1-mtSSL3 
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(N171X,G207X) plasmid DNA library into 50 µL of ZX178-08 competent cells 
then plating on SCglu and SCgal media. Transformations of the library into 
ZX178-08 were carried out as described above except recovery of the cells was 
allowed for 18 hours and cells were plated on SCglu and SCgal 150 cm plates. 
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Chapter Four: Metabolic Engineering for Triterpene Accumulation in the Green 
Alga Chlamydomonas reinhardtii 
 
Background and Introduction 
 
Botryococcus braunii race B is a green, colony forming alga with the ability 
to accumulate high levels squalene and botryococcene, linear triterpenes that 
can be further modified with additional methyl groups.9 The triterpenoids 
produced by B. braunii are an excellent feedstock for the hydrocracking and 
distillation processes currently used to produce liquid transportation fuels.14,15 
Cultivation of B. braunii on a large scale for renewable production of these 
molecules has long been considered unfeasible because of the alga’s slow 
growth rate, although recent studies may suggest otherwise.42,95 Nonetheless, 
engineering high-level accumulation of squalene or botryococcene in a faster 
growing algal host such as Chlamydomonas reinhardtii could help provide basic 
knowledge about engineering triterpene metabolism in green algae. Such efforts 
will be important for the future prospects of using green algae as a production 
platform for sustainable, renewable energy. This chapter will examine progress in 
nuclear transgene expression methodologies in C. reinhardtii then discuss these 
in relation to how they might be used for successful triterpene metabolic 
manipulations in this alga. 
Metabolic engineering in C. reinhardtii has been approached by 
introducing transgenes into either the nuclear or chloroplast genomes using a 
variety of methodologies (for review, see Wang et al. 2012, Potvin and Zhang 
2010).96,97 Recombinant DNA is thought to integrate randomly into the nuclear 
genome through non-homologous end joining98–100, whereas integration into the 
chloroplast genome has been shown to proceed through homologous 
recombination.101 While the latter offers better genetic precision and higher levels 
of protein accumulation, no significant manipulations of chloroplast metabolism 
have been reported other than those associated with loss-of-function mutants.102 
Causes for this may include protein misfolding although molecular chaperones 
are found in C. reinhardtii chloroplasts, or lack of the proper post-translational 
modifications that are needed for enzyme activity.103 Although less precise, 
nuclear expressed transgenes offer advantages not only for protein folding and 
post-translational modifications, but also the ability to target enzymes to various 
subcellular locales. Unfortunately, nuclear genetic engineering in C. reinhardtii 
has been plagued by low-level transgene expression.104,105 
Transgene promoter analyses have suggested that the transgene 
expression problems in C. reinhardtii might be due to nuclear gene silencing, 
which occurs through a chromatin based, epigenetic mechanism (histone 
methylation/acylation).106 With the Hsp70A promoter upstream of the RbcS2 
promoter and Ble gene, Strenkert et al. (2013) showed that less repressive 
chromatin states were present near the chimeric promoter and also proposed an 
important role for heat shock factor 1 (HSF1) in promoting Ble transgene 
expression.106 In addition, a study by Kumar et al. (2013) demonstrated optimal 
luciferase transgene expression when the C. reinhardtii PsaD gene promoter was 
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used in comparison to other regularly cited promoters; importantly, these authors 
observed that the terminator played a more critical role than previously 
thought.104 The PsaD gene is a highly expressed, intron-less nuclear gene that 
directs its protein product to the chloroplast via an amino-terminal signal 
sequence.107 Furthermore, Kumar et al. (2013) also determined that 
transformation with linear DNA excised from the original vector backbone was 
more efficient for recovery of transgenic lines and transgene expression.104  
Rasala et al. (2012) developed an alternative approach to 
promoter/terminator choice for increasing transgene expression in C. reinhardtii 
by exploiting the foot-and-mouth-disease-virus (FMDV) 2A self-cleavage linker 
sequence.18 When the FMDV 2A sequence is present in an mRNA transcript, a 
peptide bond in the FMDV 2A linker sequence is skipped by the ribosome during 
translation.109 Rasala et al. (2012) placed the FMDV 2A sequence in between the 
Ble and GFP genes that were under control of one promoter such that a 
polycistronic mRNA was produced.108 When translated, two separate 
polypeptides were produced due to the FMDV 2A sequence. In effect, the cell 
was forced to express both proteins for survival because of the imposed 
antibiotic selection.18 These authors were able to obtain zeocin resistant colonies 
that exhibited diffuse GFP fluorescence, which suggested that Ble and GFP were 
expressed and functional. They also utilized this methodology to express an 
active xylanase enzyme that accumulated in the media due to a secretion signal 
sequence appended to the xylanase gene.108 Presumably, this technology could 
also be used to target enzymes to various subcellular locales such as the 
endoplasmic reticulum or chloroplast.105,108  
In addition to construct design and transformation methodology, C. 
reinhardtii strains UVM4 and UVM11 were developed by Neupert et al. (2009) for 
higher-efficiency expression of non-selectable transgenes.110 First, an emetine 
resistance gene was introduced that was capable of supporting only low levels of 
antibiotic resistance (5 mg/L).110 The resulting transgenic line (Elow47) was then 
mutagenized with ultra-violet (UV) irradiation and selected for mutants capable of 
withstanding much higher emetine levels (120 mg/L). Two mutant lines, UVM4 
and UVM11, were isolated from this effort. Nuclear encoded fluorescent protein 
genes were subsequently introduced in the Elow47 and UVM lines. They were 
shown to accumulate more in the UVM4 and UVM11 lines (~0.2% total soluble 
protein) versus the Elow47 parent line (not detected).110 More recently, Kong et 
al. (2013) integrated the C. reinhardtii squalene synthase (CrSS) into the nuclear 
genome of the UVM strains under control of an Hsp70A/RbcS2 chimeric 
promoter.111 Protein levels of the epitope-tagged CrSS assessed in these studies 
were found to be higher when compared to the control strain; no squalene 
synthase enzyme activity measurements or squalene product accumulation 
determinations were reported.111 Other important aspects identified for 
successful expression of nuclear encoded transgenes in C. reinhardtii include the 
presence of introns, codon optimization, and exogenous vs. endogenous CDS 
(reviewed by Gimpel et al. (2013), Georgianna et al. (2012), Wang et al. (2012) 
and Hyka et al. (2012)).41,44,97,112 However, despite all the advances in algal 
biotechnology, no precedent setting examples have been published for algae 
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metabolically engineered to produce high levels of terpenoids from nuclear 
encoded transgenes.113–118 
Examples from higher plants have shown that exploitation of subcellular 
targeting can greatly affect terpene product accumulation. Wu et al. (2006) 
demonstrated that targeting farnesyl diphosphate synthase (FPS) and patchoulol 
synthase (PTS, sesquiterpene synthase) to the chloroplast of Nicotiana tabacum 
(tobacco) via nuclear encoded transgenes with chloroplast localization 
sequences afforded the highest levels of terpenes recorded yet.119 A similar effort 
by the same group also demonstrated high levels of squalene (triterpene) 
accumulation in tobacco using the same subcellular localization strategy (Figure 
4.1).120 These results suggested more stringent regulation of prenyl diphosphate 
substrate channeling via the cytoplasmic MVA pathway in higher plants, whereas 
flux through the plastidic MEP pathway into non-native sesquiterpene and 
triterpene products experienced much less regulation. With such results for 
higher plants, we asked whether a similar approach might be utilized for 
engineering triterpene metabolism in C. reinhardtii.  
Unlike higher plants, however, the MVA and MEP biosynthetic pathways 
responsible for supplying isopentenyl diphosphate (IPP) are dispersed differently 
in algae, a variable that must be taken into consideration before an engineering 
strategy is chosen. Primary endosymbiotic algae such as glaucophyta and 
rhodophyta (red algae) typically possess both the MVA and MEP pathways, 
whereas chlorophyta (green algae) only harbor the plastidic MEP pathway. 
Secondary endosymbiotic algae phyla euglenophyta, chlorarachniophyta, and 
heterokontophyta generally utilize both pathways (for review, see Lohr et al. 
2012).121 A second variable to consider is the metabolite of interest chosen for 
engineering. Enzymes are known that efficiently catalyze squalene and 
botryococcene,36 thus either metabolite could presumably be engineered for 
accumulation in an algal host. From an endpoint perspective, engineering 
botryococcene accumulation might be easier because this molecule would 
represent a metabolic dead end in C. reinhardtii. Squalene, however, could be 
channeled into and potentially corrupt the native sterol biosynthetic pathway, 
which might lead to undesirable consequences. 
While the long-range objective has been ultimately to engineer novel 
triterpene biosynthesis into C. reinhardtii, our initial strategy was influenced by 
previous success in developing a yeast terpene production platform. That effort 
utilized a relatively simple screen for farnesol (FOH) accumulation, the 
dephosphorylated form of FPP.89 FOH readily forms in yeast when FPP 
accumulates because of the naturally occurring, high phosphatase activity.  
Hence, we assumed that a first step in learning how to engineer terpene 
metabolism in C. reinhardtii might be to overexpress a robust FPP synthase 
(FPS) followed by FOH accumulation measurements. If we were successful in 
engineering FPS activity and observing FOH accumulation, then we could use 
that information to couple overexpression of a particular triterpene synthase with 
FPS to achieve elevated triterpene biosynthetic capabilities (Figure 4.2). Hence, 
our initial approach was to demonstrate robust nuclear transformation efficiencies 
followed by FOH measurements for transgenic lines expressing a heterologous, 
	   109 
robust FPS with and without a chloroplast targeting sequence. Unfortunately, we 
were never able to reliably observe elevated FOH levels. Subsequent efforts 
were undertaken to introduce both FPS and botryococcene synthase activities 
into C. reinhardtii but were also unsuccessful. 
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Figure 4.1 Assessment of the strategy for squalene metabolic engineering in 
tobacco where enzymes were directed to the cytosol or chloroplast 
compartments to affect carbon flux through the MVA (cytosol) and MEP 
(chloroplast) pathways.119,120 Genes encoding FPP synthase and squalene 
synthase were introduced into the nuclear genome of tobacco cells under control 
of strong, constitutive promoters and targeted to either the cytoplasm (left panel) 
or chloroplast (right panel). The transgenic lines regenerated were propagated in 
the greenhouse and leaves at different stages of development (i.e. small, upper 
leaves = young; larger, lower, fully-expanded leaves = mature) were sampled for 
squalene content by GC-MS.    
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Figure 4.2 Proposed metabolic engineering scheme to engineer production of 
botryococcene in the green alga Chlamydomonas reinhardtii. Transgenes would 
be introduced into the nuclear genome in order to target enzymes to the 
cytoplasm (blue arrows) or chloroplast (purple arrows), allowing for an 
assessment of carbon flux through the chloroplast localized MEP pathway or the 
partial MVA pathway resident in the cytoplasm.122   
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Results 
  
 First-generation nuclear transformation vectors. To determine if robust 
nuclear transformation efficiencies could be achieved and if elevated farnesol 
accumulation could be detected, a series of vectors were constructed from the 
pHsp70A/RbcS2-Chlamy123 (pHRC) vector obtained from chlamycollection.org. 
This vector contained a luciferase gene under the control of an Hsp70A/RbcS2 
chimeric promoter equipped with intron1 from the RbcS2 gene and the RbcS2 3’ 
UTR. To construct the pHRC vector series, the luciferase gene was excised and 
replaced with a synthetic FPS construct (acFPS) that encoded the Gallus gallus 
FPP synthase. acFPS was optimized for expression in C. reinhardtii by altering 
the coding sequence to match C. reinhardtii codon bias and high GC-content. 
The G. gallus FPS protein sequence was used to avoid possible endogenous 
regulatory mechanisms that might be imposed on a native or similar green algal 
FPS. Targeting to the chloroplast compartment was directed by the chloroplast 
signal sequence (tp) from the C. reinhardtii RbcS2 gene placed upstream of 
acFPS. Because it was previously shown that transformation efficiency was 
highest when both gene-of-interest and antibiotic resistance gene were 
introduced into the nuclear genome from the same plasmid versus co-
transformation with two separate plasmids,123 we relied on the double-gene 
expression constructs. The paromomycin resistance gene from pKS-aphVIII-
lox123 (also obtained from chlamycollection.org) was therefore PCR amplified with 
5’ EcoRV and 3’ XbaI sites and introduced into the corresponding sites in the 
pHRC vector backbone. The newly created vectors that contained the 
paromomycin resistance gene (aphVIII)124 under control of the beta2-tubulin 
promoter (β2Tub) and chlamyopsin1 (COP1) 3’ UTR were named pHRC1-acFPS 
(cytosolic targeted) and pHRC1-tpacFPS (chloroplast targeted) (Figure 4.3). An 
empty vector (pHRC1) was also created for use as a control by introducing a 
multiple cloning site (MCS1) in place of the acFPS gene in pHRC1-acFPS. 
Efficiency of nuclear transformation with pHRC1 vectors. Nuclear 
transformation efficiencies were obtained by transforming vectors into three C. 
reinhardtii strains: CC-503 cw92 (shorthand cc503), UVM4, and UVM11. cc503 is 
a cell wall deficient strain originally isolated in a mutant study geared toward 
dissection of cell-wall components,125 but more recently repurposed for 
facilitating isolation of genomic DNA for sequencing and easier transformation 
with foreign DNA. UVM4 and UVM11 were isolated in an effort to circumvent the 
transgene expression problems in C. reinhardtii.110 Electroporation was chosen 
as the method of transformation because it was shown to yield better 
transformation efficiency when compared to glass bead beating mediated 
transformation.126 The negative control for these experiments was cells 
transformed with no plasmid DNA. For the positive control, the pSI103124 vector 
(chlamycollection.org) was used because the pHRC1 vector was not fully 
constructed at the time. The pSI103 vector contained the paromomycin 
resistance enzyme similar to the pHRC vectors, but was under control of an 
Hsp70A/RbcS2 chimeric promoter and RbcS2 3’ UTR instead of the β2Tub 
promoter and COP 3’ UTR. Robust transformation efficiency was demonstrated 
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Figure 4.3 First-generation C. reinhardtii nuclear transformation vectors. Vectors 
were derived from pHsp70A/RbcS2-Chlamy and pKS-aphVIII-lox and meant to 
target the acFPS enzyme to either the cytosol (pHRC1-acFPS) or chloroplast 
(pHRC1-tpacFPS) compartments for an assessment of farnesol accumulation.  
β2Tub, C. reinhardtii beta2-tubulin promoter; in1, C. reinhardtii RbcS2 intron1; 
aphVIII, Streptomyces rimosus aminoglycoside 3'-phosphotransferase VIII; COP, 
C. reinhardtii chlamyopsin1 3’ UTR; Hsp70A/RbcS2, chimeric promoter; MCS1 
(XhoI-AatII-AclI-AgeI-ApeI-BamHI); RbcS2, C. reinhardtii RbcS2 3’ UTR; acFPS, 
Gallus gallus FPS gene codon optimized for C. reinhardtii expression; tp, C. 
reinhardtii RbcS2 chloroplast signal sequence. 
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in this experiment, particularly for the UVM4 and UVM11 strains with the pHRC1 
vectors (Figure 4.4). Much lower transformation efficiencies were observed for 
the cc503 strain and pSI103 vector. While not a direct comparison between 
vectors because of differences in plasmid backbones, it seemed that the aphVIII 
gene under control of the β2Tub promoter (pHRC1 vectors) was either more 
efficient at nuclear integration or served as a better expression construct than the 
aphVIII gene with the chimeric promoter (pSI103). Nonetheless, these 
experiments provided evidence that robust nuclear transformations could be 
accomplished, a pivotal accomplishment for future experiments where many 
independent lines would be needed for chemical profiling to identify high 
producers. 
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Figure 4.4 Nuclear transformation efficiency in C. reinhardtii. cc503, UVM4, and 
UVM11 C. reinhardtii strains were transformed with no DNA, pSI103, pHRC1-
acFPS, or pHRC1-tpacFPS vectors via electroporation with 5 µg of plasmid DNA. 
Two independent transformations (designated by A or B after plasmid names) 
were performed for each assessment. After 24 hours of recovery, cells were 
plated on TAP media with 30 mg/L paromomycin and grown under 23:1 
(light:dark) fluorescent lights for seven days until colonies were distinctly visible 
for scoring. 
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 Verification of transgene insertion and farnesol accumulation 
measurements. After excellent transformation efficiencies were established with 
the UVM algae strains and pHRC1 vectors, independent transgenic lines were 
subjected to a genomic DNA PCR analysis to check for the presence of the 
acFPS transgene. Good genomic DNA preparations achieved with the “QUICK 
AND EASY” method were verified by primers that amplified a small section of the 
light harvesting complex I (LHCa) gene; all preps showed amplification of a 
distinct product with the proper size (~500bp). The percentage of paromomycin 
resistant lines that tested PCR positive for the presence of the acFPS gene were: 
UVM4:pHRC1-acFPS = 40.6% (13 of 32); UVM4:pHRC1-tpacFPS = 12.3% (14 
of 114); UVM11:pHRC1-acFPS = 43.8% (14 of 32); and UVM11:pHRC1-tpacFPS 
= 26.6% (8 of 30). PCR positive transgenic lines were grown and tested for the 
presence of farnesol. None of the transgenic lines that were extracted and 
assessed via GC-FID had detectable levels (>1 ng) of FOH. 
Second-generation nuclear transformation vectors. Because engineering 
botryococcene accumulation in C. reinhardtii rather than FPP alone might be a 
more benign impact on cellular metabolism, we were stimulated to develop a 
second generation of gene constructs. The enzymes responsible for 
botryococcene production in B. braunii have been characterized and shown to be 
functional in Saccharomyces cerevisiae not only as independently expressed 
enzymes, but also as a fusion enzyme.36 The latter was important because not 
only did the fusion enzyme lead to higher product titers in yeast, but it also only 
required one additional promoter/terminator for gene expression instead of two. 
The additional promoter/terminator chosen to drive expression of the SSL1-SSL3 
fusion enzyme was from the Dunaliella tertiolecta RbcS1 gene that was shown to 
support expression of the Ble gene in C. reinhardtii.127 Using these additional 
sequences, a second series of vectors were constructed from the pHRC1 vector. 
First, pHRC2f was constructed by introducing the D. tertiolecta RbcS1 regulatory 
elements with a multiple cloning site (MCS2) in-between into the KpnI site of 
pHRC1. This vector was created for use as an empty vector control or testing 
additional constructs in the future. The acFPS and SSL1-SSL3 coding 
sequences were sequentially introduced to produce pHRC2f-acFPS-SSL1-SSL3; 
this vector was then used to introduce the tp sequence upstream of the acFPS 
and SSL1-SSL3 coding sequences to produce pHRC2f-tpacFPS-tpSSL1-SSL3 
(Figure 4.5). As before, all pHRC2f vectors contained the previously described 
aphVIII paromomycin resistance marker. These vectors were transformed into 
the UVM strains. Many independent lines that were resistant to paromomycin 
were obtained.  Unfortunately, these transgenic lines were not chemically profiled 
or assessed in any other fashion.  
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Figure 4.5 Second-generation C. reinhardtii nuclear transformation vectors. 
Vectors were derived from pHRC1 and meant to target acFPS and SSL1-SSL3 
enzymes to either the cytosol (pHRC2f-acFPS-SSL1-SSL3) or chloroplast 
(pHRC2f-tpacFPS-tpSSL1-SSL3) compartments to afford an assessment of 
botryococcene accumulation in C. reinhardtii. Not shown is the aphVIII 
paromomycin resistance construct under control of the C. reinhardtii beta2-
tubulin (β2Tub) promoter and C. reinhardtii chlamyopsin1 (COP) 3’ UTR. MCS1 
(XhoI-AatII-AclI-AgeI-ApeI-BamHI); MCS2 (XmaI-ClaI-NsiI-PciI-SpeI-AvrII); 
RbcS2 3’ UTR, C. reinhardtii RbcS2 3’ UTR; acFPS, Gallus gallus FPS gene 
codon optimized for expression in C. reinhardtii; SSL1-SSL3, B. braunii 
botryococcene synthase; RbcS1 3’ UTR, D. tertiolecta RbcS1 3’ UTR; tp, C. 
reinhardtii RbcS2 chloroplast signal sequence. 
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Third-generation nuclear transformation vectors. With the emergence of 
the FMDV 2A self-cleavage peptide technology105,108 that was demonstrated to 
be functional in C. reinhardtii and another study that provided evidence for 
averting gene silencing mechanisms in C. reinhadtii,106 a third series of vectors 
were constructed. The pHRC2f vector was used to append the FMDV 2A 
sequence downstream of the aphVIII coding sequence followed by the acFPS 
coding sequence with and without the tp sequence (Figure 4.6). This setup was 
used because the aphVIII resistance enzyme under control of the C. reinhardtii 
β2Tub and COP regulatory elements was demonstrated as functional in previous 
experiments. For exploitation of the FMDV 2A technology in expressing the 
SSL1-SSL3 fusion enzyme, another antibiotic resistance enzyme was necessary. 
The pMS188106 vector was chosen because it contained an Hsp70A/RbcS2 
chimeric promoter that was shown to be most effective at combating silencing of 
the Ble transgene when compared to a series of other Hsp70A/RbcS2 chimeric 
promoters. This vector was obtained from chlamycollection.org and similar to 
construction of the pHRC2f-aphVIII2A-(tp)acFPS vectors generated, the FMDV 
2A sequence was introduced downstream of the Ble gene followed by the SSL1-
SSL3 fusion enzyme sequence with and without the tp sequence (Figure 4.6).  
These vectors were co-transformed into the UVM4 strain and selected on 
the suggested antibiotic concentrations (15 mg/L zeocin and 30 mg/L 
paromomycin). When UVM4 was co-transformed with the pHRC2f and pMS188 
empty vectors, numerous colonies were obtained which suggested that the 
double antibiotic selection in C. reinhardtii was possible. However, no colonies 
were ever obtained when the experimental constructs were co-transformed. 
Numerous colonies were obtained when only one of the experimental vectors 
was transformed followed by selection on the appropriate single antibiotic. This 
outcome occurred for two independent experiments. These results suggested 
two possibilities: either the experimental constructs that were tested produced 
inactive resistance enzymes due to the remaining FMDV 2A peptide sequence at 
their C-terminal ends or the double antibiotic selection in concert with the 
transgenes expressed was too much metabolic burden for the cells to tolerate. 
The former seems unlikely as colonies were obtained on single antibiotic 
selection when the FMDV 2A vectors were transformed into UVM4 individually. A 
follow up experiment should be conducted to test if colonies appear with lower 
antibiotic concentrations for the double selection after co-transformation of both 
FMDV 2A vectors. If colonies are obtained, they could then be tested on 
increasing concentrations of antibiotics to provide additional confidence 
transgenic lines harbor both selection marker genes and that they are being 
significantly expressed.  
 
 
 
	   119 
 
Figure 4.6 Third-generation C. reinhardtii nuclear transformation vectors. Vectors 
were derived from pHRC2f and pMS188. Genes-of-interest were placed 
downstream of an antibiotic resistance gene and the FMDV 2A self-cleavage 
sequence which produces a polycistronic mRNA. When translated, the mRNA 
results in two separate protein products because a peptide bond is skipped by 
the ribosome in the FMDV 2A sequence. β2Tub, C. reinhardtii beta2-tubulin 
promoter; in1, C. reinhardtii RbcS2 intron1; aphVIII, Streptomyces rimosus 
aminoglycoside 3'-phosphotransferase VIII; 2A; foot-and-mouth-disease-virus 
polyprotein self-cleavage sequence; acFPS, Gallus gallus FPS codon optimized 
for expression in C. reinhardtii; COP, C. reinhardtii chlamyopsin1 3’ UTR; 
Hsp70A/RbcS2, chimeric promoter; Ble, bleomycin/zeocin resistance enzyme; 
RbcS2 3’ UTR, C. reinhardtii RbcS2 3’ UTR; tp, C. reinhardtii RbcS2 chloroplast 
signal sequence. 
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Discussion 
 
 Lackluster reports for Chlamydomonas reinhardtii terpenoid engineering 
and more general metabolic engineering insinuates underlying issues that have 
not yet been fully appreciated.113–118 One area that has been investigated 
extensively is construct design for nuclear transformation while another has been 
host strain development geared towards increasing efficiency of transgene 
expression. For the former, the FMDV 2A self-cleavage technology developed by 
Rasala et al. (2012) coupled with expression controlled by the PsaD promoter 
described by Kumar et al. (2013) might be the best available option for high-level 
transgene expression.104,105,108 The latter, tackled with the creation of the C. 
reinhardtii UVM strains, offers the best avenue for host choice to achieve 
successful transgene expression in this alga.110 Using these technologies 
together may be the superior route for assessing metabolic engineering efforts in 
C. reinhardtii. Overcoming the nuclear transgene expression problem in C. 
reinhardtii and presumably other green algae is just one of many technological 
developments that are needed before complex genetic engineering efforts such 
as expressing the entire MVA pathway in the cytosol of a green alga or adding 
extra copies of the MEP pathway enzymes can be reasonably assessed. 
High titers of naturally occurring algal terpenoids are clearly possible as 
observed for Dunaliella salina128 and Botryococcus braunii race B.62 But how 
these algae accomplish this and what the feasibility is that these mechanisms 
can be captured and deployed in other algae species remains to be determined. 
B. braunii race B accumulates 30% of its mass in triterpene oils, albeit at the cost 
of growth rate.62 Increased growth rates can be achieved under various culture 
conditions while maintaining high levels of hydrocarbon production95 – 
engineered strains that accomplish this have not been reported. Moreover, B. 
braunii hydrocarbon production and secretion into the extracellular matrix seems 
to be intimately linked with the cell cycle129,130 making prospects for deployment 
of this mechanism into other algae quite daunting. Thus, using B. braunii as a 
design template for terpenoid metabolic engineering approaches may not be as 
fruitful as other algae such as Dunaliella salina. This halophilic, marine green 
alga can accumulate 10-15% of its mass in β-carotene that is stored in plastid 
globules, and it can also form cytoplasmic globules of TAGs produced during 
stress inducing conditions.128,131–134 If the carotenogenic biosynthetic enzymes 
were knocked down/out, IPP in the chloroplast might be available for diversion 
towards the production of a designer isoprenoid. Such efforts could be bolstered 
if extra copies of DXS (a putative rate-limiting MEP enzyme) were introduced into 
the nuclear genome with chloroplast signal sequences. Nuclear copies of 
isopentenyl diphosphate isomerase (idi), farnesyl diphosphate synthase (FPS) 
and botryococcene synthase (BS) could then be introduced and targeted to the 
cytoplasm. In effect, substrates originally found in the chloroplast (pyruvate and 
G3P) might be channeled into IPP, which could then be drawn into the cytoplasm 
and channeled into botryococcene biosynthesis. These considerations are simply 
speculation until the technological means for facile genetic engineering in algae 
advances. 
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Another key area for successful metabolic engineering efforts in the future 
will be to understand algae-specific oleaginous traits. New ‘omics’ studies that 
have emerged suggest these play key roles in the ability of certain species to 
accumulate their respective lipid. For example, in the heterokont 
Nannochloropsis sp., gene dosage (13 copies of DGAT vs. 4 in C. reinhardtii) 
seems to be extremely important for accumulating high levels of TAGs.25 
Moreover, B. braunii race B constitutively expresses three distinct genes for 
DXS,137 presumably to promote high carbon flux through the MEP pathway to 
support the biosynthesis and accumulation of the abundant triterpene molecules. 
Such in silica predictions that are allowed by thorough, ‘omics’ information may 
help to improve the success rate for synthetic biology designs aimed at 
engineering metabolism in intractable organisms like algae.138 
Currently, green algae are blank slates for testing new strategies to 
engineer terpenoid accumulations. Emerging information about specialized green 
algae metabolism will buttress systems/synthetic biology approaches where 
carbon fluxes are optimized among various cellular pathways in order to achieve 
maximum growth and metabolite production rates. Coupled with improved 
genetic engineering methodology, thorough bioinformatics, machine learning, 
and network flux analyses, new strategies will appear for the successful 
manipulation of terpenoid metabolism in green algae. 
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Materials and Methods 
  
Construction of first-generation vectors. All primers used for constructs 
used in algae work can be found in Table 4.1. A synthetic FPS gene based on 
the avian (Gallus gallus) FPS protein sequence was codon optimized and 
synthesized by Genscript with the C. reinhardtii RbcS2 chloroplast targeting 
sequence (tp) appended to the 5’ end and flanked on both side by MfeI sites; this 
sequence (tpacFPS) was received in pUC57. The tpacFPS sequence was PCR 
amplified with 5’ XhoI MfeI tp and 3’ BamHI acFPS primers; this PCR product 
was then XhoI/BamHI double digested and ligated into pHsp70A/RbcS2-
Chlamy123 (pHRC) obtained from chlamycollection.org that had been digested 
with XhoI and BamHI to release the crluc coding sequence. Individual clones 
were then isolated and sequence verified; the new vector was titled pHRC-
tpacFPS. pHRC-tpacFPS was digested with MfeI to release the tp sequence then 
allowed to re-ligate. Individual clones were isolated and sequence verified; the 
new vector was titled pHRC-acFPS. The aphVIII gene cassette from pKS-
aphVIII-lox was then introduced into pHRC-acFPS and pHRC-tpacFPS EcoRV 
and XbaI sites by first amplifying it with 5’ EcoRV β2Tub Pro and 3’ XbaI COP 3’ 
UTR primers, digesting the PCR product with EcoRV and XbaI, then ligating it 
into the appropriately digested pHRC vectors. Independent clones were isolated 
and sequence verified. These vectors were titled pHRC1-acFPS and pHRC1-
tpacFPS. pHRC1 empty vector was created by digesting pHRC1-acFPS with 
XhoI and BamHI to release acFPS then ligating in 5’ pHRC MCS1 and 3’ pHRC 
MCS1 primers designed to anneal such that they had XhoI and BamHI sticky 
ends. Independent clones were isolated and sequence verified. 
Construction of second-generation vectors. Genomic DNA isolated from 
D. tertiolecta was used as template to PCR amplify 236bp of the RbcS1 promoter 
with 5’ KpnI D.tert RbcS1 Pro -236 and 3’ KpnI/NheI/AvrII/XmaI D.tert RbcS1 Pro 
primers; the RbcS1 terminator was PCR amplified with 5’ AvrII D.tert RbcS1 
Term and 3’ NheI D.tert RbcS1 Term primers. These PCR products were ligated 
into pGEM-T Easy, independent clones were isolated, then sequence verified.  
The pGEM-T Easy plasmid with D. tertiolecta RbcS1 terminator flanked by 5’ 
AvrII and 3’ NheI sites was digested to release the AvrII/NheI fragment which 
was subcloned into the pGEM-T Easy plasmid with the RbcS1 promoter 
containing AvrII and NheI sites at the 3’ end of the introduced fragment. After 
sequence verification, this new vector with the D. tertiolecta RbcS1 promoter and 
terminator was digested with AvrII and XmaI so that the 5’ pHRC MCS2 and 3’ 
pHRC MCS2 primers designed to anneal with AvrII and XmaI sticky ends could 
be ligated in. Independent clones were isolated and sequence verified then used 
in a KpnI digestion to release the entire cassette for subcloning into pHRC1 that 
was KpnI digested; clones sequence verified with the cassette in the forward 
direction were kept and titled pHRC2f. Next, pHRC2f-tpacFPS was created by 
subcloning tpacFPS as a XhoI/BamHI fragment from pHRC1-tpacFPS; a 
sequence verified pHRC2f-tpacFPS clone was then digested with MfeI to release 
the tp sequence. The vector backbone was then allowed to self-ligate creating 
pHRC2f-acFPS. SSL1-SSL3 fusion enzyme was PCR amplified from plasmid  
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Table 4.1 Primers used for cloning and screening algae constructs.  
Primer 5’ à 3’ Sequence 
5' XhoI/MfeI tp tcccctcgagcaattgatggccgccgtcattgcc 
5' XhoI/MfeI acFPS tccccccgggcaattgatgcacaagttcaccggcgtgaacg 
3' BamHI acFPS cgcggatccttacttctggcgcttgtagatcttctgcg 
5' EcoRV β2Tub Pro ccggatatctctttcttgcgctatgacacttcc 
3' XbaI COP 3' UTR ctagtctagagtaccatcaactgacgttacattc 
5’ pHRC MCS1 tcgaggacgtcaacgttaccggtgggcccg 
3’ pHRC MCS1 gatccgggcccaccggtaacgttgacgtcc 
5' KpnI D.tert RbcS1 Pro -236 cggggtaccgcacttgcattcttccttgcatcc 
3' KpnI/NheI/AvrII/XmaI D.tert 
RbcS1 Pro 
ggtaccgctagccctaggcccgggtgtgtgttttgtgaagggtg
tgtgg 
5' AvrII D.tert RbcS1 Term ctagcctagggctgttagcacagcacttgcc 
3' NheI D.tert RbcS1 Term ctagctagcccatcctttctgtactgcttatacag 
5’ pHRC MCS2 ccgggatcgatatgcatacatgtactagtc 
3’ pHRC MCS2 ctaggactagtacatgtatgcatatcgatc 
5’ SpeI/EcoRI SSL-1 ggactagtgaattcatgactatgcaccaagaccacg 
3’ AvrII SSL-3 ctagcctaggttaagcacccttagctgaaacc 
3' AphVIII-2A gcttcagcaggtcgaagttcagggtctgcttcaccggggcgaa
gaactcgtccaacagcc 
5' 1st 2A-MfeI-acFPS ctggcgggcgacgtggagagcaacccgggcccccaattgat
gcacaagttcaccggcgtg 
5' 2nd 2A-MfeI-acFPS ggtgaagcagaccctgaacttcgacctgctgaagctggcggg
cgacgtggagagcaaccc 
3' acFPS-G8-flag tcatccttgtaatcgccaccgccaccgccaccgccacccttctg
gcgcttgtagatcttc 
5' G8-flag-COP ggtggcggtggcgattacaaggatgacgacgataagtgagg
gacctgatggtgttggtgg 
5' SphI-pMS188-Ble acatgcatgcagcccctggagcggtgccctcctg 
3' 1st BamHI EcoRI 2ABle gctctccacgtcgcccgccagcttcagcaggtcgaagttcagg 
3' 2nd BamHI EcoRI 2ABle 
 
cgggatccgaattcggggcccgggttgctctccacgtcgcccg
ccagc 
5' EcoRI-SSL1 cggtgaagcagaccctgaacttcgacctgctgaagctggcgg
gcgacgtggagagcaacc 
3' 1st SSL1-G8-myc-Linker 
 
tcaacttctgttcgccaccgccaccgccaccgccacccttggtg
ggagttggggctgcgc 
3’ 2nd SSL1-G8-myc-Linker ccagaaccaccaccagaaccaccgaggtcttcttcggaaatc
aacttctgttcgccaccg 
5’ Linker-SSL3 v2 gttctggtggtggttctggtggtggttctggtatgaaacttcggga
agtcttgcagcacc 
3' BamHI-pMS188-SSL3 cgggatcctctagagtcgggtcgacgtcggtcaagcaccctta
gctgaaacctttcc 
5' SSL3 (-BamHI 663bp) IF ggaggatgtcttggaggaccctcctcgcatctggtgg 
3' SSL3 (-BamHI 663bp) IR ccaccagatgcgaggagggtcctccaagacatcctcc 
5' SSL3 (-BamHI 1047bp) IF ccaagtgtgtgagggaggaccccaactttgcactcacag 
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Table 4.1 (continued) 
3' SSL3 (-BamHI 1047bp) IR ctgtgagtgcaaagttggggtcctccctcacacacttgg 
5' LHCa 3'UTR gcgcctctctcttgagttgagtgg 
3' LHCa 3'UTR cccatggtacgtttacaggaaagg 
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DNA obtained from Niehaus et al. (2011) using primers 5’ SpeI/EcoRI SSL-1 and 
3’ AvrII SSL-3. This PCR product was digested with SpeI and AvrII then ligated 
into pHRC2f-acFPS and pHRC2f-tpacFPS SpeI and AvrII sites in MCS2. 
Sequence verified clones were titled pHRC2f-acFPS-SSL1-SSL3 and pHRC2f-
tpacFPS-SSL1-SSL3. pHRC2f-tpacFPS-SSL1-SSL3 was then digested with 
EcoRI and ligated with a EcoRI/EcoRI tp fragment to afford pHRC2f-tpacFPS-
tpSSL1-SSL3. The correct direction of the newly inserted tp sequence was 
sequence verified. 
Construction of third-generation vectors. To construct pHRC2f-aphVIII2A-
acFPS, a sequence overlap extension PCR strategy was employed. Four 
different PCR reactions were performed as follows: 1) pHRC2f as template with 
5’ EcoRV β2Tub Pro and 3’ aphVIII-2A primers to amplify the β2Tub promoter 
and aphVIII with 2A appended to the 3’ end of aphVIII, 2) pHRC1-acFPS as 
template with 5’ 1st 2A-MfeI-acFPS and 3’ acFPS-G8-flag primers to append a 
portion of 2A to the 5’ end and a FLAG epitope spaced by an octa-glycine (G8) 
linker139 to the 3’ end of acFPS, 3) PCR product from reaction 2 as template with 
5’ 2nd 2A-MfeI-acFPS and 3’ acFPS-G8-flag primers to finish appending the 2A 
sequence to the 5’ end of acFPS, and 4) pHRC2f as template with 5’ G8-flag-
COP and 3’ XbaI COP 3’ UTR primers to add overlapping sequence to the COP 
3’ UTR. In a fifth reaction, PCR products from reactions 1, 3, and 4 were used as 
template with 5’ EcoRV β2Tub Pro and 3’ XbaI COP 3’ UTR primers to assemble 
the entire construct. The PCR product was double digested with EcoRV/XbaI and 
ligated into purified pHRC2f vector backbone that was digested with EcoRV and 
XbaI. Positive clones were identified and sequence verified; this vector was titled 
pHRC2f-aphVIII2A-acFPS. MfeI was used to linearize pHRC2f-aphVIII2A-acFPS 
so that an MfeI/MfeI tp fragment could be introduced in-frame at the 5’ end of 
acFPS. Independent clones were isolated and sequenced to verify the correct 
orientation of the tp sequence. This new vector was titled pHRC2f-aphVIII2A-
tpacFPS.  
Another SOE PCR strategy was employed to construct the pMS188-
Ble2A-SSL1-SSL3 and pMS188-Ble2A-tpSSL1-SSL3 with a few additional steps. 
First, a pMS188-Ble2A plasmid was generated that removed the TAA for the Ble 
gene and introduced the 2A sequence and an EcoRI site. This was accomplished 
by first PCR amplifying Ble from pMS188 with the 5’ SphI pMS188 Ble and 3’ 1st 
BamHI EcoRI 2ABle primers then using this PCR product as template in a 
second reaction with 5’ SphI pMS188 Ble and 3’ 2nd BamHI EcoRI 2ABle primers. 
The PCR product of the second reaction was SphI/BamHI double digested and 
ligated into pMS188 backbone digested with SphI/BamHI. Second, to afford use 
of the introduced EcoRI site and a BamHI site already present in the pMS188-
Ble2A plasmid to clone in SSL1-SSL3, two BamHI sites were synonymously 
mutated in SSL-3 and a G8 linker-myc epitope was introduced to give the 
following: EcoRI-SSL1-G8-myc-linker-SSL3-BamHI. This was accomplished 
using SOE PCR as follows: 1) pET28a:SSL-1 was used as template with 5’ 
EcoRI SSL1 and 3' 1st SSL1-G8-myc-Linker primers, 2) PCR product from 
reaction 1 was used as template with 5’ EcoRI SSL1 and 3’ 2nd SSL1-G8-myc-
Linker primers, 3) pET28a:SSL-3 was used as template with 5’ Linker-SSL3 v2 
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and 3’ SSL3 (–BamHI 663bp) IR primers, 4) pET28a:SSL-3 was used as 
template with 5’ SSL3 (-BamHI 663bp) IF and 3’ SSL3 (-BamHI 1047bp) IR 
primers, 5) pET28a was used as template with 5’ SSL3 (-BamHI 1047bp) IF and 
3' BamHI-pMS188-SSL3 primers, and 6) PCR products from reactions 3, 4, and 
5 were used as template with 5’ Linker-SSL3 v2 and 3’ BamHI-pMS188-SSL3 
primers. In a seventh reaction, PCR products from reactions 2 and 6 were used 
as template with 5’ EcoRI SSL1 and 3’ BamHI-pMS188-SSL3 primers to 
assemble the entire EcoRI-SSL1-G8-myc-linker-SSL3-BamHI construct. This 
PCR product was EcoRI/BamHI double digested and ligated into the 
EcoRI/BamHI double digested pMS188-Ble2A vector. Once sequence verified, 
this new vector (pMS188-Ble2A-SSL1-SSL3) was linearized with EcoRI so that 
the tp sequence flanked by EcoRI sites could be ligated in. Positive clones with 
the tp insert were identified and sequenced to verify the correct orientation of the 
tp sequence. The new vector was titled pMS188-Ble2A-tpSSL1-SSL3. 
C. reinhardtii and D. tertiolecta maintenance and media. All C. reinhardtii 
strains (CC-503 cw92, UVM4, and UVM11) used in this work were maintained on 
TAP solid media at room temperature; cultures were restreaked monthly. Dr. 
Wayne Curtis (Penn State) provided strain CC-503, while UVM4 and UVM11 
were obtained from Neupert et al. (2009). TAP media recipe was used as 
described by Gorman and Levine (1965).140 Liquid TAP cultures were typically 
grown in shake flasks under 23:1 (light:dark) fluorescent lighting with 100 rpm 
orbital shaking at room temperature. Dunaliella tertiolecta (ATCC 30929) was 
cultured in liquid f/2 media as described by Guillard and Ryther (1962) and 
Guillard (1975) but with artificial seawater replacing seawater.141,55 D. tertiolecta 
cultures were grown in shake flasks with under 23:1 (light:dark) fluorescent 
lighting with 100 rpm orbital shaking at room temperature. Genomic DNA was 
isolated from D. tertiolecta using a plant genomic DNA isolation kit from 
Promega.  
C. reinhardtii electroporation protocol for nuclear transformation. To begin, 
a starter culture was generated by inoculating 10 mL of TAP media in a 50 mL 
flask with cells from a slant culture and grown under 23:1 (light:dark) fluorescent 
lighting with 100 rpm orbital shaking for 3 days at room temperature. 500 mL of 
TAP media in a 2 L flask was inoculated with 5 mL of the starter culture and 
grown to OD550 0.4-06 (~2-3 x 108 cells/mL). Cells from 50 mL of culture were 
pelleted by centrifugation then resuspended in 700 µL TAP + 40 mM sucrose. 
Cells were transferred to 4 mm sterile cuvette with 5 µg supercoiled plasmid 
DNA, incubated on ice for 1 minute immediately prior to the electroporation 
event, making sure to wipe outside of cuvette dry before electroporation to 
prevent electrical arcing. Electroporation conditions: exponential decay, 800 V, 
25 µF, ∞ Ω. Cells were recovered by transferring from cuvette to a 50 mL flask 
with 10 mL of TAP + 40 mM sucrose then grown under 23:1 (light:dark) 
fluorescent lighting with 100 rpm orbital shaking at room temperature for 24 
hours. Cells were collected by centrifugation, resuspended in TAP media, and 
plated on solid TAP media with the appropriate antibiotic (paromomycin = 30 
mg/L; zeocin = 15 mg/L). Colonies were typically visible around 5 days and big 
enough to be restreaked around 7 days. 
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PCR screening for acFPS transgene insertion. Initial colonies obtained on 
selection were named and restreaked on fresh selection media. Once enough 
biological material was available, the "QUICK AND EASY" method described by 
Steve Pollock, Louisiana State University found at chlamy.org was used to 
prepare genomic DNA for PCR screening to check for the presence of acFPS in 
paromomycin resistant lines. 
Chemical profiling of hydrocarbon products in transgenic lines. Using only 
PCR verified transgenic lines, a 10 mL TAP media culture was grown in a 50 mL 
flask under 23:1 (light:dark) fluorescent lighting with 100 rpm orbital shaking at 
room temperature for 5 days. 1 mL of the 10 mL culture was transferred to a 4 
mL glass screw cap vial with 1 mL of acetone and vortexed vigorously 
periodically for 30 minutes then 1 mL of hexane was added followed by vigorous 
vortexing periodically for 30 minutes. After phase separation, 900 µL of the 
hexane phase was transferred to a 2 mL glass vial and dried to completion. The 
sample was resuspended in 50 µL of hexane followed by GC-FID analysis of 1 
µL using an HP-5 column with the following oven program: initial oven 
temperature held at 150°C for 1 minute followed by a 10°C/min ramp to 280°C 
then a 5°C/min ramp to 310°C which was held for 1 minute. Authentic farnesol, 
squalene, and botryococcene standards were analyzed with each sample set for 
comparison. 
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Chapter Five: Concluding Remarks 
 
 Deposited in this dissertation are new layers of enzymology knowledge for 
triterpene synthases (Chapter 2) and the foundation for a directed-evolution, 
selection platform (Chapter 3) in yeast that should allow for unbiased studies of 
squalene synthase-like (SSL) enzymes. Highlights of Chapter 2 include the 
identification of N171 and G207 in SSL-3 that control product specificity for 
botryococcene or squalene. This mutant was exploited in Chapter 3 to develop a 
yeast selection platform that led to the identification of additional substitutions in 
positions N171 and G207 of SSL-3 that affect product specificity. Follow up work 
should include kinetic assessments of the mutant enzymes described in Chapter 
2 and construction of SSL mutant enzyme libraries for screening with the 
selection platform described in Chapter 3 to identify SSL mutants converted to 
fully functional squalene synthases.   
A very stimulating observation inadvertently stumbled upon in Chapter 3 
was that under certain conditions, Botryococcus braunii squalene synthase 
(BbSS) could complement the squalene synthase knockout (erg9Δ) in 
Saccharomyces cerevisiae. Previous studies have suggested that non-fungal 
squalene synthases are unable to complement because they cannot associate 
with a metabolon involved in ergosterol formation.84–86 While this idea of 
metabolon formation is still very possible, an interesting notion to entertain is that 
the carboxy-terminal region of squalene synthase may be more heavily involved 
in sterol homeostasis than previously thought. As discussed in Chapter 3, the 
effects of BbSS and ScSS that were observed under the different conditions 
tested were suggestive of a ‘toxic effect’ when too much squalene was fluxed into 
the ergosterol biosynthetic pathway. In a recent review by Wriessnegger and 
Pichler (2013), the effects of altering membrane sterol profiles in S. cerevisiae 
were discussed in relation to proper membrane function.142 Several studies were 
pointed out that suggested perturbations to the sterol profile as a result of 
mutations in ergosterol biosynthetic machinery (erg6Δ and erg2Δ) caused 
negative consequences for membrane permeability, bilayer lipid packing, and 
osmotic stresses.143–145 These observations are intriguing to consider if it is the 
case that too much squalene fluxed into the ergosterol biosynthetic pathway 
perturbs sterol profiles, thus leading to sub-optimal membrane properties and 
ultimately death. 
Discussed in Chapter 4 is an effort to engineer triterpene metabolism in 
Chlamydomonas reinhardtii through traditional means of introducing biosynthetic 
enzymes. Mentioned in this chapter are the technological hurdles that need to be 
addressed before this alga and likely others become viable options for strain 
optimization as high-level production platforms for valuable renewable chemicals. 
Although not a solution for the transgene expression problem in C. reinhardtii, an 
approach developed for the production of novel terpenoids in S. cerevisiae89 
might be applicable in C. reinhardtii to provide a photosynthetic production 
platform for novel terpenes. While sterols themselves are not dispensable in S. 
cerevisiae, the biosynthetic pathway is because sterols can be supplied 
exogenously and taken up from the media. By eliminating the biosynthetic 
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pathway at the point of squalene synthase in S. cerevisiae, high levels of FPP 
can be accumulated which is available for conversion to terpenoids of interest. In 
C. reinhardtii, the main membrane sterol is also ergosterol146 making the yeast 
methodology for strain development an interesting angle to consider. While it 
would not be exactly applicable to the C. reinhardtii system, the overall principle 
is similar and could offer an alternative approach to achieve high levels of FPP in 
C. reinhardtii. If successful, this system might promote expression of terpene 
synthase transgenes in C. reinhardtii to favor homeostasis of prenyl 
diphosphates. Nevertheless, pathway independent routes to achieve high FPP 
levels in C. reinhardtii will inevitably involve nuclear transgene expression. 
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